Personensuche
Personensuche
Es wurde 1 Person gefunden.
Funktionen
-
Direktor, Klinik für Nuklearmedizin
Aktuelle Veranstaltungen
-
2024 WS
- Kurs: Bildgebende Verfahren, Strahlenbehandlung, Strahlenschutz - Teil 2
- Kursus für bildgebende Verfahren, Strahlenbehandlung, Strahlenschutz, Teil II (PV)
- Diagnostik, Therapie und Therapieplanung mit ionisierenden Strahlen für höhere Semester (mit Patientenvorstellung) (PV)
- begl. Vorlesung: Bildgebende Verfahren, Strahlenbehandlung, Strahlenschutz - Teil 1
- Kurs: Bildgebende Verfahren, Strahlenbehandlung, Strahlenschutz - Teil 1
- Ringvorlesung: Tumordiagnostik (mit Patientenvorstellung) (*)
- Kursus für bildgebende Verfahren, Strahlenbehandlung, Strahlenschutz Teil III (WA)
- begl. Vorlesung: Bildgebende Verfahren, Strahlenbehandlung, Strahlenschutz - Teil 2
- Anleitung zu selbständigen wissenschaftlichen Arbeiten in der Nuklearmedizin
- Systematische Befundung in der Nuklearmedizin
- Radiologische Klinik für klinischen Studienabschnitt: Diagnostische Radiologie
- Diagnostik, Therapie und Therapieplanung mit ionisierenden Strahlen (Nuklearmedizin und Strahlentherapie) für höhere Semester (mit Patientenvorstellung) (*)
- Multimodale Bildgebung (PET/CT, PET/MRT, SPECT/CT)
- Wahlfach: Einführung in die Nuklearmedizin
- PJ - Seminar
- Klinische Nuklearmedizin: Grundlagen und Indikationen
- Kurs: Bildgebende Verfahren, Strahlenbehandlung, Strahlenschutz - Teil 3
- Wahlfach: Klinische Nuklearmedizin
- Kursus für Bildgebende Verfahren, Strahlenbehandlung, Strahlenschutz, Teil III (PV)
- Kursus für Bildgebende Verfahren, Strahlenbehandlung, Strahlenschutz, Teil II (WA) begleitende Vorlesung zum Kurs
- Kursus für Bildgebende Verfahren, Strahlenbehandlung, Strahlenschutz, Teil I (PV)
- Der nuklearmedizinische Fall der Woche: Bildbeispiele, Indikationen und Grundlagen
- Kursus für Bildgebende Verfahren, Strahlenbehandlung, Strahlenschutz, Teil I (WA) (begleitende Vorlesung zum Kurs)
Vergangene Veranstaltungen (max. 10)
-
2024 SS
- Kursus für bildgebende Verfahren, Strahlenbehandlung, Strahlenschutz, Teil II (PV)
- Diagnostik, Therapie und Therapieplanung mit ionisierenden Strahlen für höhere Semester (mit Patientenvorstellung) (PV)
- begl. Vorlesung: Bildgebende Verfahren, Strahlenbehandlung, Strahlenschutz - Teil 1
- Diagnostik, Therapie und Therapieplanung mit ionisierenden Strahlen (Nuklearmedizin und Strahlentherapie) für höhere Semester (mit Patientenvorstellung) (*)
- Kurs: Bildgebende Verfahren, Strahlenbehandlung, Strahlenschutz - Teil 1
- Anleitung zu selbständigen wissenschaftlichen Arbeiten in der Nuklearmedizin
- Ringvorlesung: Tumordiagnostik (mit Patientenvorstellung) (*)
- Kurs: Bildgebende Verfahren, Strahlenbehandlung, Strahlenschutz - Teil 2
- begl. Vorlesung: Bildgebende Verfahren, Strahlenbehandlung, Strahlenschutz - Teil 2
- Systematische Befundung in der Nuklearmedizin
Die folgenden Publikationen sind in der Online-Universitätsbibliographie der Universität Duisburg-Essen verzeichnet. Weitere Informationen finden Sie gegebenenfalls auch auf den persönlichen Webseiten der Person.
-
68Ga-Fibroblast Activation Protein Inhibitor PET/CT Improves Detection of Intermediate and Low-Grade Sarcomas and Identifies Candidates for Radiopharmaceutical TherapyIn: Journal of Nuclear Medicine (JNM) Jg. 65 (2024) Nr. 6, S. 880 - 887Online Volltext: dx.doi.org/
-
Activity of Lutetium-177 Prostate-specific Membrane Antigen and Determinants of Outcomes in Patients with Metastatic Castration-resistant Prostate Cancer Previously Treated with Cabazitaxel: The PACAP StudyIn: European Urology Oncology Jg. 7 (2024) Nr. 5, S. 1132 - 1140Online Volltext: dx.doi.org/
-
Assessment of response to PRRT including anatomical and molecular imaging as well as novel biomarkersIn: Journal of Neuroendocrinology (2024) e13461 in pressOnline Volltext: dx.doi.org/ (Open Access)
-
Assessment of the therapeutic efficacy of [¹⁷⁷Lu]Lu-PSMA-X compared to taxane chemotherapy in taxane-chemo-naïve patients with metastatic castration-resistant prostate cancer : A systematic review and meta-analysisIn: European Journal of Nuclear Medicine and Molecular Imaging (2024) in pressOnline Volltext: dx.doi.org/
-
Association of Declining Prostate-specific Antigen Levels with Clinical Outcomes in Patients with Metastatic Castration-resistant Prostate Cancer Receiving [¹⁷⁷Lu]Lu-PSMA-617 in the Phase 3 VISION TrialIn: European Urology (2024) in pressOnline Volltext: dx.doi.org/ (Open Access)
-
Biodistribution and radiation dosimetry of ¹²⁴I-mIBG in adult patients with neural crest tumours and extrapolation to paediatric modelsIn: EJNMMI Physics Jg. 11 (2024) Nr. 1, 3Online Volltext: dx.doi.org/ (Open Access)
-
Changes in tumor-to-blood ratio as a prognostic marker for progression-free survival and overall survival in neuroendocrine tumor patients undergoing PRRTIn: European Journal of Nuclear Medicine and Molecular Imaging Jg. 51 (2024) Nr. 3, S. 841 - 851Online Volltext: dx.doi.org/ (Open Access)
-
Combining PSMA-PET and PROMISE to re-define disease stage and risk in patients with prostate cancer : A multicentre retrospective studyIn: The Lancet Oncology Jg. 25 (2024) Nr. 9, S. 1188 - 1201Online Volltext: dx.doi.org/ (Open Access)
-
Correlation analyses of radiographic progression-free survival with clinical and health-related quality of life outcomes in metastatic castration-resistant prostate cancer : Analysis of the phase 3 VISION trialIn: Cancer Jg. 130 (2024) Nr. 20, S. 3426 - 3435Online Volltext: dx.doi.org/ (Open Access)
-
Cost-Effectiveness and Budget Impact Analyses of Selective Internal Radiation Therapy versus Atezolizumab Plus Bevacizumab from a German Statutory Health Insurance PerspectiveIn: ClinicoEconomics and Outcomes Research Jg. 16 (2024) S. 483 - 492Online Volltext: dx.doi.org/ (Open Access)
-
Cranioencephalic functional lymphoid units in glioblastomaIn: Nature Medicine (2024) in pressOnline Volltext: dx.doi.org/ (Open Access)
-
Delayed ⁶⁸Ga-FAPI-46 PET/MR imaging confirms ongoing fibroblast activation in patients after acute myocardial infarctionIn: International Journal of Cardiology (IJC) Heart & Vasculature Jg. 50 (2024) 101340Online Volltext: dx.doi.org/ (Open Access)
-
Delphi consensus project on prostate-specific membrane antigen (PSMA)-targeted surgery : Outcomes from an international multidisciplinary panelIn: European Journal of Nuclear Medicine and Molecular Imaging Jg. 51 (2024) Nr. 10, S. 2893 - 2902Online Volltext: dx.doi.org/
-
Design Considerations in the PSMAfore TrialIn: Journal of Nuclear Medicine (JNM) Jg. 65 (2024) Nr. 2, S. 226 - 227Online Volltext: dx.doi.org/ (Open Access)
-
Detection and quantification of small and low-uptake lesions for differentiated thyroid carcinoma using non-time-of-flight iodine-124 PET/MRIIn: Medical Physics (2024) in pressOnline Volltext: dx.doi.org/ (Open Access)
-
Detection of tumour heterogeneity in patients with advanced, metastatic castration-resistant prostate cancer on [⁶⁸Ga]Ga-/[¹⁸F]F-PSMA-11/-1007, [⁶⁸Ga]Ga-FAPI-46 and 2-[¹⁸F]FDG PET/CT : a pilot studyIn: European Journal of Nuclear Medicine and Molecular Imaging (2024) in pressOnline Volltext: dx.doi.org/ (Open Access)
-
Determining the cut-off value for the Minimal Documentation System (MIDOS2) screening tool to initiate specialized palliative care based on patient’s subjective need for palliative support and symptom burden in inpatients with advanced cancerIn: Journal of Cancer Research and Clinical Oncology Jg. 150 (2024) Nr. 7, 360Online Volltext: dx.doi.org/ (Open Access)
-
Diagnostic Accuracy of [¹⁸F]FDG PET/MRI in Head and Neck Squamous Cell Carcinoma : A Systematic Review and MetaanalysisIn: Journal of Nuclear Medicine (JNM) Jg. 65 (2024) Nr. 10, S. 1533 - 1539Online Volltext: dx.doi.org/
-
Diagnostic Accuracy of ⁶⁸Ga-FAPI Versus ¹⁸F-FDG PET in Patients with Various MalignanciesIn: Journal of Nuclear Medicine (JNM) Jg. 65 (2024) Nr. 3, S. 372 - 378Online Volltext: dx.doi.org/ (Open Access)
-
Diagnostic accuracy of Afirma gene expression classifier, Afirma gene sequencing classifier, ThyroSeq v2 and ThyroSeq v3 for indeterminate (Bethesda III and IV) thyroid nodules : A meta-analysisIn: Endocrine Connections Jg. 13 (2024) Nr. 7, e240170Online Volltext: dx.doi.org/ (Open Access)
-
Differences and Common Ground in ¹⁷⁷Lu-PSMA Radioligand Therapy Practice Patterns : International Survey of 95 Theranostic CentersIn: Journal of Nuclear Medicine (JNM) Jg. 65 (2024) Nr. 3, S. 438 - 445Online Volltext: dx.doi.org/ (Open Access)
-
Dose-Response Relationship in Patients with Liver Metastases from Neuroendocrine Neoplasms Undergoing Radioembolization with ⁹⁰Y Glass MicrospheresIn: Journal of Nuclear Medicine (JNM) Jg. 65 (2024) Nr. 8, S. 1175 - 1180Online Volltext: dx.doi.org/
-
EANM expert opinion: How can lessons from radiobiology be applied to the design of clinical trials? : Part I: back to the basics of absorbed dose–response and threshold absorbed dosesIn: European Journal of Nuclear Medicine and Molecular Imaging (2024) in pressOnline Volltext: dx.doi.org/ (Open Access)
-
EANM guidance document: dosimetry for first-in-human studies and early phase clinical trialsIn: European Journal of Nuclear Medicine and Molecular Imaging Jg. 51 (2024) Nr. 7, S. 1909 - 1922Online Volltext: dx.doi.org/ (Open Access)
-
Early Metabolic Response by PET Predicts Sensitivity to Next-Line Targeted Therapy in EGFR-Mutated Lung Cancer with Unknown Mechanism of Acquired ResistanceIn: Journal of Nuclear Medicine (JNM) Jg. 65 (2024) Nr. 6, S. 851 - 855Online Volltext: dx.doi.org/
-
Establishing Medical Intelligence - Leveraging Fast Healthcare Interoperability Resources to Improve Clinical Management : Retrospective Cohort and Clinical Implementation StudyIn: Journal of Medical Internet Research (JMIR) Jg. 26 (2024) e55148Online Volltext: dx.doi.org/ (Open Access)
-
European Association of Nuclear Medicine Focus 5 : Consensus on Molecular Imaging and Theranostics in Prostate CancerIn: European Urology Jg. 85 (2024) Nr. 1, S. 49 - 60Online Volltext: dx.doi.org/ (Open Access)
-
FAPI PET Imaging Supports Clinical Decision Making in Academic Cardiology Practice : A Pictorial Imaging VignetteIn: JACC Cardiovascular Imaging Jg. 17 (2024) Nr. 7, S. 811 - 823Online Volltext: dx.doi.org/ (Open Access)
-
Fibroblast Activation Protein α-Directed Imaging and Therapy of Solitary Fibrous TumorIn: Journal of Nuclear Medicine (JNM) Jg. 65 (2024) Nr. 2, S. 252 - 257Online Volltext: dx.doi.org/ (Open Access)
-
Fibroblast Activation Protein-Directed Imaging Outperforms ¹⁸F-FDG PET/CT in Malignant Mesothelioma : A Prospective, Single-Center, Observational TrialIn: Journal of Nuclear Medicine (JNM) Jg. 65 (2024) Nr. 8, S. 1188 - 1193Online Volltext: dx.doi.org/
-
Future Perspectives of Artificial Intelligence in Bone Marrow Dosimetry and Individualized Radioligand TherapyIn: Seminars in Nuclear Medicine Jg. 54 (2024) Nr. 4, S. 460 - 469Online Volltext: dx.doi.org/ (Open Access)
-
Head-to-head comparison of ⁶⁸ Ga-FAPI-46 PET/CT, ¹⁸F-FDG PET/CT, and contrast-enhanced CT for the detection of various tumorsIn: Annals of Nuclear Medicine (2024) in pressOnline Volltext: dx.doi.org/
-
Hypercalcemia as a rare manifestation of immune reconstitution inflammatory syndrome (IRIS) in a person living with Human Immunodeficiency Virus (HIV) with disseminated nontuberculous mycobacteriosisIn: Infection - A Journal of Infectious Disease Jg. 52 (2024) Nr. 4, S. 1627 - 1631Online Volltext: dx.doi.org/ (Open Access)
-
Imaging of Cardiac Fibrosis : How Far Have We Moved From Extracellular to Cellular?In: Seminars in Nuclear Medicine (2024) in pressOnline Volltext: dx.doi.org/ (Open Access)
-
Joint EANM/EANO/RANO/SNMMI practice guideline/procedure standards for diagnostics and therapy (theranostics) of meningiomas using radiolabeled somatostatin receptor ligands : Version 1.0In: European Journal of Nuclear Medicine and Molecular Imaging Jg. 51 (2024) Nr. 12, S. 3662 - 3679Online Volltext: dx.doi.org/ (Open Access)
-
Kick-Starting Molecular Theranostics in Renal Cell CarcinomaIn: Journal of Nuclear Medicine (JNM) Jg. 65 (2024) Nr. 5, S. 744 - 745Online Volltext: dx.doi.org/ (Open Access)
-
Long-Term Survival in Patients with Oligometastatic Non-Small Cell Lung Cancer by a Multimodality Treatment : Comparison with Stage III DiseaseIn: Cancers Jg. 16 (2024) Nr. 6, 1174Online Volltext: dx.doi.org/ (Open Access)
-
Management of Patients with Advanced Prostate Cancer : Report from the 2024 Advanced Prostate Cancer Consensus Conference (APCCC)In: European Urology (2024) in pressOnline Volltext: dx.doi.org/ (Open Access)
-
Multicenter development of a PET-based risk assessment tool for product-specific outcome prediction in large B-cell lymphoma patients undergoing CAR T-cell therapyIn: European Journal of Nuclear Medicine and Molecular Imaging Jg. 51 (2024) Nr. 5, S. 1361 - 1370Online Volltext: dx.doi.org/ (Open Access)
-
Multivariable models of outcomes with [¹⁷⁷Lu]Lu-PSMA-617 : analysis of the phase 3 VISION trialIn: eClinicalMedicine Jg. 77 (2024) 102862Online Volltext: dx.doi.org/ (Open Access)
-
Near-infrared fluorescence lymph node template region dissection plus backup lymphadenectomy in open radical cystectomy for bladder cancer using an innovative handheld device : A single center experienceIn: Journal of Surgical Oncology Jg. 129 (2024) Nr. 7, S. 1325 - 1331Online Volltext: dx.doi.org/ (Open Access)
-
Novel Radiopharmaceuticals and Future of Theranostics in Genitourinary CancersIn: European Urology (2024) in pressOnline Volltext: dx.doi.org/
-
PET quantification performance of the oversize-volume-of-interest approach in the context of tumour dosimetry in radionuclide therapy planningIn: Physics in Medicine and Biology Jg. 69 (2024) Nr. 16, 165007Online Volltext: dx.doi.org/ (Open Access)
-
PSMA Radioligand Therapy in Prostate Cancer Where Are We and Where Are We Heading?In: Clinical Nuclear Medicine Jg. 49 (2024) Nr. 1, S. 45 - 55Online Volltext: dx.doi.org/
-
PSMA-PET follow-up to assess response in patients not receiving PSMA therapy : Is there value beyond localization of disease?In: Theranostics Jg. 14 (2024) Nr. 9, S. 3623 - 3633Online Volltext: dx.doi.org/ (Open Access)
-
Prediction of therapy response of breast cancer patients with machine learning based on clinical data and imaging data derived from breast [¹⁸F]FDG-PET/MRIIn: European Journal of Nuclear Medicine and Molecular Imaging Jg. 51 (2024) Nr. 5, S. 1451 - 1461Online Volltext: dx.doi.org/ (Open Access)
-
Prognostic Implications of ⁶⁸Ga-FAPI-46 PET/CT-Derived Parameters on Overall Survival in Various Types of Solid TumorsIn: Journal of Nuclear Medicine (JNM) Jg. 65 (2024) Nr. 7, S. 1027 - 1034Online Volltext: dx.doi.org/
-
Prostate-specific Membrane Antigen Positron Emission Tomography–detected Disease Extent and Overall Survival of Patients with High-risk Nonmetastatic Castration-resistant Prostate Cancer : An International Multicenter Retrospective StudyIn: European Urology Jg. 85 (2024) Nr. 6, S. 511 - 516Online Volltext: dx.doi.org/ (Open Access)
-
Quantitative ⁶⁸Ga-PSMA-11 PET and Clinical Outcomes in Metastatic Castration-resistant Prostate Cancer Following ¹⁷⁷Lu-PSMA-617 (VISION Trial)In: Radiology Jg. 312 (2024) Nr. 2, e233460Online Volltext: dx.doi.org/
-
RECIP 1.0 Predicts Progression-Free Survival After [¹⁷⁷Lu]Lu-PSMA Radiopharmaceutical Therapy in Patients with Metastatic Castration-Resistant Prostate CancerIn: Journal of Nuclear Medicine (JNM) Jg. 65 (2024) Nr. 6, S. 917 - 922Online Volltext: dx.doi.org/
-
Radiotheranostics Global Market and Future DevelopmentsIn: Seminars in Nuclear Medicine Jg. 54 (2024) Nr. 4, S. 622 - 633Online Volltext: dx.doi.org/
-
Randomized Trial of Prostate-Specific Membrane Antigen PET/CT Before Definitive Radiotherapy for Unfavorable Intermediate- and High-Risk Prostate Cancer (PSMA-dRT Trial)In: Journal of Nuclear Medicine (JNM) Jg. 65 (2024) Nr. 7, S. 1076 - 1079Online Volltext: dx.doi.org/
-
Recurrent prostate cancer : combined role for MRI and PSMA-PET in ⁶⁸Ga-PSMA-11 PET/MRIIn: European Radiology Jg. 34 (2024) Nr. 7, S. 4789 - 4800Online Volltext: dx.doi.org/ (Open Access)
-
Renal and Multiorgan Safety of ¹⁷⁷Lu-PSMA-617 in Patients with Metastatic Castration-Resistant Prostate Cancer in the VISION Dosimetry SubstudyIn: Journal of Nuclear Medicine (JNM) Jg. 65 (2024) Nr. 1, S. 71 - 78Online Volltext: dx.doi.org/ (Open Access)
-
Risk and Incidence of Endocrine Immune-Related Adverse Effects under Checkpoint Inhibitor Mono- or Combination Therapy in Solid Tumors : A Meta-Analysis of Randomized Controlled TrialsIn: The Journal of Clinical Endocrinology & Metabolism (JCEM) Jg. 109 (2024) Nr. 4, S. 1132 - 1144Online Volltext: dx.doi.org/
-
Safety Analyses of the Phase 3 VISION Trial of [¹⁷⁷Lu]Lu-PSMA-617 in Patients with Metastatic Castration-resistant Prostate CancerIn: European Urology Jg. 85 (2024) Nr. 4, S. 382 - 391Online Volltext: dx.doi.org/ (Open Access)
-
Safety and Efficacy of Extended Therapy with [¹⁷⁷Lu]Lu-PSMA : A German Multicenter StudyIn: Journal of Nuclear Medicine (JNM) Jg. 65 (2024) Nr. 6, S. 909 - 916Online Volltext: dx.doi.org/
-
Safety and Efficacy of Para-Aminohippurate Coinfusion for Renal Protection During Peptide Receptor Radiotherapy in Patients with Neuroendocrine TumorsIn: Journal of Nuclear Medicine (JNM) Jg. 65 (2024) Nr. 6, S. 931 - 937Online Volltext: dx.doi.org/
-
Screening for Occult Transthyretin Amyloidosis in Patients with Severe Aortic Stenosis and Amyloid Red FlagsIn: Journal of Clinical Medicine (JCM) Jg. 13 (2024) Nr. 3, 671Online Volltext: dx.doi.org/ (Open Access)
-
Stellenwert der Peptid-Radio-Rezeptor-Therapie für das Management neuroendokriner TumorenIn: Die Onkologie (2024) in pressOnline Volltext: dx.doi.org/
-
The Incidence of Distant Metastases in Patients with Pleural Mesothelioma Screened for a Multimodal Approach : How Much Staging Do We Really Need?In: Cancers Jg. 16 (2024) Nr. 10, 1917Online Volltext: dx.doi.org/ Online Volltext (Open Access)
-
The Role of Fibroblast Activation Protein in Glioblastoma and Gliosarcoma : A Comparison of Tissue, ⁶⁸Ga-FAPI-46 PET Data, and Survival DataIn: Journal of Nuclear Medicine (JNM) Jg. 65 (2024) Nr. 8, S. 1217 - 1223Online Volltext: dx.doi.org/
-
Theranostics in Neurooncology : Heading Toward New HorizonsIn: Journal of Nuclear Medicine (JNM) Jg. 65 (2024) Nr. 2, S. 167 - 173Online Volltext: dx.doi.org/ (Open Access)
-
Theranostics with somatostatin receptor antagonists in SCLC : Correlation of 68Ga-SSO120 PET with immunohistochemistry and survivalIn: Theranostics Jg. 14 (2024) Nr. 14, S. 5400 - 5412Online Volltext: dx.doi.org/ (Open Access)
-
Utility of pre-procedural [⁹⁹mTc]TcMAA SPECT/CT Multicompartment Dosimetry for Treatment Planning of ⁹⁰Y Glass microspheres in patients with Hepatocellular Carcinoma : Comparison of anatomic versus [⁹⁹mTc]TcMAA-based SegmentationIn: European Journal of Nuclear Medicine and Molecular Imaging (2024) in pressOnline Volltext: dx.doi.org/ (Open Access)
-
[¹⁷⁷Lu]Lu-DOTA-TATE plus long-acting octreotide versus high‑dose long-acting octreotide for the treatment of newly diagnosed, advanced grade 2–3, well-differentiated, gastroenteropancreatic neuroendocrine tumours (NETTER-2) : an open-label, randomised, phase 3 studyIn: Lancet Jg. 403 (2024) Nr. 10446, S. 2807 - 2817Online Volltext: dx.doi.org/
-
[⁶⁸Ga]Ga-FAPI versus 2-[¹⁸F]FDG PET/CT in patients with autoimmune thyroiditis : A case control studyIn: EJNMMI Research Jg. 14 (2024) Nr. 1, 66Online Volltext: dx.doi.org/ (Open Access)
-
¹⁷⁷Lu]Lu-DOTATATE May Resensitize Neuroendocrine Tumors to Hormonal Therapy : Initial Clinical Experience in Renal CarcinoidIn: Journal of Nuclear Medicine (JNM) Jg. 65 (2024) Nr. 9, 1494Online Volltext: dx.doi.org/
-
18F-PSMA Cerenkov Luminescence and Flexible Autoradiography Imaging in a Prostate Cancer Mouse Model and First Results of a Radical Prostatectomy Feasibility Study in MenIn: Journal of Nuclear Medicine (JNM) Jg. 64 (2023) Nr. 4, S. 598 - 604Online Volltext: dx.doi.org/ (Open Access)
-
68Ga-FAPI PET/CT Interobserver Agreement on Tumor Assessment : An International Multicenter Prospective StudyIn: Journal of Nuclear Medicine (JNM) Jg. 64 (2023) Nr. 7, S. 1043 - 1048Online Volltext: dx.doi.org/ (Open Access)
-
68Ga-Labeled Fibroblast Activation Protein Inhibitor (⁶⁸Ga-FAPI) PET for Pancreatic Adenocarcinoma : Data from the ⁶⁸Ga-FAPI PET Observational TrialIn: Journal of Nuclear Medicine (JNM) Jg. 64 (2023) Nr. 12, S. 1910 - 1917Online Volltext: dx.doi.org/ (Open Access)
-
68Ga-SSO-120 PET for Initial Staging of Small Cell Lung Cancer Patients : A Single-Center Retrospective StudyIn: Journal of Nuclear Medicine (JNM) Jg. 64 (2023) Nr. 10, S. 1540 - 1549Online Volltext: dx.doi.org/ (Open Access)
-
A Retrospective Multicenter Analysis of the Incidence of Bone-Only Disease at PSMA PET/CT in Castration Resistant Prostate Cancer PatientsIn: Cancers Jg. 15 (2023) Nr. 8, 2208Online Volltext: dx.doi.org/ (Open Access)
-
Accuracy of nodal staging by 18F-FDG-PET/CT in limited disease small-cell lung cancerIn: Asian Cardiovascular and Thoracic Annals Jg. 31 (2023) Nr. 6, S. 506 - 511Online Volltext: dx.doi.org/ (Open Access)
-
Advancing Clinical Trial Innovation in Pancreatic Cancer : A Conversation Between Diane Simeone, Ken Herrmann, and Johannes CzerninIn: Journal of Nuclear Medicine (JNM) Jg. 64 (2023) Nr. 2, S. 185 - 187Online Volltext: dx.doi.org/ (Open Access)
-
Analysing the tumor transcriptome of prostate cancer to predict efficacy of Lu-PSMA therapyIn: Journal for ImmunoTherapy of Cancer Jg. 11 (2023) Nr. 10, e007354Online Volltext: dx.doi.org/ (Open Access)
-
Are We Approaching a Change in Paradigm in PET/CT Imaging of Solid Gastrointestinal (or Digestive) Tract Tumors with the Clinical Application of FAPI Imaging?In: Clinical Nuclear Medicine Jg. 48 (2023) Nr. 4, S. 318 - 319Online Volltext: dx.doi.org/
-
Bilobar Radioembolization Carries the Risk of Radioembolization-Induced Liver Disease in the Treatment of Advanced Hepatocellular Carcinoma : Safety and Efficacy Comparison to Systemic Therapy with Atezolizumab/BevacizumabIn: Cancers Jg. 15 (2023) Nr. 17, 4274Online Volltext: dx.doi.org/ (Open Access)
-
Bone Metastases in Patients with Pancreatic NETs : Prevalence and PrognosisIn: Hormone and Metabolic Research Jg. 28 (2023) Nr. 4,Online Volltext: dx.doi.org/
-
Clinical Decision Support for Axillary Lymph Node Staging in Newly Diagnosed Breast Cancer Patients Based on ¹⁸F-FDG PET/MRI and Machine LearningIn: Journal of Nuclear Medicine (JNM) Jg. 64 (2023) Nr. 2, S. 304 - 311Online Volltext: dx.doi.org/ (Open Access)
-
Clinical Translation of Targeted α-Therapy: An Evolution or a Revolution?In: Journal of Nuclear Medicine (JNM) Jg. 64 (2023) Nr. 5, S. 685 - 692Online Volltext: dx.doi.org/ (Open Access)
-
Conventional Imaging, MRI and ¹⁸F-FDG PET/MRI for N and M Staging in Patients with Newly Diagnosed Breast CancerIn: Cancers Jg. 15 (2023) Nr. 14, 3646Online Volltext: dx.doi.org/ (Open Access)
-
Corneal confocal microscopy identifies corneal nerve loss and increased Langerhans cells in presymptomatic carriers and patients with hereditary transthyretin amyloidosisIn: Journal of Neurology Jg. 270 (2023) Nr. 7, S. 3483 - 3491Online Volltext: dx.doi.org/ (Open Access)
-
Correction to: EANM enabling guide: how to improve the accessibility of clinical dosimetryIn: European Journal of Nuclear Medicine and Molecular Imaging Jg. 50 (2023) Nr. 10, S. 3157 - 3158Online Volltext: dx.doi.org/ (Open Access)
-
Correction to: European Association of Nuclear Medicine (EANM) response to the proposed ASTRO’s framework for radiopharmaceutical therapy curriculum development for traineesIn: European Journal of Nuclear Medicine and Molecular Imaging Jg. 50 (2023) Nr. 2, S. 630 - 630Online Volltext: dx.doi.org/ (Open Access)
-
Correction to: Nuclear medicine in the assessment and prevention of cancer therapy‑related cardiotoxicity : prospects and proposal of use by the European Association of Nuclear Medicine (EANM) (European Journal of Nuclear Medicine and Molecular Imaging, (2023), 50, 3, (792-812), 10.1007/s00259-022-05991-7)In: European Journal of Nuclear Medicine and Molecular Imaging Jg. 50 (2023) Nr. 3, S. 970Online Volltext: dx.doi.org/ (Open Access)
-
Correction: Fully Automated, High-Dose Radiosynthesis of [18F]PARPiIn: Pharmaceuticals Jg. 16 (2023) Nr. 7, 1024Online Volltext: dx.doi.org/ (Open Access)
-
Correlation between Imaging Markers Derived from PET/MRI and Invasive Acquired Biomarkers in Newly Diagnosed Breast CancerIn: Cancers Jg. 15 (2023) Nr. 6, 1651Online Volltext: dx.doi.org/ (Open Access)
-
DGN-Handlungsempfehlung (S1-Leitlinie) : PSMA-Liganden-PET/CT in der Diagnostik des Prostatakarzinoms - Stand: 01/2022 - AWMF-Registernummer: 031-055In: Nuklearmedizin = Nuclear Medicine Jg. 62 (2023) Nr. 1, S. 5 - 19Online Volltext: dx.doi.org/
-
DOTATOC PET/CT imaging of a typical carcinoid tumor in a human ex-vivo perfused lung lobeIn: Quantitative Imaging in Medicine and Surgery Jg. 13 (2023) Nr. 7, S. 4716 - 4722Online Volltext: dx.doi.org/ Online Volltext (Open Access)
-
Demonstration of the Early Cardiac Bioavailability of a Non-Specific Cell-Targeted Peptide Using Radionuclide-Based Imaging In VivoIn: Pharmaceuticals Jg. 16 (2023) Nr. 6, 824Online Volltext: dx.doi.org/ Online Volltext (Open Access)
-
Designing clinical trials based on modern imaging and metastasis-directed treatments in patients with oligometastatic breast cancer : a consensus recommendation from the EORTC Imaging and Breast Cancer GroupsIn: The Lancet Oncology Jg. 24 (2023) Nr. 8, S. e331 - e343Online Volltext: dx.doi.org/
-
Developing a Patient-Reported Outcome Measure for Radionuclide Therapy for Prostate CancerIn: Journal of Nuclear Medicine (JNM) Jg. 64 (2023) Nr. 6, S. 869 - 872Online Volltext: dx.doi.org/ (Open Access)
-
Direct comparison and reproducibility of two segmentation methods for multicompartment dosimetry : Round robin study on radioembolization treatment planning in hepatocellular carcinomaIn: European Journal of Nuclear Medicine and Molecular Imaging Jg. 51 (2023) Nr. 1, S. 245 - 257Online Volltext: dx.doi.org/ (Open Access)
-
EANM enabling guide : How to improve the accessibility of clinical dosimetryIn: European Journal of Nuclear Medicine and Molecular Imaging Jg. 50 (2023) Nr. 7, S. 1861 - 1868Online Volltext: dx.doi.org/
-
EANM practice guideline for quantitative SPECT-CTIn: European Journal of Nuclear Medicine and Molecular Imaging Jg. 50 (2023) Nr. 4, S. 980 - 995Online Volltext: dx.doi.org/ (Open Access)
-
Efficacy and Safety of¹²⁴I-MIBG Dosimetry-Guided High-Activity¹³¹I-MIBG Therapy of Advanced Pheochromocytoma or NeuroblastomaIn: Journal of Nuclear Medicine (JNM) Jg. 64 (2023) Nr. 6, S. 885 - 891Online Volltext: dx.doi.org/ (Open Access)
-
European Association of Nuclear Medicine (EANM) Focus 4 consensus recommendations : molecular imaging and therapy in haematological tumoursIn: The Lancet Haematology Jg. 10 (2023) Nr. 5, S. e367 - e381Online Volltext: dx.doi.org/
-
Evaluation of [⁶⁸Ga]-DOTATOC PET/MRI in Patients with Meningioma of the Subcranial and Intraorbital SpaceIn: Journal of Nuclear Medicine (JNM) Jg. 64 (2023) Nr. 8, S. 1185 - 1190Online Volltext: dx.doi.org/ (Open Access)
-
Evaluation of thresholding methods for the quantification of [⁶⁸Ga]Ga-PSMA-11 PET molecular tumor volume and their effect on survival prediction in patients with advanced prostate cancer undergoing [¹⁷⁷Lu]Lu-PSMA-617 radioligand therapyIn: European Journal of Nuclear Medicine and Molecular Imaging Jg. 50 (2023) Nr. 7, S. 2196 - 2209Online Volltext: dx.doi.org/ (Open Access)
-
Feasibility and tolerability of trofosfamide and etoposide in progressive glioblastomaIn: Neuro-Oncology Advances Jg. 5 (2023) Nr. 1, vdad090Online Volltext: dx.doi.org/ Online Volltext (Open Access)
-
Fibroblast Activation Protein Inhibitor Theranostics : The Case for Use in SarcomaIn: PET Clinics Jg. 18 (2023) Nr. 3, S. 361 - 367Online Volltext: dx.doi.org/
-
Fibroblast-Activation Protein PET and Histopathology in a Single-Center Database of 324 Patients and 21 Tumor EntitiesIn: Journal of Nuclear Medicine (JNM) Jg. 64 (2023) Nr. 5, S. 711 - 716Online Volltext: dx.doi.org/ (Open Access)
-
Gallium-68-labeled fibroblast activation protein inhibitor-46 PET in patients with resectable or borderline resectable pancreatic ductal adenocarcinoma : A phase 2, multicenter, single arm, open label non-randomized study protocolIn: PLoS ONE Jg. 18 (2023) Nr. 11, e0294564Online Volltext: dx.doi.org/ (Open Access)
-
Health-related quality of life and pain outcomes with [¹⁷⁷Lu]Lu-PSMA-617 plus standard of care versus standard of care in patients with metastatic castration-resistant prostate cancer (VISION) : a multicentre, open-label, randomised, phase 3 trialIn: The Lancet Oncology Jg. 24 (2023) Nr. 6, S. 597 - 610Online Volltext: dx.doi.org/
-
In Patients Treated by Selective Internal Radiotherapy, Cellular In Vitro Immune Function Is Predictive of SurvivalIn: Cancers Jg. 15 (2023) Nr. 16, 4055Online Volltext: dx.doi.org/ (Open Access)
-
Incidental Detection of a Tenosynovial Giant Cell Tumor of the Thigh on [⁶⁸Ga]Ga-FAPI PET/CT : Presentation of an Unusual CaseIn: Journal of Nuclear Medicine (JNM) Jg. 64 (2023) Nr. 7, S. 1162 - 1163Online Volltext: dx.doi.org/
-
International EANM-SNMMI-ISMRM consensus recommendation for PET/MRI in oncologyIn: European Journal of Nuclear Medicine and Molecular Imaging Jg. 50 (2023) Nr. 12, S. 3513 - 3537Online Volltext: dx.doi.org/ (Open Access)
-
Intraoperative Molecular Positron Emission Tomography Imaging for Intraoperative Assessment of Radical Prostatectomy SpecimensIn: European Urology Open Science Jg. 54 (2023) S. 28 - 32Online Volltext: dx.doi.org/ (Open Access)
-
Is ¹⁸F-FDG PET Needed to Assess ¹⁷⁷Lu-PSMA Therapy Eligibility? : A VISION-like, Single-Center AnalysisIn: Journal of Nuclear Medicine (JNM) Jg. 64 (2023) Nr. 5, S. 731 - 737Online Volltext: dx.doi.org/ (Open Access)
-
Joint EANM/SNMMI procedure guideline for the use of ¹⁷⁷Lu-labeled PSMA-targeted radioligand-therapy (¹⁷⁷Lu-PSMA-RLT)In: European Journal of Nuclear Medicine and Molecular Imaging Jg. 50 (2023) Nr. 9, S. 2830 - 2845Online Volltext: dx.doi.org/ (Open Access)
-
Lesion Quantification Accuracy of Digital 90Y PET Imaging in the Context of Dosimetry in Systemic FAPI Radionuclide TherapyIn: Journal of Nuclear Medicine (JNM) Jg. 64 (2023) Nr. 2, S. 329 - 336Online Volltext: dx.doi.org/ (Open Access)
-
Location of Recurrences after Trimodality Treatment for Glioblastoma with Respect to the Delivered Radiation Dose Distribution and Its Influence on PrognosisIn: Cancers Jg. 15 (2023) Nr. 11, 2982Online Volltext: dx.doi.org/ (Open Access)
-
Management of Patients with Advanced Prostate Cancer : Part I: Intermediate-/High-risk and Locally Advanced Disease, Biochemical Relapse, and Side Effects of Hormonal Treatment: Report of the Advanced Prostate Cancer Consensus Conference 2022In: European Urology Jg. 83 (2023) Nr. 3, S. 267 - 293Online Volltext: dx.doi.org/ (Open Access)
-
Management of patients with advanced prostate cancer—metastatic and/or castration-resistant prostate cancer : report of the Advanced Prostate Cancer Consensus Conference (APCCC) 2022In: European Journal of Cancer (EJC) Jg. 185 (2023) S. 178 - 215Online Volltext: dx.doi.org/
-
Metastatic Prostate Cancer : A Review of Current Treatment Options and Promising New ApproachesIn: Cancers Jg. 15 (2023) Nr. 2, 461Online Volltext: dx.doi.org/ Online Volltext (Open Access)
-
Molecular Imaging Biomarkers in Cardiooncology : A View on Established Technologies and Future PerspectivesIn: Journal of Nuclear Medicine (JNM) Jg. 64 (2023) Nr. Suppl. 2, S. 29S - 38SOnline Volltext: dx.doi.org/ (Open Access)
-
Molecular Imaging of Lymphoma : Future Directions and PerspectivesIn: Seminars in Nuclear Medicine Jg. 53 (2023) Nr. 3, S. 449 - 456Online Volltext: dx.doi.org/
-
Molecular Markers Are Associated with Onset of Radioiodine Refractoriness in Patients with Papillary Thyroid CarcinomaIn: Journal of Nuclear Medicine (JNM) Jg. 64 (2023) Nr. 12, S. 1865 - 1868Online Volltext: dx.doi.org/ (Open Access)
-
Next generation radiotheranostics promoting precision medicineIn: Annals of Oncology Jg. 34 (2023) Nr. 6, S. 507 - 519Online Volltext: dx.doi.org/
-
Novel ⁶⁸Ga-FAPI PET/CT Offers Oncologic Staging Without COVID-19 Vaccine-Related PitfallsIn: Journal of Nuclear Medicine (JNM) Jg. 64 (2023) Nr. 3, S. 368 - 371Online Volltext: dx.doi.org/ (Open Access)
-
Oncologic Staging with ⁶⁸Ga-FAPI PET/CT Demonstrates a Lower Rate of Nonspecific Lymph Node Findings Than ¹⁸F-FDG PET/CTIn: Journal of Nuclear Medicine (JNM) Jg. 64 (2023) Nr. 12, S. 1906 - 1909Online Volltext: dx.doi.org/ (Open Access)
-
One Third of Malignant Pleural Mesothelioma Shows High Immunohistochemical Expression of MSLN or CXCR4 Which Indicates Potent Candidates for Endo-RadiotherapyIn: International Journal of Molecular Sciences (IJMS) Jg. 24 (2023) Nr. 7, S. 6356Online Volltext: dx.doi.org/ (Open Access)
-
Outcome Prediction in Patients With Large B-cell Lymphoma Undergoing Chimeric Antigen Receptor T-cell TherapyIn: HemaSphere: Open Access Journal of the European Hematology Association Jg. 7 (2023) Nr. 1, S. E817Online Volltext: dx.doi.org/ (Open Access)
-
PSMA PET/CT : Joint EANM procedure guideline/SNMMI procedure standard for prostate cancer imaging 2.0In: European Journal of Nuclear Medicine and Molecular Imaging Jg. 50 (2023) Nr. 5, S. 1466 - 1486Online Volltext: dx.doi.org/ (Open Access)
-
PSMA-Directed Imaging and Therapy of Salivary Gland Tumors : A Single-Center Retrospective StudyIn: Journal of Nuclear Medicine (JNM) Jg. 64 (2023) Nr. 3, S. 372 - 378Online Volltext: dx.doi.org/ (Open Access)
-
Pain Outcomes in Patients with Metastatic Castration-Resistant Prostate Cancer Treated with ²²³Ra : PARABO, a Prospective, Noninterventional StudyIn: Journal of Nuclear Medicine (JNM) Jg. 64 (2023) Nr. 9, S. 1392 - 1398Online Volltext: dx.doi.org/ (Open Access)
-
Personalized Treatment for Patients With Lung CancerIn: Deutsches Ärzteblatt international Jg. 120 (2023) Nr. 17, S. 300 - 310Online Volltext: dx.doi.org/ (Open Access)
-
Precision neuro-oncology : A pilot analysis of personalized treatment in recurrent gliomaIn: Journal of Cancer Research and Clinical Oncology Jg. 149 (2023) Nr. 7, S. 3513 - 3526Online Volltext: dx.doi.org/ (Open Access)
-
Predictive value of highly sensitive basal versus stimulated thyroglobulin measurement in long-term follow-up of thyroid cancerIn: Endocrine Connections Jg. 12 (2023) Nr. 2, e220312Online Volltext: dx.doi.org/ Online Volltext (Open Access)
-
Preoperative PET-SUVmax and volume based PET parameters of the primary tumor fail to predict nodal upstaging in early-stage lung cancerIn: Lung Cancer Jg. 176 (2023) S. 82 - 88Online Volltext: dx.doi.org/
-
Presurgical ⁶⁸Ga-PSMA-11 Positron Emission Tomography for Biochemical Recurrence Risk Assessment : A Follow-up Analysis of a Multicenter Prospective Phase 3 Imaging TrialIn: European Urology Jg. 84 (2023) Nr. 6, S. 588 - 596Online Volltext: dx.doi.org/
-
Prognostic role of early prostate specific antigen changes after [¹⁷⁷Lu]Lu-PSMA radioligand therapy of metastasized prostate cancer : A meta-analysisIn: European Journal of Clinical Investigation Jg. 53 (2023) Nr. 9, e14014Online Volltext: dx.doi.org/ (Open Access)
-
Prostate-specific Membrane Antigen Positron Emission Tomography as a Biomarker to Assess Treatment Response in Patients with Advanced Prostate CancerIn: European Urology Focus Jg. 9 (2023) Nr. 4, S. 596 - 605Online Volltext: dx.doi.org/
-
Quantification performance of silicon photomultiplier-based PET for small ¹⁸F-, ⁶⁸Ga- and ¹²⁴I-avid lesions in the context of radionuclide therapy planningIn: Physica Medica: European Journal of Medical Physics Jg. 114 (2023) 103149Online Volltext: dx.doi.org/
-
Quantitative In Vivo Imaging of the Androgen Receptor Axis Reveals Degree of Prostate Cancer Radiotherapy ResponseIn: Molecular Cancer Research Jg. 21 (2023) Nr. 4, S. 307 - 315Online Volltext: dx.doi.org/ Online Volltext (Open Access)
-
Quantitative ⁹⁹mTc-DPD-SPECT/CT assessment of cardiac amyloidosisIn: Journal of Nuclear Cardiology Jg. 30 (2023) Nr. 1, S. 101 - 111Online Volltext: dx.doi.org/ (Open Access)
-
Rabbit fever : granulomatous inflammation by Francisella tularensis mimics lung cancer in dual tracer ¹⁸FDG and ⁶⁸Ga-FAPI PET/CTIn: European Journal of Nuclear Medicine and Molecular Imaging Jg. 50 (2023) Nr. 8, S. 2567 - 2569Online Volltext: dx.doi.org/ (Open Access)
-
Radioiodine Ablation of Thyroid Remnants in Patients with Graves' OrbitopathyIn: Journal of Nuclear Medicine (JNM) Jg. 64 (2023) Nr. 4, S. 561 - 566Online Volltext: dx.doi.org/ (Open Access)
-
Radioligand therapies in cancer : Mapping the educational landscape in EuropeIn: European Journal of Nuclear Medicine and Molecular Imaging Jg. 50 (2023) Nr. 9, S. 2692 - 2698Online Volltext: dx.doi.org/ (Open Access)
-
Re: First-in-Human Study of the Radioligand ⁶⁸Ga-N188 Targeting Nectin-4 for PET/CT Imaging of Advanced Urothelial Carcinoma : Navigating Metastatic Urothelial Cancer with Nectin-4 PET/CTIn: European Urology Jg. 84 (2023) Nr. 5, S. 514 - 515Online Volltext: dx.doi.org/
-
Reduction of emission time for [68Ga]Ga-PSMA PET/CT using the digital biograph vision : A phantom studyIn: The Quarterly Journal of Nuclear Medicine and Molecular Imaging Jg. 67 (2023) Nr. 1, S. 57 - 68Online Volltext: dx.doi.org/
-
Regression of Myocardial ⁹⁹mTc-DPD Uptake After Tafamidis Treatment of Cardiac Transthyretin AmyloidosisIn: Journal of Nuclear Medicine (JNM) Jg. 64 (2023) Nr. 7, S. 1083 - 1086Online Volltext: dx.doi.org/ (Open Access)
-
Response Evaluation Criteria in PSMA PET/CT (RECIP 1.0) in Metastatic Castration-resistant Prostate CancerIn: Radiology Jg. 308 (2023) Nr. 1, e222148Online Volltext: dx.doi.org/
-
SNMMI Procedure Standard/EANM Practice Guideline for SSTR PET : Imaging Neuroendocrine TumorsIn: Journal of Nuclear Medicine (JNM) Jg. 64 (2023) Nr. 2, S. 204 - 210Online Volltext: dx.doi.org/ (Open Access)
-
SUVmₐₓ Above 20 in ¹⁸F-FDG PET/CT at Initial Diagnostic Workup Associates with Favorable Survival in Patients with Cancer of Unknown PrimaryIn: Journal of Nuclear Medicine (JNM) Jg. 64 (2023) Nr. 8, S. 1191 - 1194Online Volltext: dx.doi.org/ (Open Access)
-
Second Version of the Prostate Cancer Molecular Imaging Standardized Evaluation Framework Including Response Evaluation for Clinical Trials (PROMISE V2)In: European Urology Jg. 83 (2023) Nr. 5, S. 405 - 412Online Volltext: dx.doi.org/ (Open Access)
-
Standardized PSMA-PET Imaging of Advanced Prostate CancerIn: Seminars in Nuclear Medicine Jg. 54 (2023) Nr. 1, S. 60 - 68Online Volltext: dx.doi.org/
-
Superior Tumor Detection for ⁶⁸Ga-FAPI-46 Versus ¹⁸F-FDG PET/CT and Conventional CT in Patients with CholangiocarcinomaIn: Journal of Nuclear Medicine (JNM) Jg. 64 (2023) Nr. 7, S. 1049 - 1055Online Volltext: dx.doi.org/ (Open Access)
-
Tackling the Last Mile : A Major Component to Successfully Establish Radioligand TherapyIn: Journal of Nuclear Medicine (JNM) Jg. 64 (2023) Nr. 3, S. 347 - 348Online Volltext: dx.doi.org/ (Open Access)
-
The Future of Targeted α-Therapy Is Bright, but Rigorous Studies Are Necessary to Advance the FieldIn: Journal of Nuclear Medicine (JNM) Jg. 64 (2023) Nr. 2, S. 219 - 220Online Volltext: dx.doi.org/ (Open Access)
-
Towards a fast PET/MRI protocol for breast cancer imaging : maintaining diagnostic confidence while reducing PET and MRI acquisition timesIn: European Radiology Jg. 33 (2023) Nr. 9, S. 6179 - 6188Online Volltext: dx.doi.org/ (Open Access)
-
Unspecific ¹⁸F-PSMA-1007 Bone Uptake Evaluated Through PSMA-11 PET, Bone Scanning, and MRI Triple Validation in Patients with Biochemical Recurrence of Prostate CancerIn: Journal of Nuclear Medicine (JNM) Jg. 64 (2023) Nr. 5, S. 738 - 743Online Volltext: dx.doi.org/ (Open Access)
-
Update on Calcitonin Screening for Medullary Thyroid Carcinoma and the Results of a Retrospective Analysis of 12,984 Patients with Thyroid NodulesIn: Cancers Jg. 15 (2023) Nr. 8, 2333Online Volltext: dx.doi.org/ (Open Access)
-
Visualization of fibroblast activation using ⁶⁸Ga-FAPI PET/CT after pulmonary vein isolation with pulsed field compared with cryoballoon ablationIn: Journal of Nuclear Cardiology Jg. 30 (2023) Nr. 5, S. 2018 - 2028Online Volltext: dx.doi.org/ (Open Access)
-
Voxel-Based Dosimetry Predicts Hepatotoxicity in Hepatocellular Carcinoma Patients Undergoing Radioembolization with ⁹⁰Y Glass MicrospheresIn: Journal of Nuclear Medicine (JNM) Jg. 64 (2023) Nr. 7, S. 1102 - 1108Online Volltext: dx.doi.org/ (Open Access)
-
What Role Does PET/MRI Play in Musculoskeletal Disorders?In: Seminars in Nuclear Medicine (2023) in pressOnline Volltext: dx.doi.org/
-
[¹⁸F]FDG PET/MRI in children suffering from lymphoma : does MRI contrast media make a difference?In: European Radiology Jg. 33 (2023) Nr. 11, S. 8366 - 8375Online Volltext: dx.doi.org/ (Open Access)
-
18F-FDG PET/CT Imaging Biomarkers for Early and Late Evaluation of Response to First-Line Chemotherapy in Patients with Pancreatic Ductal AdenocarcinomaIn: Journal of Nuclear Medicine (JNM) Jg. 63 (2022) Nr. 2, S. 199 - 204Online Volltext: dx.doi.org/ (Open Access)
-
A Questionnaire Survey of German Thyroidologists on the Use of Thyroid Hormones in Hypothyroid and Euthyroid Patients : The THESIS (Treatment of Hypothyroidism in Europe by Specialists: An International Survey) CollaborativeIn: Experimental and Clinical Endocrinology & Diabetes Jg. 130 (2022) Nr. 9, S. 577 - 586Online Volltext: dx.doi.org/ (Open Access)
-
A Role for PET/CT in response assessment of malignant pleural mesotheliomaIn: Seminars in Nuclear Medicine Jg. 52 (2022) Nr. 6, S. 816 - 823Online Volltext: dx.doi.org/
-
A Role of PET/MR in Breast Cancer?In: Seminars in Nuclear Medicine Jg. 52 (2022) Nr. 5, S. 611 - 618Online Volltext: dx.doi.org/
-
A global evaluation of advanced dosimetry in transarterial radioembolization of hepatocellular carcinoma with Yttrium-90 : The TARGET studyIn: European Journal of Nuclear Medicine and Molecular Imaging Jg. 49 (2022) Nr. 10, S. 3340 - 3352Online Volltext: dx.doi.org/ (Open Access)
-
Administration Routes for SSTR-/PSMA- and FAP-Directed Theranostic Radioligands in MiceIn: Journal of Nuclear Medicine (JNM) Jg. 63 (2022) Nr. 9, S. 1357 - 1363Online Volltext: dx.doi.org/ Online Volltext (Open Access)
-
Artificial intelligence guided enhancement of digital PET : Scans as fast as CT?In: European Journal of Nuclear Medicine and Molecular Imaging Jg. 49 (2022) Nr. 13, S. 4503 - 4515Online Volltext: dx.doi.org/ (Open Access)
-
COVID-19 Pandemic : What Have We Learned and What to Expect in the Future?In: Seminars in Nuclear Medicine Jg. 52 (2022) Nr. 1, S. 86 - 89Online Volltext: dx.doi.org/ (Open Access)
-
Chaperone Therapy in Fabry DiseaseIn: International Journal of Molecular Sciences (IJMS) Jg. 23 (2022) Nr. 3, 1887Online Volltext: dx.doi.org/ (Open Access)
-
Clinical Use of PET/MR in Oncology : An UpdateIn: Seminars in Nuclear Medicine Jg. 52 (2022) Nr. 3, S. 356 - 364Online Volltext: dx.doi.org/
-
Comparison of nodal staging between CT, MRI, and [¹⁸F]-FDG PET/MRI in patients with newly diagnosed breast cancerIn: European Journal of Nuclear Medicine and Molecular Imaging Jg. 49 (2022) S. 992 - 1001Online Volltext: dx.doi.org/ (Open Access)
-
Corneal confocal microscopy to detect early immune-mediated small nerve fibre loss in AL amyloidosisIn: Annals of Clinical and Translational Neurology Jg. 9 (2022) Nr. 6, S. 853 - 863Online Volltext: dx.doi.org/ Online Volltext (Open Access)
-
Correction to: Joint EANM/SNMMI/ESTRO practice recommendations for the use of 2-[¹⁸F]FDG PET/CT external beam radiation treatment planning in lung cancer V1.0 (European Journal of Nuclear Medicine and Molecular Imaging, (2022), 49, 4, (1386-1406), 10.1007/s00259-021-05624-5)In: European Journal of Nuclear Medicine and Molecular Imaging Jg. 49 (2022) Nr. 9, S. 3300 - 3301Online Volltext: dx.doi.org/ (Open Access)
-
Correction: Individualized treatment of differentiated thyroid cancer : The value of surgery in combination with radioiodine imaging and therapy - A German position paper from Surgery and Nuclear MedicineIn: Nuklearmedizin = Nuclear Medicine (2022) in pressOnline Volltext: dx.doi.org/
-
Diagnostic Performance of ¹²⁴I-Metaiodobenzylguanidine PET/CT in Patients with PheochromocytomaIn: Journal of Nuclear Medicine (JNM) Jg. 63 (2022) Nr. 6, S. 869 - 874Online Volltext: dx.doi.org/ (Open Access)
-
Distribution of Functional Status of Thyroid Nodules and Malignancy Rates of Hyperfunctioning and Hypofunctioning Thyroid Nodules in GermanyIn: Nuklearmedizin = Nuclear Medicine Jg. 61 (2022) Nr. 5, S. 376 - 384Online Volltext: dx.doi.org/
-
EANM procedure guideline for the treatment of liver cancer and liver metastases with intra-arterial radioactive compoundsIn: European Journal of Nuclear Medicine and Molecular Imaging Jg. 49 (2022) Nr. 5, S. 1682 - 1699Online Volltext: dx.doi.org/ (Open Access)
-
EAU-EANM Consensus Statements on the Role of Prostate-specific Membrane Antigen Positron Emission Tomography/Computed Tomography in Patients with Prostate Cancer and with Respect to [¹⁷⁷Lu]Lu-PSMA Radioligand TherapyIn: European Urology Oncology Jg. 5 (2022) Nr. 5, S. 530 - 536Online Volltext: dx.doi.org/ (Open Access)
-
Effectiveness of durvalumab consolidation in stage III non-small-cell lung cancer : focus on treatment selection and prognostic factorsIn: Immunotherapy Jg. 14 (2022) Nr. 12, S. 927 - 944Online Volltext: dx.doi.org/ (Open Access)
-
Effects of Anti-Tumor Necrosis Factor Therapy on Osteoblastic Activity at Sites of Inflammatory and Structural Lesions in Radiographic Axial Spondyloarthritis : A Prospective Proof-of-Concept Study Using Positron Emission Tomography/Magnetic Resonance Imaging of the Sacroiliac Joints and SpineIn: Arthritis & Rheumatology Jg. 74 (2022) Nr. 9, S. 1497 - 1505Online Volltext: dx.doi.org/ (Open Access)
-
Enhancing Radioiodine Incorporation into Radioiodine-Refractory Thyroid Cancer with MAPK Inhibition (ERRITI) : A Single-Center Prospective Two-Arm StudyIn: Clinical Cancer Research Jg. 28 (2022) Nr. 19, S. 4194 - 4202Online Volltext: dx.doi.org/ (Open Access)
-
False Positive Ventilation/Perfusion SPECT/CT Mismatch Mimicking Pulmonary Embolism in a Patient With Bilateral Lung TransplantIn: Clinical Nuclear Medicine Jg. 47 (2022) Nr. 11, S. e718 - e721Online Volltext: dx.doi.org/
-
First experiences with dynamic renal [⁶⁸Ga]Ga-DOTA PET/CT : A comparison to renal scintigraphy and compartmental modelling to non-invasively estimate the glomerular filtration rateIn: European Journal of Nuclear Medicine and Molecular Imaging Jg. 49 (2022) Nr. 10, S. 3373 - 3386Online Volltext: dx.doi.org/ (Open Access)
-
First multicentric real-life experience with the combination of CCNU and temozolomide in newly diagnosed MGMT promoter methylated IDH wildtype glioblastomaIn: Neuro-Oncology Advances Jg. 4 (2022) Nr. 1, S. vdac137Online Volltext: dx.doi.org/ (Open Access)
-
Free-breathing 3D Stack of Stars GRE (StarVIBE) sequence for detecting pulmonary nodules in 18F-FDG PET/MRIIn: EJNMMI Physics Jg. 9 (2022) Nr. 1, 11Online Volltext: dx.doi.org/ (Open Access)
-
Fully Automated, High-Dose Radiosynthesis of [18F]PARPiIn: Pharmaceuticals Jg. 15 (2022) Nr. 7, 865Online Volltext: dx.doi.org/ Online Volltext (Open Access)
-
Hybrid total-body pet scanners : current status and future perspectivesIn: European Journal of Nuclear Medicine and Molecular Imaging Jg. 49 (2022) S. 445 - 459Online Volltext: dx.doi.org/ (Open Access)
-
Imaging standardisation in metastatic colorectal cancer : A joint EORTC-ESOI-ESGAR expert consensus recommendationIn: European Journal of Cancer (EJC) Jg. 176 (2022) S. 193 - 206Online Volltext: dx.doi.org/ (Open Access)
-
Imaging the Inflammatory Response in Checkpoint Inhibition MyocarditisIn: Journal of Nuclear Medicine (JNM) Jg. 63 (2022) Nr. 1, S. 14 - 16Online Volltext: dx.doi.org/ (Open Access)
-
Improved production of ⁶⁸Ga-Pentixafor using cartridge mediated cation exchange purificationIn: Applied Radiation and Isotopes Jg. 189 (2022) 110447Online Volltext: dx.doi.org/
-
Individualized treatment of differentiated thyroid cancer : The value of surgery in combination with radioiodine imaging and therapy - A German position paper from Surgery and Nuclear MedicineIn: Nuklearmedizin = Nuclear Medicine Jg. 61 (2022) Nr. 02, S. 87 - 96Online Volltext: dx.doi.org/ (Open Access)
-
Initial Clinical Experience with ⁹⁰Y-FAPI-46 Radioligand Therapy for Advanced-Stage Solid Tumors : A Case Series of 9 PatientsIn: Journal of Nuclear Medicine (JNM) Jg. 63 (2022) Nr. 5, S. 727 - 734Online Volltext: dx.doi.org/ (Open Access)
-
Interim FDG-PET analysis to identify patients with aggressive non-Hodgkin lymphoma who benefit from treatment intensification : A post-hoc analysis of the PETAL trialIn: Leukemia Jg. 36 (2022) Nr. 12, S. 2845 - 2852Online Volltext: dx.doi.org/ (Open Access)
-
Intra-Individual Comparison of 124I-PET/CT and 124I-PET/MR Hybrid Imaging of Patients with Resected Differentiated Thyroid Carcinoma : Aspects of Attenuation CorrectionIn: Cancers Jg. 14 (2022) Nr. 13, 3040Online Volltext: dx.doi.org/ Online Volltext (Open Access)
-
Joint EANM, SNMMI and IAEA enabling guide : How to set up a theranostics centreIn: European Journal of Nuclear Medicine and Molecular Imaging Jg. 49 (2022) Nr. 7, S. 2300 - 2309Online Volltext: dx.doi.org/ (Open Access)
-
Joint EANM, SNMMI, and IAEA Enabling Guide : How to Set up a Theranostics CenterIn: Journal of Nuclear Medicine (JNM) Jg. 63 (2022) Nr. 12, S. 1836 - 1843Online Volltext: dx.doi.org/
-
Joint EANM/SNMMI/ESTRO practice recommendations for the use of 2-[18F]FDG PET/CT external beam radiation treatment planning in lung cancer V1.0In: European Journal of Nuclear Medicine and Molecular Imaging Jg. 49 (2022) Nr. 4, S. 1386 - 1406Online Volltext: dx.doi.org/ (Open Access)
-
Leading in Urology and Pioneering in Social Media Outreach : A Conversation Among Declan Murphy, Ken Herrmann, and Michael HofmanIn: Journal of Nuclear Medicine (JNM) Jg. 63 (2022) Nr. 12, S. 1783 - 1785Online Volltext: dx.doi.org/
-
LiMAx Prior to Radioembolization for Hepatocellular Carcinoma as an Additional Tool for Patient Selection in Patients with Liver CirrhosisIn: Cancers Jg. 14 (2022) Nr. 19, 4584Online Volltext: dx.doi.org/ (Open Access)
-
Lung Nodules Missed in Initial Staging of Breast Cancer Patients in PET/MRI : Clinically Relevant?In: Cancers Jg. 14 (2022) Nr. 14, 3454Online Volltext: dx.doi.org/ (Open Access)
-
Lymph node classification in E‑PSMA reporting guidelines for PSMA‑PETIn: European Journal of Nuclear Medicine and Molecular Imaging Jg. 50 (2022) Nr. 1, S. 10 - 11Online Volltext: dx.doi.org/
-
Measuring response in metastatic castration-resistant prostate cancer using PSMA PET/CT : comparison of RECIST 1.1, aPCWG3, aPERCIST, PPP, and RECIP 1.0 criteriaIn: European Journal of Nuclear Medicine and Molecular Imaging Jg. 49 (2022) Nr. 12, S. 4271 - 4281Online Volltext: dx.doi.org/ (Open Access)
-
Metabolic imaging with FDG-PET and time to progression in patients discontinuing immune-checkpoint inhibition for metastatic melanomaIn: Cancer Imaging Jg. 22 (2022) Nr. 1,Online Volltext: dx.doi.org/ Online Volltext (Open Access)
-
Multiparametric¹⁸F-FDG PET/MRI-Based Radiomics for Prediction of Pathological Complete Response to Neoadjuvant Chemotherapy in Breast CancerIn: Cancers Jg. 14 (2022) Nr. 7, 1727Online Volltext: dx.doi.org/ (Open Access)
-
Novel Framework for Treatment Response Evaluation Using PSMA PET/CT in Patients with Metastatic Castration-Resistant Prostate Cancer (RECIP 1.0) : An International Multicenter StudyIn: Journal of Nuclear Medicine (JNM) Jg. 63 (2022) Nr. 11, S. 1651 - 1658Online Volltext: dx.doi.org/ (Open Access)
-
Onkologische Theranostik in der NuklearmedizinIn: Die Radiologie Jg. 62 (2022) Nr. 10, S. 875 - 884Online Volltext: dx.doi.org/
-
Onkologische Theranostik in der NuklearmedizinIn: Die Onkologie Jg. 28 (2022) Nr. 7, S. 612 - 622Online Volltext: dx.doi.org/
-
PSMA PET Validates Higher Rates of Metastatic Disease for European Association of Urology Biochemical Recurrence Risk Groups : An International Multicenter StudyIn: Journal of Nuclear Medicine (JNM) Jg. 63 (2022) Nr. 1, S. 76 - 80Online Volltext: dx.doi.org/ (Open Access)
-
PSMA PET for the Evaluation of Liver Metastases in Castration-Resistant Prostate Cancer Patients : A Multicenter Retrospective StudyIn: Cancers Jg. 14 (2022) Nr. 22, 5680Online Volltext: dx.doi.org/ (Open Access)
-
Perspective paper about the joint EANM/SNMMI/ESTRO practice recommendations for the use of 2-[¹⁸F]FDG-PET/CT external beam radiation treatment planning in lung cancerIn: Radiotherapy and Oncology (The Green Journal) Jg. 168 (2022) S. 37 - 39Online Volltext: dx.doi.org/ (Open Access)
-
Phantom-based acquisition time and image reconstruction parameter optimisation for oncologic FDG PET/CT examinations using a digital systemIn: BMC Cancer Jg. 22 (2022) Nr. 1, 899Online Volltext: dx.doi.org/ Online Volltext (Open Access)
-
Practicing Medicine in Wartime Ukraine : A Conversation Between Yaroslav Kmetyuk, Johannes Czernin, and Ken HerrmannIn: Journal of Nuclear Medicine (JNM) Jg. 63 (2022) Nr. 8, S. 1127 - 1130Online Volltext: dx.doi.org/ (Open Access)
-
Prediction of left lobe hypertrophy after right lobe radioembolization of the liver using a clinical data model with external validationIn: Scientific Reports Jg. 12 (2022) Nr. 1, 20718Online Volltext: dx.doi.org/ Online Volltext (Open Access)
-
Prediction of malignant lymph nodes in NSCLC by machine-learning classifiers using EBUS-TBNA and PET/CTIn: Scientific Reports Jg. 12 (2022) Nr. 1, 17511Online Volltext: dx.doi.org/ Online Volltext (Open Access)
-
Prostate Cancer Treatment : 177Lu-PSMA-617 Considerations, Concepts, and LimitationsIn: Journal of Nuclear Medicine (JNM) Jg. 63 (2022) Nr. 6, S. 823 - 829Online Volltext: dx.doi.org/ (Open Access)
-
Radiation Protection and Occupational Exposure on ⁶⁸Ga-PSMA-11-Based Cerenkov Luminescence Imaging Procedures in Robot-Assisted ProstatectomyIn: Journal of Nuclear Medicine (JNM) Jg. 63 (2022) Nr. 9, S. 1349 - 1356Online Volltext: dx.doi.org/ (Open Access)
-
Radiotheranostics in oncology : current challenges and emerging opportunitiesIn: Nature Reviews Clinical Oncology Jg. 19 (2022) Nr. 8, S. 534 - 550Online Volltext: dx.doi.org/ Online Volltext (Open Access)
-
Re: Lutetium-177-PSMA-617 for Metastatic Castration-Resistant Prostate CancerIn: The Journal of Urology Jg. 207 (2022) Nr. 2, S. 467 - 468Online Volltext: dx.doi.org/
-
Repeatability of ⁶⁸Ga-PSMA-HBED-CC PET/CT-Derived Total Molecular Tumor VolumeIn: Journal of Nuclear Medicine (JNM) Jg. 63 (2022) Nr. 5, S. 746 - 753Online Volltext: dx.doi.org/ (Open Access)
-
Response to Combined Peptide Receptor Radionuclide Therapy and Checkpoint Immunotherapy with Ipilimumab Plus Nivolumab in Metastatic Merkel Cell CarcinomaIn: Journal of Nuclear Medicine (JNM) Jg. 63 (2022) Nr. 3, S. 396 - 398Online Volltext: dx.doi.org/ (Open Access)
-
Safety and Efficacy of 90Y-FAPI-46 Radioligand Therapy in Patients with Advanced Sarcoma and Other Cancer EntitiesIn: Clinical Cancer Research Jg. 28 (2022) Nr. 19, S. 4346 - 4353Online Volltext: dx.doi.org/ (Open Access)
-
Shining Damaged Hearts : Immunotherapy-Related Cardiotoxicity in the Spotlight of Nuclear CardiologyIn: International Journal of Molecular Sciences (IJMS) Jg. 23 (2022) Nr. 7, 3802Online Volltext: dx.doi.org/ Online Volltext (Open Access)
-
Streptozocin/5-fluorouracil chemotherapy of pancreatic neuroendocrine tumours in the era of targeted therapyIn: Endocrine Jg. 75 (2022) Nr. 1, S. 293 - 302Online Volltext: dx.doi.org/ (Open Access)
-
Targeting early stages of cardiotoxicity from anti-PD1 immune checkpoint inhibitor therapyIn: European Heart Journal Jg. 43 (2022) Nr. 4, S. 316 - 329Online Volltext: dx.doi.org/
-
The Future Role of PET Imaging in Metastatic Breast CancerIn: Oncology Research and Treatment Jg. 45 (2022) Nr. 1-2, S. 18 - 25Online Volltext: dx.doi.org/
-
Training on Reporting and Data System (RADS) for Somatostatin-Receptor Targeted Molecular Imaging Can Reduce the Test Anxiety of Inexperienced ReadersIn: Molecular Imaging and Biology Jg. 24 (2022) Nr. 4, S. 631 - 640Online Volltext: dx.doi.org/ (Open Access)
-
Tumor Sink Effect in ⁶⁸Ga-PSMA-11 PET : Myth or Reality?In: Journal of Nuclear Medicine (JNM) Jg. 63 (2022) Nr. 2, S. 226 - 232Online Volltext: dx.doi.org/ (Open Access)
-
Utility of Integrated PET/MRI for the Primary Diagnostic Work-Up of Patients with Ewing Sarcoma : Preliminary ResultsIn: Diagnostics Jg. 12 (2022) Nr. 10, 2278Online Volltext: dx.doi.org/ Online Volltext (Open Access)
-
Virtual Biopsy : Just an AI Software or a Medical Procedure?In: Journal of Nuclear Medicine (JNM) Jg. 63 (2022) Nr. 4, S. 511 - 513Online Volltext: dx.doi.org/ Online Volltext (Open Access)
-
Virtual Prostate Biopsy with Prostate-specific Membrane Antigen and Magnetic Resonance Imaging : Closer to Reality in a Subgroup of Prostate Cancer Patients?In: European Urology Open Science Jg. 44 (2022) S. 11 - 12Online Volltext: dx.doi.org/ (Open Access)
-
Vom Aussterben bedroht? : Eine Demografie der Nuklearmedizin in Deutschland 1996–2021 anhand der Zahlen der BundesärztekammerIn: Nuklearmedizin = Nuclear Medicine Jg. 61 (2022) Nr. 05, S. 358 - 366Online Volltext: dx.doi.org/
-
[⁶⁸Ga]/[⁹⁰Y]FAPI-46 : Automated production and analytical validation of a theranostic pairIn: Nuclear Medicine and Biology Jg. 110-111 (2022) S. 37 - 44Online Volltext: dx.doi.org/
-
¹⁸F-FLT PET/CT as a Prognostic Imaging Biomarker of Disease-Specific Survival in Patients with Primary Soft-Tissue SarcomaIn: Journal of Nuclear Medicine (JNM) Jg. 63 (2022) Nr. 5, S. 708 - 712Online Volltext: dx.doi.org/ (Open Access)
-
¹⁸F-flutemetamol positron emission tomography in cardiac amyloidosisIn: Journal of Nuclear Cardiology Jg. 29 (2022) Nr. 2, S. 779 - 789Online Volltext: dx.doi.org/ (Open Access)
-
⁶⁸Ga]FAPI-PET/CT for radiation therapy planning in biliary tract, pancreatic ductal adeno-, and adenoidcystic carcinomasIn: Scientific Reports Jg. 12 (2022) Nr. 1, 16261Online Volltext: dx.doi.org/ Online Volltext (Open Access)
-
An international expert opinion statement on the utility of PET/MR for imaging of skeletal metastasesIn: European Journal of Nuclear Medicine and Molecular Imaging Jg. 48 (2021) Nr. 5, S. 1522 - 1537Online Volltext: dx.doi.org/ Online Volltext (Open Access)
-
Analysis of risk factors and prognosis in differentiated thyroid cancer with focus on minimal extrathyroidal extensionIn: BMC Endocrine Disorders Jg. 21 (2021) Nr. 1, 161Online Volltext: dx.doi.org/ Online Volltext (Open Access)
-
Atypical bilateral ventilation/perfusion mismatches in an asymptomatic patient suffering from metastatic thyroid cancerIn: European Journal of Hybrid Imaging: EJNMMI Multimodality Journal Jg. 5 (2021) Nr. 1, 25Online Volltext: dx.doi.org/ Online Volltext (Open Access)
-
Auswirkungen von COVID-19 auf nuklearmedizinische Untersuchungen und Therapien im Verlauf von 2020 : Ergebnisse einer nationalen UmfrageIn: Nuklearmedizin = Nuclear Medicine Jg. 60 (2021) Nr. 3, S. 210 - 215Online Volltext: dx.doi.org/
-
Bone Metastases Are Measurable : The Role of Whole-Body MRI and Positron Emission TomographyIn: Frontiers in Oncology Jg. 11 (2021) 772530Online Volltext: dx.doi.org/ (Open Access)
-
Can a ToF-PET photon attenuation reconstruction test stopping-power estimations in proton therapy? : A phantom studyIn: Physics in Medicine and Biology Jg. 66 (2021) Nr. 21, 215010Online Volltext: dx.doi.org/
-
Changes in the global impact of COVID-19 on nuclear medicine departments during 2020 : An international follow-up surveyIn: European Journal of Nuclear Medicine and Molecular Imaging Jg. 48 (2021) Nr. 13, S. 4318 - 4330Online Volltext: dx.doi.org/ (Open Access)
-
Comparing lesion detection efficacy and image quality across different PET system generations to optimize the iodine-124 PET protocol for recurrent thyroid cancerIn: EJNMMI Physics Jg. 8 (2021) Nr. 1, 14Online Volltext: dx.doi.org/ Online Volltext (Open Access)
-
Comparison of pre- and post-contrast-enhanced attenuation correction using a CAIPI-accelerated T1-weighted Dixon 3D-VIBE sequence in ⁶⁸Ga-DOTATOC PET/MRIIn: European Journal of Radiology Jg. 139 (2021) S. 109691Online Volltext: dx.doi.org/
-
Complete metabolic response in patients with advanced nonsmall cell lung cancer with prolonged response to immune checkpoint inhibitor therapyIn: Journal for ImmunoTherapy of Cancer Jg. 9 (2021) Nr. 3, S. 002262Online Volltext: dx.doi.org/ Online Volltext (Open Access)
-
Consensus on molecular imaging and theranostics in neuroendocrine neoplasmsIn: European Journal of Cancer (EJC) Jg. 146 (2021) S. 56 - 73Online Volltext: dx.doi.org/ Online Volltext (Open Access)
-
Consensus statements on PSMA PET/CT response assessment criteria in prostate cancerIn: European Journal of Nuclear Medicine and Molecular Imaging Jg. 48 (2021) Nr. 2, S. 469 - 476Online Volltext: dx.doi.org/ (Open Access)
-
Correlation between contrast enhancement, standardized uptake value (SUV), and diffusion restriction (ADC) with tumor grading in patients with therapy-naive neuroendocrine neoplasms using hybrid ⁶⁸Ga-DOTATOC PET/MRIIn: European Journal of Radiology Jg. 137 (2021) S. 109588Online Volltext: dx.doi.org/
-
Correlation of the apparent diffusion coefficient (ADC) and standardized uptake values (SUV) with overall survival in patients with primary non-small cell lung cancer (NSCLC) using ¹⁸F-FDG PET/MRIIn: European Journal of Radiology Jg. 134 (2021) S. 109422Online Volltext: dx.doi.org/ (Open Access)
-
Determining the Axillary Nodal Status with 4 Current Imaging Modalities, Including 18F-FDG PET/MRI, in Newly Diagnosed Breast Cancer : A Comparative Study Using Histopathology as the Reference StandardIn: Journal of Nuclear Medicine (JNM) Jg. 62 (2021) Nr. 12, S. 1677 - 1683Online Volltext: dx.doi.org/ (Open Access)
-
Diagnostic Accuracy of ⁶⁸Ga-PSMA-11 PET for Pelvic Nodal Metastasis Detection Prior to Radical Prostatectomy and Pelvic Lymph Node Dissection : A Multicenter Prospective Phase 3 Imaging TrialIn: JAMA Oncology Jg. 7 (2021) Nr. 11, S. 1635 - 1642Online Volltext: dx.doi.org/ (Open Access)
-
Diagnostic accuracy of routine calcitonin measurement for the detection of medullary thyroid carcinoma in the management of patients with nodular thyroid disease : A meta-analysisIn: Endocrine Connections Jg. 10 (2021) Nr. 3, S. 358 - 370Online Volltext: dx.doi.org/ (Open Access)
-
Diagnostic performance of kwak, eu, acr, and korean tirads as well as ata guidelines for the ultrasound risk stratification of non-autonomously functioning thyroid nodules in a region with long history of iodine deficiency : A German multicenter trialIn: Cancers Jg. 13 (2021) Nr. 17, 4467Online Volltext: dx.doi.org/ (Open Access)
-
Digital and respiratory-gated FDG PET/CT for characterization of lung lesionsIn: European Journal of Nuclear Medicine and Molecular Imaging Jg. 48 (2021) Nr. Suppl. 1, S. 83
-
Direct proton range verification using oxygen-18 enriched water as a contrast agentIn: Radiation Physics and Chemistry Jg. 182 (2021) 109385Online Volltext: dx.doi.org/ (Open Access)
-
Dose-escalated radiotherapy with PET/CT based treatment planning in combination with induction and concurrent chemotherapy in locally advanced (uT3/T4) squamous cell cancer of the esophagus : mature results of a phase I/II trialIn: Radiation Oncology Jg. 16 (2021) Nr. 1, S. 59Online Volltext: dx.doi.org/ Online Volltext (Open Access)
-
Drug and molecular radiotherapy combinations for metastatic castration resistant prostate cancerIn: Nuclear Medicine and Biology Jg. 96-97 (2021) S. 101 - 111Online Volltext: dx.doi.org/ (Open Access)
-
E-PSMA : The EANM standardized reporting guidelines v1.0 for PSMA-PETIn: European Journal of Nuclear Medicine and Molecular Imaging Jg. 48 (2021) Nr. 5, S. 1626 - 1638Online Volltext: dx.doi.org/ (Open Access)
-
EANM position paper on article 56 of the Council Directive 2013/59/Euratom (basic safety standards) for nuclear medicine therapyIn: European Journal of Nuclear Medicine and Molecular Imaging Jg. 48 (2021) S. 67 - 72Online Volltext: dx.doi.org/ (Open Access)
-
Enzalutamide enhances psma expression of psma-low prostate cancerIn: International Journal of Molecular Sciences (IJMS) Jg. 22 (2021) Nr. 14, 7431Online Volltext: dx.doi.org/ Online Volltext (Open Access)
-
European Cancer Organisation Essential Requirements for Quality Cancer Care (ERQCC) : Pancreatic CancerIn: Cancer Treatment Reviews Jg. 99 (2021) 102208Online Volltext: dx.doi.org/
-
Evaluation of [⁶⁸Ga]Ga-PSMA PET/CT images acquired with a reduced scan time duration in prostate cancer patients using the digital biograph visionIn: EJNMMI Research Jg. 11 (2021) Nr. 1, S. 21Online Volltext: dx.doi.org/ Online Volltext (Open Access)
-
Evaluation of a new automated assay for high-sensitivity thyroglobulin measurement and comparison with two established high-sensitivity thyroglobulin assaysIn: Practical Laboratory Medicine Jg. 26 (2021) e00250Online Volltext: dx.doi.org/ Online Volltext (Open Access)
-
Evaluation of the Diagnostic Performance of Positron Emission Tomography/Magnetic Resonance for the Diagnosis of Liver MetastasesIn: Investigative Radiology Jg. 56 (2021) Nr. 10, S. 621 - 628Online Volltext: dx.doi.org/
-
Evaluation of the predictive potential of 18F-FDG PET and DWI data sets for relevant prognostic parameters of primary soft-tissue sarcomasIn: Cancers Jg. 13 (2021) Nr. 11, 2753Online Volltext: dx.doi.org/ (Open Access)
-
Evaluation of ¹⁸F-FDG PET and DWI Datasets for Predicting Therapy Response of Soft-Tissue Sarcomas Under Neoadjuvant Isolated Limb PerfusionIn: Journal of Nuclear Medicine (JNM) Jg. 62 (2021) Nr. 3, S. 348 - 353Online Volltext: dx.doi.org/ (Open Access)
-
Evaluation of ¹⁸F-FDG PET/CT images acquired with a reduced scan time duration in lymphoma patients using the digital biograph visionIn: BMC Cancer Jg. 21 (2021) Nr. 1, 62Online Volltext: dx.doi.org/ Online Volltext (Open Access)
-
FDG PET/CT to detect bone marrow involvement in the initial staging of patients with aggressive non-Hodgkin lymphoma : Results from the prospective, multicenter PETAL and OPTIMAL>60 trialsIn: European Journal of Nuclear Medicine and Molecular Imaging Jg. 48 (2021) Nr. 11, S. 3550 - 3559Online Volltext: dx.doi.org/ (Open Access)
-
FDG PET/CT to detect bone marrow involvement in the initial staging of patients with aggressive non-Hodgkin lymphoma : Results from the prospective, multicenter PETAL and OPTIMAL>60 trialsIn: European Journal of Nuclear Medicine and Molecular Imaging Jg. 48 (2021) Nr. 11, S. 3550 - 3559Online Volltext: dx.doi.org/ (Open Access)
-
FDG-PET/CT Variants and Pitfalls in Haematological MalignanciesIn: Seminars in Nuclear Medicine Jg. 51 (2021) Nr. 6, S. 554 - 571Online Volltext: dx.doi.org/
-
Fabry Cardiomyopathy : Current Treatment and Future OptionsIn: Journal of Clinical Medicine (JCM) Jg. 10 (2021) Nr. 14, 3026Online Volltext: dx.doi.org/ (Open Access)
-
Factors predicting biochemical response and survival benefits following radioligand therapy with [¹⁷⁷Lu]Lu-PSMA in metastatic castrate-resistant prostate cancer : A reviewIn: European Journal of Nuclear Medicine and Molecular Imaging Jg. 48 (2021) Nr. 12, S. 4028 - 4041Online Volltext: dx.doi.org/ (Open Access)
-
False positive PSMA PET for tumor remnants in the irradiated prostate and other interpretation pitfalls in a prospective multi-center trialIn: European Journal of Nuclear Medicine and Molecular Imaging Jg. 48 (2021) Nr. 2, S. 501 - 508Online Volltext: dx.doi.org/ (Open Access)
-
Identification of PCWG3 Target Populations Is More Accurate and Reproducible with PSMA PET Than with Conventional Imaging : A Multicenter Retrospective StudyIn: Journal of Nuclear Medicine (JNM) Jg. 62 (2021) Nr. 5, S. 675 - 678Online Volltext: dx.doi.org/ (Open Access)
-
Imaging Inflammation with Positron Emission TomographyIn: Biomedicines Jg. 9 (2021) Nr. 2, S. 212Online Volltext: dx.doi.org/ Online Volltext (Open Access)
-
Impact of EBUS-TBNA in addition to [¹⁸F]FDG-PET/CT imaging on target volume definition for radiochemotherapy in stage III NSCLCIn: European Journal of Nuclear Medicine and Molecular Imaging Jg. 48 (2021) S. 2894 - 2903Online Volltext: dx.doi.org/ (Open Access)
-
In vivo targeting of cxcr4 : new horizonsIn: Cancers Jg. 13 (2021) Nr. 23, 5920Online Volltext: dx.doi.org/ (Open Access)
-
Insights into immunometabolism : A dataset correlating the ¹⁸FDG PET/CT maximum standard uptake value of the primary tumor with the CCL18 serum level in non-small cell lung cancerIn: Data in Brief Jg. 35 (2021) 106859Online Volltext: dx.doi.org/ Online Volltext (Open Access)
-
Irène Buvat and Ken Herrmann Talk with Alexander Stremitzer, Kevin Tobia, and Aileen NielsenIn: Journal of Nuclear Medicine (JNM) Jg. 62 (2021) Nr. 1, S. 3 - 5Online Volltext: dx.doi.org/ (Open Access)
-
Just another “Clever Hans”? : Neural networks and FDG PET-CT to predict the outcome of patients with breast cancerIn: European Journal of Nuclear Medicine and Molecular Imaging Jg. 48 (2021) Nr. 10, S. 3141 - 3150Online Volltext: dx.doi.org/ (Open Access)
-
Lutetium-177-PSMA-617 for Metastatic Castration-Resistant Prostate CancerIn: The New England Journal of Medicine Jg. 385 (2021) S. 1091 - 1103Online Volltext: dx.doi.org/ Online Volltext (Open Access)
-
Machine learning-based differentiation between multiple sclerosis and glioma WHO II°-IV° using O-(2-[18F] fluoroethyl)-L-tyrosine positron emission tomographyIn: Journal of Neuro-Oncology Jg. 152 (2021) S. 325 - 332Online Volltext: dx.doi.org/
-
Mental health burden of german cancer patients before and after the outbreak of covid-19 : Predictors of mental health impairmentIn: International Journal of Environmental Research and Public Health = IJERPH Jg. 18 (2021) Nr. 5, 2318Online Volltext: dx.doi.org/ Online Volltext (Open Access)
-
Multiparametric integrated¹⁸f-fdg pet/mri-based radiomics for breast cancer phenotyping and tumor decodingIn: Cancers Jg. 13 (2021) Nr. 12, 2928Online Volltext: dx.doi.org/ (Open Access)
-
N-staging in large cell neuroendocrine carcinoma of the lung : diagnostic value of [¹⁸F]FDG PET/CT compared to the histopathology reference standardIn: EJNMMI Research Jg. 11 (2021) Nr. 1, 68Online Volltext: dx.doi.org/ Online Volltext (Open Access)
-
New PET technologies : embracing progress and pushing the limitsIn: European Journal of Nuclear Medicine and Molecular Imaging Jg. 48 (2021) S. 2711 - 2726Online Volltext: dx.doi.org/ (Open Access)
-
Nomograms to predict outcomes after ¹⁷⁷Lu-PSMA therapy in men with metastatic castration-resistant prostate cancer : An international, multicentre, retrospective studyIn: The Lancet Oncology Jg. 22 (2021) Nr. 8, S. 1115 - 1125Online Volltext: dx.doi.org/ (Open Access)
-
Novel CYP11B-ligand [¹²³/¹³¹I]IMAZA as promising theranostic tool for adrenocortical tumors : Comprehensive preclinical characterization and first clinical experienceIn: European Journal of Nuclear Medicine and Molecular Imaging Jg. 49 (2021) S. 301 - 310Online Volltext: dx.doi.org/ (Open Access)
-
Nuclear medicine theranostics comes of ageIn: The Lancet Oncology Jg. 22 (2021) Nr. 11, S. 1497 - 1498Online Volltext: dx.doi.org/
-
Oldies (but Goldies) : Die Peritonealszintigrafie bei PeritonealdialyseIn: Nuklearmedizin = Nuclear Medicine Jg. 60 (2021) Nr. 06, S. 450 - 453Online Volltext: dx.doi.org/
-
PSMA PET total tumor volume predicts outcome of patients with advanced prostate cancer receiving [¹⁷⁷Lu]Lu-PSMA-617 radioligand therapy in a bicentric analysisIn: European Journal of Nuclear Medicine and Molecular Imaging Jg. 48 (2021) Nr. 4, S. 1200 - 1210Online Volltext: dx.doi.org/ (Open Access)
-
PSMA-PET for the assessment of metastatic hormone-sensitive prostate cancer volume of diseaseIn: Journal of Nuclear Medicine (JNM) Jg. 62 (2021) Nr. 12, S. 1747 - 1750Online Volltext: dx.doi.org/ (Open Access)
-
PSMA-ligand PET for early castration-resistant prostate cancer : a retrospective single-center studyIn: Journal of Nuclear Medicine (JNM) Jg. 62 (2021) Nr. 1, S. 88 - 91Online Volltext: dx.doi.org/ (Open Access)
-
Patterns of nodal spread in stage III NSCLC : Importance of EBUS-TBNA and ¹⁸F-FDG PET/CT for radiotherapy target volume definitionIn: Radiation Oncology Jg. 16 (2021) Nr. 1, 176Online Volltext: dx.doi.org/ Online Volltext (Open Access)
-
Phase 3 multicenter randomized trial of PSMA PET/CT prior to definitive radiation therapy for unfavorable intermediate-risk or high-risk prostate cancer [PSMA dRT] : study protocolIn: BMC Cancer Jg. 21 (2021) 512Online Volltext: dx.doi.org/ (Open Access)
-
Positron Emission Tomography and Whole-body Magnetic Resonance Imaging for Metastasis-directed Therapy in Hormone-sensitive Oligometastatic Prostate Cancer After Primary Radical Treatment : A Systematic ReviewIn: European Urology Oncology Jg. 4 (2021) Nr. 5, S. 714 - 730Online Volltext: dx.doi.org/
-
Practical recommendations for the management of patients with gastroenteropancreatic and thoracic (carcinoid) neuroendocrine neoplasms in the COVID-19 eraIn: European Journal of Cancer (EJC) Jg. 144 (2021) S. 200 - 214Online Volltext: dx.doi.org/ Online Volltext (Open Access)
-
Predictive Factors for RAI-Refractory Disease and Short Overall Survival in PDTCIn: Cancers Jg. 13 (2021) Nr. 7, S. 1728Online Volltext: dx.doi.org/ Online Volltext (Open Access)
-
Prognostic Value of Postinduction Chemotherapy Volumetric PET/CT Parameters for Stage IIIA or IIIB Non-Small Cell Lung Cancer Patients Receiving Definitive ChemoradiotherapyIn: Journal of Nuclear Medicine (JNM) Jg. 62 (2021) Nr. 12, S. 1684 - 1691Online Volltext: dx.doi.org/ Online Volltext (Open Access)
-
Prospective Correlation of Prognostic Immunohistochemical Markers With SUV and ADC Derived From Dedicated Hybrid Breast 18F-FDG PET/MRI in Women With Newly Diagnosed Breast CancerIn: Clinical Nuclear Medicine Jg. 46 (2021) Nr. 3, S. 201 - 205Online Volltext: dx.doi.org/
-
Prospective comparison of CT and ¹⁸F-FDG PET/MRI in N and M staging of primary breast cancer patients : Initial resultsIn: PLoS ONE Jg. 16 (2021) e0260804Online Volltext: dx.doi.org/ (Open Access)
-
Prospective comparison of the diagnostic accuracy of 18F-FDG PET/MRI, MRI, CT, and bone scintigraphy for the detection of bone metastases in the initial staging of primary breast cancer patientsIn: European Radiology Jg. 31 (2021) Nr. 11, S. 8714 - 8724Online Volltext: dx.doi.org/ (Open Access)
-
Prospective phase 2 trial of PSMA-targeted molecular RadiothErapy with 177Lu-PSMA-617 for metastatic castration-reSISTant Prostate Cancer (RESIST-PC) : efficacy results of the UCLA cohortIn: Journal of Nuclear Medicine (JNM) Jg. 62 (2021) Nr. 10, S. 1440 - 1446Online Volltext: dx.doi.org/ Online Volltext (Open Access)
-
Prostate specific membrane antigen-radio guided surgery using Cerenkov luminescence imaging : Utilization of a short-pass filter to reduce technical pitfallsIn: Translational Andrology and Urology Jg. 10 (2021) Nr. 10, S. 3972 - 3985Online Volltext: dx.doi.org/ (Open Access)
-
Prostate-specific Membrane Antigen–based Imaging of Castration-resistant Prostate CancerIn: European Urology Focus Jg. 7 (2021) Nr. 2, S. 279 - 287Online Volltext: dx.doi.org/
-
Radioembolization With Chemotherapy for Colorectal Liver Metastases : A Randomized, Open-Label, International, Multicenter, Phase III TrialIn: Journal of Clinical Oncology (JCO) Jg. 39 (2021) Nr. 35, S. 3897 - 3907Online Volltext: dx.doi.org/ (Open Access)
-
Re: Lutetium-177-PSMA-617 for Metastatic Castration-Resistant Prostate CancerIn: European Urology Jg. 80 (2021) Nr. 4, S. 520 - 521Online Volltext: dx.doi.org/
-
Safety of PSMA-Targeted Molecular Radioligand Therapy with 177Lu-PSMA-617 : Results from the Prospective Multicenter Phase 2 Trial RESIST-PC (NCT03042312)In: Journal of Nuclear Medicine (JNM) Jg. 62 (2021) Nr. 10, S. 1447 - 1456Online Volltext: dx.doi.org/ Online Volltext (Open Access)
-
Silicon-photomultiplier-based PET/CT reduces the minimum detectable activity of iodine-124In: Scientific Reports Jg. 11 (2021) Nr. 1, 17477Online Volltext: dx.doi.org/ Online Volltext (Open Access)
-
The Disappearing Act of Nuclear Medicine in The Netherlands : Just a New Trick by the Great Harry Houdini?In: Journal of Nuclear Medicine (JNM) Jg. 62 (2021) Nr. 7, S. 903 - 904Online Volltext: dx.doi.org/ (Open Access)
-
The influence of ⁶⁸Ga-prostate-specific membrane antigen PET/computed tomography on prostate cancer staging and planning of definitive radiation therapyIn: Nuclear Medicine Communications Jg. 42 (2021) Nr. 7, S. 811 - 817Online Volltext: dx.doi.org/
-
The salivary glands as a dose limiting organ of PSMA- targeted radionuclide therapy : A review of the lessons learnt so farIn: Nuclear Medicine and Biology Jg. 98-99 (2021) S. 30 - 39Online Volltext: dx.doi.org/ (Open Access)
-
Theranostics in Boron neutron capture therapyIn: Life Jg. 11 (2021) Nr. 4, S. 330Online Volltext: dx.doi.org/ (Open Access)
-
Thymic hyperplasia after mRNA based Covid-19 vaccinationIn: Radiology Case Reports Jg. 16 (2021) Nr. 12, S. 3744 - 3745Online Volltext: dx.doi.org/ (Open Access)
-
Towards using secondary gamma-rays from proton-induced radioactivation of titanium implants for off-line field verificationIn: Nuclear Instruments and Methods in Physics Research Section B: Beam Interactions with Materials and Atoms Jg. 492 (2021) S. 56 - 63Online Volltext: dx.doi.org/
-
Volumetric PET Response Assessment Outperforms Conventional Criteria in Patients Receiving High-Dose Pembrolizumab for Malignant MesotheliomaIn: Journal of Nuclear Medicine (JNM) Jg. 62 (2021) Nr. 2, S. 191 - 194Online Volltext: dx.doi.org/ (Open Access)
-
[18F]-Fluorodeoxyglucose Positron Emission Tomography/CT to Assess the Early Metabolic Response in Patients with Hormone Receptor-Positive HER2-Negative Metastasized Breast Cancer Treated with Cyclin-Dependent 4/6 Kinase InhibitorsIn: Oncology Research and Treatment Jg. 44 (2021) Nr. 7-8, S. 400 - 407Online Volltext: dx.doi.org/ (Open Access)
-
[⁶⁸Ga]Ga-PSMA-11 PET/CT improves tumor detection and impacts management in patients with hepatocellular carcinomaIn: Journal of Nuclear Medicine (JNM) Jg. 62 (2021) Nr. 9, S. 1235 - 1241Online Volltext: dx.doi.org/ (Open Access)
-
18F-FDG PET/MR versus MR Alone in Whole-Body Primary Staging and Restaging of Patients with Rectal Cancer : What Is the Benefit of PET?In: Journal of Clinical Medicine (JCM) Jg. 9 (2020) Nr. 10, 3163Online Volltext: dx.doi.org/ Online Volltext (Open Access)
-
A conversation between Ignasi Carrió and Ken HerrmannIn: Journal of Nuclear Medicine (JNM) Jg. 61 (2020) Nr. 5, S. 638 - 640Online Volltext: dx.doi.org/ (Open Access)
-
AU-ESMO Consensus Statements on the Management of Advanced and Variant Bladder Cancer—An International Collaborative Multistakeholder Effort : Under the Auspices of the EAU-ESMO Guidelines CommitteesIn: European Urology Jg. 77 (2020) Nr. 2, S. 223 - 250Online Volltext: dx.doi.org/ (Open Access)
-
Analysis of PSMA expression and outcome in patients with advanced Prostate Cancer receiving 177Lu-PSMA-617 Radioligand TherapyIn: Theranostics Jg. 10 (2020) Nr. 17, S. 7812 - 7820Online Volltext: dx.doi.org/ (Open Access)
-
Assessing the quality of life of patients with metastatic castration-resistant prostate cancer with bone metastases receiving [223Ra]RaCl2 therapyIn: Medicine Jg. 99 (2020) Nr. 38, e22287Online Volltext: dx.doi.org/ (Open Access)
-
Assessment of Suspected Malignancy or Infection in Immunocompromised Patients After Solid Organ Transplantation by [¹⁸F]FDG PET/CT and [¹⁸F]FDG PET/MRIIn: Nuclear Medicine and Molecular Imaging Jg. 54 (2020) Nr. 4, S. 183 - 191Online Volltext: dx.doi.org/ Online Volltext (Open Access)
-
COVID-19-Related Fear and Health-Related Safety Behavior in Oncological PatientsIn: Frontiers in Psychology Jg. 11 (2020) S. 1984Online Volltext: dx.doi.org/ (Open Access)
-
Can the injected dose be reduced in ⁶⁸Ga-PSMA-11 PET/CT while maintaining high image quality for lesion detection?In: Journal of Nuclear Medicine (JNM) Jg. 61 (2020) Nr. 2, S. 189 - 193Online Volltext: dx.doi.org/ (Open Access)
-
Cardiac PET/MRI : Current Clinical Status and Future PerspectivesIn: Seminars in Nuclear Medicine Jg. 50 (2020) Nr. 3, S. 260 - 269Online Volltext: dx.doi.org/
-
Clinical response to crizotinib and emergence of resistance in lung adenocarcinoma harboring a MET c-Cbl binding site mutationIn: Lung Cancer Jg. 139 (2020) S. 165 - 168Online Volltext: dx.doi.org/
-
Comparison of acceptance of PET/MR enterography and ileocolonoscopy in patients with inflammatory bowel diseasesIn: Clinical Imaging Jg. 64 (2020) S. 11 - 17Online Volltext: dx.doi.org/
-
Comparison of ¹⁸F-FDG PET-MR and fecal biomarkers in the assessment of disease activity in patients with ulcerative colitisIn: The British Journal of Radiology (BJR) Jg. 93 (2020) Nr. 1112, S. 20200167Online Volltext: dx.doi.org/ (Open Access)
-
Coronavirus SARS-CoV-2 : Empfehlungen für die nuklearmedizinische Versorgung in nuklearmedizinischen Kliniken/Abteilungen mit Therapiestation und Praxen, Instituten sowie OrdinationenIn: Nuklearmedizin = Nuclear Medicine Jg. 59 (2020) Nr. 2, S. E1 - E4Online Volltext: dx.doi.org/ (Open Access)
-
Correction for hyperfunctioning radiation-induced stunning (CHRIS) in benign thyroid diseasesIn: Endocrine Jg. 69 (2020) Nr. 2, S. 466 - 473Online Volltext: dx.doi.org/
-
Correction to: Nuclear medicine services after COVID-19: gearing up back to normalityIn: European Journal of Nuclear Medicine and Molecular Imaging Jg. 47 (2020) Nr. 9, S. 2220Online Volltext: dx.doi.org/ (Open Access)
-
Corrigendum to ‘EAU-ESMO Consensus Statements on the Management of Advanced and Variant Bladder Cancer—An International Collaborative Multistakeholder Effort Under the Auspices of the EAU-ESMO Guidelines CommitteesIn: European Urology Jg. 78 (2020) Nr. 1, S. e48 - e50Online Volltext: dx.doi.org/ (Open Access)
-
Diagnosis and screening of patients with fabry diseaseIn: Therapeutics and Clinical Risk Management Jg. 16 (2020) S. 551 - 558Online Volltext: dx.doi.org/ (Open Access)
-
Diagnostic Performance of Simultaneous [18F]-FDG PET/MR for Assessing Endoscopically Active Inflammation in Patients with Ulcerative Colitis : A Prospective StudyIn: Journal of Clinical Medicine (JCM) Jg. 9 (2020) Nr. 8, 2474Online Volltext: dx.doi.org/ (Open Access)
-
Efficacy and Safety of ¹⁷⁷Lu-labeled Prostate-specific Membrane Antigen Radionuclide Treatment in Patients with Diffuse Bone Marrow Involvement : A Multicenter Retrospective StudyIn: European Urology Jg. 78 (2020) Nr. 2, S. 148 - 154Online Volltext: dx.doi.org/
-
Evaluation of improved attenuation correction in whole-body PET/MR on patients with bone metastasis using various radiotracersIn: European Journal of Nuclear Medicine and Molecular Imaging Jg. 47 (2020) Nr. 10, S. 2269 - 2279Online Volltext: dx.doi.org/ (Open Access)
-
First-in-man intraoperative Cerenkov luminescence imaging for oligometastatic prostate cancer using ⁶⁸Ga-PSMA-11In: European Journal of Nuclear Medicine and Molecular Imaging Jg. 47 (2020) Nr. 13, S. 3194 - 3195Online Volltext: dx.doi.org/
-
Global impact of COVID-19 on nuclear medicine departments : An international survey in April 2020In: Journal of Nuclear Medicine (JNM) Jg. 61 (2020) Nr. 9, S. 1278 - 1283Online Volltext: dx.doi.org/ (Open Access)
-
Imaging inflammation after myocardial infarction : implications for prognosis and therapeutic guidanceIn: The Quarterly Journal of Nuclear Medicine and Molecular Imaging Jg. 64 (2020) Nr. 1, S. 35 - 50Online Volltext: dx.doi.org/
-
Immunohistochemical Profile and 47-Gene Next-Generation Sequencing (NGS) Solid Tumor Panel Analysis of a Series of 13 Strumal CarcinoidsIn: Endocrine Pathology Jg. 31 (2020) S. 101 - 107Online Volltext: dx.doi.org/ (Open Access)
-
Impact of 68Ga-PSMA-11 PET on the Management of recurrent Prostate Cancer in a Prospective Single-Arm Clinical TrialIn: Journal of Nuclear Medicine (JNM) Jg. 61 (2020) Nr. 12, S. 1793 - 1799Online Volltext: dx.doi.org/ (Open Access)
-
Impact of COVID-19 on Nuclear Medicine in Germany, Austria and Switzerland : An International Survey in April 2020In: Nuklearmedizin = Nuclear Medicine Jg. 59 (2020) Nr. 4, S. 294 - 299Online Volltext: dx.doi.org/
-
Impact of ¹⁸F-FDG PET/MR on therapeutic management in high risk primary breast cancer patients : A prospective evaluation of staging algorithmsIn: European Journal of Radiology Jg. 128 (2020) S. 108975Online Volltext: dx.doi.org/ Online Volltext (Open Access)
-
In vivo biodistribution of calcium phosphate nanoparticles after intravascular, intramuscular, intratumoral, and soft tissue administration in mice investigated by small animal PET/CTIn: Acta Biomaterialia Jg. 109 (2020) S. 244 - 253Online Volltext: dx.doi.org/
-
Intraoperative 68Gallium-PSMA Cerenkov Luminescence Imaging for surgical margins in radical prostatectomy : A feasibility studyIn: Journal of Nuclear Medicine (JNM) Jg. 61 (2020) Nr. 10, S. 1500 - 1506Online Volltext: dx.doi.org/ Online Volltext (Open Access)
-
Is there a connection between immunohistochemical markers and grading of lung cancer with apparent diffusion coefficient (ADC) and standardised uptake values (SUV) of hybrid 18F-FDG-PET/MRI?In: Journal of Medical Imaging and Radiation Oncology Jg. 64 (2020) Nr. 6, S. 779 - 786Online Volltext: dx.doi.org/
-
Joint Imaging Platform for Federated Clinical Data AnalyticsIn: JCO Clinical Cancer Informatics (JCO CCI) Jg. 4 (2020) S. 1027 - 1038Online Volltext: dx.doi.org/ (Open Access)
-
Konsensusempfehlung zur strukturierten Befunderstellung onkologischer PET-HybridbildgebungIn: Nuklearmedizin = Nuclear Medicine Jg. 59 (2020) Nr. 4, S. 288 - 293Online Volltext: dx.doi.org/ (Open Access)
-
Konsensusempfehlung zur strukturierten Befunderstellung onkologischer PET-Hybridbildgebung*In: RöFo: Fortschritte auf dem Gebiet der Röntgenstrahlen und der bildgebenden Verfahren Jg. 192 (2020) Nr. 8, S. 739 - 744Online Volltext: dx.doi.org/ (Open Access)
-
Longer-term recurrence rate after low versus high dose radioiodine ablation for differentiated thyroid Cancer in low and intermediate risk patients : a meta-analysisIn: BMC Cancer Jg. 20 (2020) Nr. 1, 550Online Volltext: dx.doi.org/ (Open Access)
-
Management implications of fluorodeoxyglucose positron emission tomography/magnetic resonance in untreated intrahepatic cholangiocarcinomaIn: European Journal of Nuclear Medicine and Molecular Imaging Jg. 47 (2020) Nr. 8, S. 1871 - 1884Online Volltext: dx.doi.org/
-
Mapping Prostate Cancer Lesions Before and After Unsuccessful Salvage Lymph Node Dissection Using Repeat PSMA PETIn: Journal of Nuclear Medicine (JNM) Jg. 61 (2020) Nr. 7, S. 1037 - 1042Online Volltext: dx.doi.org/ Online Volltext (Open Access)
-
Molecular Imaging and Therapy of Colorectal and Anal CancerIn: Seminars in Nuclear Medicine Jg. 50 (2020) Nr. 5, S. 465 - 470Online Volltext: dx.doi.org/
-
Molecular imaging and theranosticsIn: Der Onkologe Jg. 26 (2020) Nr. 1, S. 14 - 21Online Volltext: dx.doi.org/
-
Molecular profiling of neuroendocrine tumours to predict response and toxicity to peptide receptor radionuclide therapyIn: The Lancet Oncology Jg. 21 (2020) Nr. 9, S. e431 - e443Online Volltext: dx.doi.org/ Online Volltext (Open Access)
-
Neuroendokrine Neoplasien des VerdauungstraktsIn: Best Practice Onkologie Jg. 15 (2020) Nr. 7-8, S. 320 - 333Online Volltext: dx.doi.org/
-
Non-invasive tumor decoding and phenotyping of cerebral gliomas utilizing multiparametric ¹⁸F-FET PET-MRI and MR FingerprintingIn: European Journal of Nuclear Medicine and Molecular Imaging Jg. 47 (2020) Nr. 6, S. 1435 - 1445Online Volltext: dx.doi.org/
-
Nuclear medicine and molecular imaging advances in the 21st centuryIn: The British Journal of Radiology (BJR) Jg. 93 (2020) Nr. 1110, S. 20200095Online Volltext: dx.doi.org/
-
Nuclear medicine operations in the times of COVID-19: Strategies, precautions, and experiencesIn: Journal of Nuclear Medicine (JNM) Jg. 61 (2020) Nr. 5, S. 626 - 629Online Volltext: dx.doi.org/ (Open Access)
-
PET/MRI Versus PET/CT for Whole-Body Staging : Results from a Single-Center Observational Study on 1,003 Sequential ExaminationsIn: Journal of Nuclear Medicine (JNM) Jg. 61 (2020) Nr. 8, S. 1131 - 1136Online Volltext: dx.doi.org/ (Open Access)
-
Peptide Receptor Radionuclide Therapy During the COVID-19 Pandemic : Are There Any Concerns?In: Journal of Nuclear Medicine (JNM) Jg. 61 (2020) Nr. 8, S. 1094 - 1095Online Volltext: dx.doi.org/ (Open Access)
-
Prognostic Factors for Overall Survival in Advanced Intrahepatic Cholangiocarcinoma Treated with Yttrium-90 RadioembolizationIn: Journal of Clinical Medicine (JCM) Jg. 9 (2020) Nr. 1, 56Online Volltext: dx.doi.org/ (Open Access)
-
Prospective evaluation of whole-body MRI and ¹⁸F-FDG PET/MRI in N and M staging of primary breast cancer patientsIn: European Journal of Nuclear Medicine and Molecular Imaging Jg. 47 (2020) Nr. 12, S. 2816 - 2825Online Volltext: dx.doi.org/ (Open Access)
-
Prostate-specific membrane antigen targeted PET imaging for prostate cancer recurrenceIn: Current Opinion in Urology Jg. 30 (2020) Nr. 5, S. 635 - 640Online Volltext: dx.doi.org/
-
Publisher Correction to: 18F-florbetaben positron emission tomography detects cardiac involvement in systemic AA amyloidosisIn: European Journal of Nuclear Medicine and Molecular Imaging Jg. 47 (2020) Nr. 13, S. 3196Online Volltext: dx.doi.org/ (Open Access)
-
Radiomics Analysis of Multiparametric PET/MRI for N- and M-Staging in Patients with Primary Cervical CancerIn: RöFo: Fortschritte auf dem Gebiet der Röntgenstrahlen und der bildgebenden Verfahren Jg. 192 (2020) Nr. 8, S. 754 - 763Online Volltext: dx.doi.org/ (Open Access)
-
Radionuklidtherapie mit PSMA-Liganden bei fortgeschrittenem ProstatakarzinomIn: Der Urologe Jg. 59 (2020) Nr. 6, S. 680 - 686Online Volltext: dx.doi.org/
-
Radiotheranostics : A roadmap for future developmentIn: The Lancet Oncology Jg. 21 (2020) Nr. 3, S. e146 - e156Online Volltext: dx.doi.org/ Online Volltext (Open Access)
-
Re: Prostate-specific Membrane Antigen PET-CT in Patients with High-risk Prostate Cancer Before Curative-intent Surgery or Radiotherapy (proPSMA) : A Prospective, Randomised, Multi-centre StudyIn: European Urology Jg. 78 (2020) Nr. 3, S. 470 - 471Online Volltext: dx.doi.org/
-
Semi-automatically quantified tumor volume using Ga-68-PSMA-11-PET as biomarker for survival in patients with advanced prostate cancerIn: Journal of Nuclear Medicine (JNM) Jg. 61 (2020) Nr. 12, S. 1786 - 1792Online Volltext: dx.doi.org/ (Open Access)
-
Textural analysis of hybrid DOTATOC-PET/MRI and its association with histological grading in patients with liver metastases from neuroendocrine tumorsIn: Nuclear Medicine Communications Jg. 41 (2020) Nr. 4, S. 363 - 369Online Volltext: dx.doi.org/
-
The Future of Nuclear Medicine, Molecular Imaging, and TheranosticsIn: Journal of Nuclear Medicine (JNM) Jg. 61 (2020) Nr. Supplement 2, S. 263S - 272SOnline Volltext: dx.doi.org/ Online Volltext (Open Access)
-
Therapy Response Assessment of Pediatric Tumors with Whole-Body Diffusion-weighted MRI and FDG PET/MRIIn: Radiology Jg. 296 (2020) Nr. 1, S. 143 - 151Online Volltext: dx.doi.org/ Online Volltext (Open Access)
-
Treatment-related changes in neuroendocrine tumors as assessed by textural features derived from ⁶⁸Ga-DOTATOC PET/MRI with simultaneous acquisition of apparent diffusion coefficientIn: BMC Cancer Jg. 20 (2020) Nr. 1, 326Online Volltext: dx.doi.org/ Online Volltext (Open Access)
-
Whole-Body Integrated [⁶⁸Ga]PSMA-11-PET/MR Imaging in Patients with Recurrent Prostate Cancer : Comparison with Whole-Body PET/CT as the Standard of ReferenceIn: Molecular Imaging and Biology Jg. 22 (2020) Nr. 3, S. 788 - 796Online Volltext: dx.doi.org/
-
¹⁸F-FDG PET-MR enterography in predicting histological active disease using the Nancy index in ulcerative colitis : A randomized controlled trialIn: European Journal of Nuclear Medicine and Molecular Imaging Jg. 47 (2020) Nr. 4, S. 768 - 777Online Volltext: dx.doi.org/
-
¹⁸F-FDG-PET/MRI in the diagnostic work-up of limbic encephalitisIn: PLoS ONE Jg. 15 (2020) Nr. 1, S. e0227906Online Volltext: dx.doi.org/ Online Volltext (Open Access)
-
¹⁸F-florbetaben positron computed tomography detects cardiac involvement in systemic AA amyloidosisIn: European Journal of Nuclear Medicine and Molecular Imaging Jg. 47 (2020) Nr. 13, S. 3186 - 3187Online Volltext: dx.doi.org/ (Open Access)
-
“COVID-19 Pandemic as stimulator to Re-Establish Nuclear Medicine as Clinical Specialty” based on a report of Prof. Dr. Ignasi CarrioIn: Nuklearmedizin = Nuclear Medicine Jg. 59 (2020) Nr. 6, S. 405 - 408Online Volltext: dx.doi.org/
-
18F-FDG PET/MRI for Therapy Response Assessment of Isolated Limb Perfusion in Patients with Soft-Tissue SarcomasIn: Journal of Nuclear Medicine (JNM) Jg. 60 (2019) Nr. 11, S. 1537 - 1542Online Volltext: dx.doi.org/ (Open Access)
-
A conversation between Stefano Buono and Ken HerrmannIn: Journal of Nuclear Medicine (JNM) Jg. 60 (2019) Nr. 12, S. 1659 - 1662Online Volltext: dx.doi.org/ (Open Access)
-
A conversation between Susanne Schaffert and Ken HerrmannIn: Journal of Nuclear Medicine (JNM) Jg. 60 (2019) Nr. 7, S. 875 - 878Online Volltext: dx.doi.org/ (Open Access)
-
Assessment of ileocolonic inflammation in Crohn’s disease : Which surrogate marker is better—MAria, Clermont, or PET/MR index? Initial results of a feasibility trialIn: Journal of Nuclear Medicine (JNM) Jg. 60 (2019) Nr. 6, S. 851 - 857Online Volltext: dx.doi.org/ (Open Access)
-
Assessment of ⁶⁸Ga-PSMA-11 PET Accuracy in Localizing Recurrent Prostate Cancer : A Prospective Single-Arm Clinical TrialIn: JAMA Oncology Jg. 5 (2019) Nr. 6, S. 856 - 863Online Volltext: dx.doi.org/ (Open Access)
-
Cardiac PET/MRI—an updateIn: European Journal of Hybrid Imaging: EJNMMI Multimodality Journal Jg. 3 (2019) Nr. 1, 2Online Volltext: dx.doi.org/ (Open Access)
-
Changing trends of incidence and prognosis of thyroid carcinomaIn: Nuklearmedizin = Nuclear Medicine Jg. 58 (2019) Nr. 2, S. 86 - 92Online Volltext: dx.doi.org/
-
Comparison of L-Methyl-11C-Methionine PET With Magnetic Resonance Spectroscopy in Detecting Newly Diagnosed GliomaIn: Clinical Nuclear Medicine Jg. 44 (2019) Nr. 6, S. e375 - e381Online Volltext: dx.doi.org/
-
Development and characterization of a theranostic multimodal anti-PSMA targeting agent for imaging, surgical guidance, and targeted photodynamic therapy of PSMA-expressing tumorsIn: Theranostics Jg. 9 (2019) S. 2924 - 2938Online Volltext: dx.doi.org/ (Open Access)
-
Driving the Future of Nuclear MedicineIn: Journal of Nuclear Medicine (JNM) Jg. 60 (2019) Nr. 9, S. 1S - 2SOnline Volltext: dx.doi.org/ (Open Access)
-
EANM procedure guidelines for radionuclide therapy with ¹⁷⁷Lu-labelled PSMA-ligands (¹⁷⁷Lu-PSMA-RLT)In: European Journal of Nuclear Medicine and Molecular Imaging Jg. 46 (2019) Nr. 12, S. 2536 - 2544Online Volltext: dx.doi.org/
-
EAU–ESMO consensus statements on the management of advanced and variant bladder cancer - an international collaborative multi-stakeholder effort : under the auspices of the EAU and ESMO Guidelines CommitteesIn: Annals of Oncology Jg. 30 (2019) Nr. 11, S. 1697 - 1727Online Volltext: dx.doi.org/ (Open Access)
-
Ga-PSMA-11 Positron Emission Tomography Detects Residual Prostate Cancer after Prostatectomy in a Multicenter Retrospective StudyIn: The Journal of Urology Jg. 202 (2019) Nr. 6, S. 1174 - 1181Online Volltext: dx.doi.org/
-
In vitro and in vivo characterization of an ¹⁸F-ALF-labeled PSMA ligand for imaging of PSMA-expressing xenograftsIn: Journal of Nuclear Medicine (JNM) Jg. 60 (2019) Nr. 7, S. 1017 - 1022Online Volltext: dx.doi.org/ (Open Access)
-
Molecular Imaging for Primary Staging of Prostate CancerIn: Seminars in Nuclear Medicine Jg. 49 (2019) Nr. 4, S. 271 - 279Online Volltext: dx.doi.org/
-
Morphologische Diagnosekriterien der nichtinvasiven follikulären Neoplasie mit PTC-äquivalenten Kernmerkmalen (NIFTP) : Eine diagnostische Herausforderung zum Nutzen des PatientenIn: Der Pathologe Jg. 40 (2019) Nr. 3, S. 220 - 226Online Volltext: dx.doi.org/
-
NAFLD-Associated Comorbidities in Advanced Stage HCC Do Not Alter the Safety and Efficacy of Yttrium-90 RadioembolizationIn: Liver Cancer Jg. 8 (2019) Nr. 6, S. 491 - 504Online Volltext: dx.doi.org/ (Open Access)
-
Novel structured reporting systems for theranostic radiotracersIn: Journal of Nuclear Medicine (JNM) Jg. 60 (2019) Nr. 5, S. 577 - 584Online Volltext: dx.doi.org/ Online Volltext (Open Access)
-
Nuklearmedizinische Diagnostik der SarkoidoseIn: Atemwegs- und Lungenkrankheiten Jg. 45 (2019) Nr. 12, S. 573 - 580Online Volltext: dx.doi.org/
-
PET/MR Imaging of the Female PelvisIn: Seminars in Nuclear Medicine Jg. 49 (2019) Nr. 6, S. 512 - 520Online Volltext: dx.doi.org/
-
PSA-Anstieg nach definitiver TherapieIn: Der Urologe Jg. 58 (2019) Nr. 5, S. 569 - 582Online Volltext: dx.doi.org/
-
Post-radiosynovectomy imaging utilizing Erbium-169 citrateIn: Applied Radiation and Isotopes Jg. 154 (2019) 108853Online Volltext: dx.doi.org/
-
Pretreatment metabolic tumour volume in stage IIIA/B non-small-cell lung cancer uncovers differences in effectiveness of definitive radiochemotherapy schedules : analysis of the ESPATUE randomized phase 3 trialIn: European Journal of Nuclear Medicine and Molecular Imaging Jg. 46 (2019) Nr. 7, S. 1439 - 1447Online Volltext: dx.doi.org/
-
Production of [¹¹C]Formaldehyde by the XeF2 mediated oxidation of [¹¹C]Methanol and its application in the labeling of α-(N-[¹¹C]Methylamino)isobutyric acidIn: Applied Radiation and Isotopes Jg. 148 (2019) S. 178 - 183Online Volltext: dx.doi.org/
-
Prospective comparison of ¹⁸F-FDG PET/MRI and ¹⁸F-FDG PET/CT for thoracic staging of non-small cell lung cancerIn: European Journal of Nuclear Medicine and Molecular Imaging Jg. 46 (2019) Nr. 2, S. 437 - 445Online Volltext: dx.doi.org/
-
Prostate-specific membrane antigen ligand positron emission tomography in men with nonmetastatic castration-resistant prostate cancerIn: Clinical Cancer Research Jg. 25 (2019) Nr. 24, S. 7448 - 7454Online Volltext: dx.doi.org/ (Open Access)
-
Radiomics Analysis of Multiparametric PET/MRI for N- and M-Staging in Patients with Primary Cervical CancerIn: Nuklearmedizin = Nuclear Medicine Jg. 63 (2019) Nr. 1, S. 34 - 42Online Volltext: dx.doi.org/
-
Reply by AuthorsIn: The Journal of Urology Jg. 202 (2019) Nr. 6, S. 1181Online Volltext: dx.doi.org/
-
Sentinel lymph node excision with or without preoperative hybrid single-photon emission computed tomography/computed tomography (SPECT/CT) in melanoma : Study protocol for a multicentric randomized controlled trialIn: Trials Jg. 20 (2019) Nr. 1, S. 99Online Volltext: dx.doi.org/ Online Volltext (Open Access)
-
The beginning of the end for conventional RECIST — novel therapies require novel imaging approachesIn: Nature Reviews Clinical Oncology Jg. 16 (2019) Nr. 7, S. 442 - 458Online Volltext: dx.doi.org/
-
The role of 124I PET/CT lesion dosimetry in differentiated thyroid cancerIn: The Quarterly Journal of Nuclear Medicine and Molecular Imaging Jg. 63 (2019) Nr. 3, S. 235 - 252Online Volltext: dx.doi.org/
-
Theranostics for Advanced Prostate Cancer : Current Indications and Future DevelopmentsIn: European Urology Oncology Jg. 2 (2019) Nr. 2, S. 152 - 162Online Volltext: dx.doi.org/
-
Theranostik von soliden Tumoren : Renaissance eines alten KonzeptsIn: Best Practice Onkologie Jg. 14 (2019) Nr. 12, S. 526 - 534Online Volltext: dx.doi.org/
-
Thyroid stunning in radioiodine-131 therapy of benign thyroid diseasesIn: Endocrine Jg. 63 (2019) Nr. 3, S. 537 - 544Online Volltext: dx.doi.org/
-
Whole-Body [18F]-FDG-PET/MRI for Oncology : A Consensus RecommendationIn: Nuklearmedizin = Nuclear Medicine Jg. 191 (2019) Nr. 2, S. 68 - 76Online Volltext: dx.doi.org/ (Open Access)
-
Whole-Body [18F]-FDG-PET/MRI for oncology : a consensus recommendationIn: RöFo: Fortschritte auf dem Gebiet der Röntgenstrahlen und der bildgebenden Verfahren Jg. 191 (2019) Nr. 4, S. 289 - 297Online Volltext: dx.doi.org/ (Open Access)
-
[⁶⁸Ga]PSMA PET/CT Improves Initial Staging and Management Plan of Patients with High-Risk Prostate CancerIn: Molecular Imaging and Biology Jg. 21 (2019) Nr. 3, S. 574 - 581Online Volltext: dx.doi.org/
-
11C-MET PET/MRI for detection of recurrent gliomaIn: European Journal of Nuclear Medicine and Molecular Imaging Jg. 45 (2018) Nr. 4, S. 593 - 601Online Volltext: dx.doi.org/
-
18F-fluorothymidine PET for predicting survival in patients with resectable pancreatic cancerIn: OncoTarget Jg. 9 (2018) Nr. 11, S. 10128 - 10134Online Volltext: dx.doi.org/ (Open Access)
-
Appropriate use criteria for somatostatin receptor PET imaging in neuroendocrine tumorsIn: Journal of Nuclear Medicine (JNM) Jg. 59 (2018) Nr. 1, S. 66 - 74Online Volltext: dx.doi.org/ (Open Access)
-
CUP syndrome : Metastatic malignancy with unknown primary tumorIn: Deutsches Ärzteblatt international Jg. 115 (2018) Nr. 10, S. 157 - 162Online Volltext: dx.doi.org/ (Open Access)
-
Characterization of site-specifically conjugated monomethyl auristatin E-and duocarmycin-based anti-PSMA antibody-drug conjugates for treatment of PSMA-expressing tumorsIn: Journal of Nuclear Medicine (JNM) Jg. 59 (2018) Nr. 3, S. 494 - 501Online Volltext: dx.doi.org/ (Open Access)
-
Comparison of the clinical performance of upper abdominal PET/DCE-MRI with and without concurrent respiratory motion correction (MoCo)In: European Journal of Nuclear Medicine and Molecular Imaging Jg. 45 (2018) Nr. 12, S. 2147 - 2154Online Volltext: dx.doi.org/
-
Comparison of ¹⁸F-FDG PET/MRI and MRI for pre-therapeutic tumor staging of patients with primary cancer of the uterine cervixIn: European Journal of Nuclear Medicine and Molecular Imaging Jg. 45 (2018) Nr. 1, S. 67 - 76Online Volltext: dx.doi.org/
-
Comparison of ¹⁸F–FDG PET/MRI and MRI alone for whole-body staging and potential impact on therapeutic management of women with suspected recurrent pelvic cancer : a follow-up studyIn: European Journal of Nuclear Medicine and Molecular Imaging Jg. 45 (2018) Nr. 4, S. 622 - 629Online Volltext: dx.doi.org/
-
Comparison of ⁶⁸Ga-PSMA-11 and ¹⁸F-Fluciclovine PET/CT in a case series of 10 patients with prostate cancer recurrenceIn: Journal of Nuclear Medicine (JNM) Jg. 59 (2018) Nr. 5, S. 789 - 794Online Volltext: dx.doi.org/ (Open Access)
-
Consensus on molecular imaging and theranostics in prostate cancerIn: The Lancet Oncology Jg. 19 (2018) Nr. 12, S. e696 - e708Online Volltext: dx.doi.org/
-
Correlation of immunohistochemical parameters, apparent diffusion coefficient (ADC) and standardized uptake value (SUV) in lung cancer using hybrid PET/MRIIn: European Journal of Nuclear Medicine and Molecular Imaging Jg. 45 (2018) Nr. Suppl. 1, S. 176
-
Detection Threshold and Reproducibility of ⁶⁸Ga-PSMA11 PET/CT in a Mouse Model of Prostate CancerIn: Journal of Nuclear Medicine (JNM) Jg. 59 (2018) Nr. 9, S. 1392 - 1397Online Volltext: dx.doi.org/ (Open Access)
-
Dual‐phase hybrid 18F‐Fluoride Positron emission tomography/MRI in ankylosing spondylitis : Investigating the link between MRI bone changes, regional hyperaemia and increased osteoblastic activityIn: Journal of Medical Imaging and Radiation Oncology Jg. 62 (2018) Nr. 3, S. 313 - 319Online Volltext: dx.doi.org/
-
Extrahepatic Comorbidities Do Not Alter the Safety and Efficacy of Radioembolization of NAFLD-Associated HCCIn: Hepatology Jg. 68 (2018) Nr. Suppl. 1, S. 852A - 853A
-
Impact of Ga-PSMA-11 PET/CT on the Management of Prostate Cancer Patients with Biochemical RecurrenceIn: Journal of Nuclear Medicine (JNM) Jg. 59 (2018) Nr. 3, S. 434 - 441Online Volltext: dx.doi.org/ (Open Access)
-
Impact of prompt gamma coincidence correction on absorbed dose estimation in differentiated thyroid cancer using 124 i PET/CT imagingIn: Nuclear Medicine Communications Jg. 39 (2018) Nr. 12, S. 1156 - 1164Online Volltext: dx.doi.org/
-
Integrated ⁶⁸Gallium Labelled Prostate-Specific Membrane Antigen-11 Positron Emission Tomography/Magnetic Resonance Imaging Enhances Discriminatory Power of Multi-Parametric Prostate Magnetic Resonance ImagingIn: Urologia Internationalis Jg. 100 (2018) Nr. 2, S. 164 - 171Online Volltext: dx.doi.org/
-
Local and whole-body staging in patients with primary breast cancer : a comparison of one-step to two-step staging utilizing ¹⁸F-FDG-PET/MRIIn: European Journal of Nuclear Medicine and Molecular Imaging Jg. 45 (2018) Nr. 13, S. 2328 - 2337Online Volltext: dx.doi.org/
-
Local and whole-body staging in patients with primary breast cancer : A comparison of one-step to two-step-staging utilizing F-18-FDG-PET/MRIIn: European Journal of Nuclear Medicine and Molecular Imaging Jg. 45 (2018) Nr. Suppl. 1, S. 456
-
Lutetium-177-PSMA-Radioligandentherapie : Konsensus im Rahmen der GKV-finanzierten Versorgung zwischen den Hochschulkliniken in Aachen, Bonn, Düsseldorf, Essen und Köln und dem MDK NordrheinIn: Der Urologe Jg. 57 (2018) Nr. 6, S. 709 - 713Online Volltext: dx.doi.org/
-
MET Expression in Advanced Non–Small-Cell Lung Cancer : Effect on Clinical Outcomes of Chemotherapy, Targeted Therapy, and ImmunotherapyIn: Clinical Lung Cancer Jg. 19 (2018) Nr. 4, S. e441 - e463Online Volltext: dx.doi.org/
-
Microscale radiosynthesis, preclinical imaging and dosimetry study of [¹⁸F]AMBF₃-TATE : A potential PET tracer for clinical imaging of somatostatin receptorsIn: Nuclear Medicine and Biology Jg. 61 (2018) S. 36 - 44Online Volltext: dx.doi.org/ Online Volltext (Open Access)
-
Potential impact of ⁶⁸Ga-PSMA-11 PET/CT on the planning of definitive radiation therapy for prostate cancerIn: Journal of Nuclear Medicine (JNM) Jg. 59 (2018) Nr. 11, S. 1714 - 1721Online Volltext: dx.doi.org/ (Open Access)
-
Preclinical evaluation of PSMA expression in response to androgen receptor blockade for theranostics in prostate cancerIn: EJNMMI Research Jg. 8 (2018) Nr. 1, 96Online Volltext: dx.doi.org/ (Open Access)
-
Pretherapeutic 124 i dosimetry reliably predicts intratherapeutic blood kinetics of 131 i in patients with differentiated thyroid carcinoma receiving high therapeutic activitiesIn: Nuclear Medicine Communications Jg. 39 (2018) Nr. 5, S. 457 - 464Online Volltext: dx.doi.org/
-
Prostate cancer molecular imaging standardized evaluation (PROMISE) : Proposed miTNM classification for the interpretation of PSMA-ligand PET/CTIn: Journal of Nuclear Medicine (JNM) Jg. 59 (2018) Nr. 3, S. 469 - 478Online Volltext: dx.doi.org/ (Open Access)
-
Quantitative performance evaluation of I PET/MRI lesion dosimetry in differentiated thyroid cancerIn: Physics in Medicine and Biology Jg. 63 (2018) Nr. 1, S. 015014Online Volltext: dx.doi.org/ Online Volltext (Open Access)
-
Quantitative performance of ¹²⁴I PET/MR of neck lesions in thyroid cancer patients using ¹²⁴I PET/CT as referenceIn: EJNMMI Physics Jg. 5 (2018) Nr. 1, 13Online Volltext: dx.doi.org/ Online Volltext (Open Access)
-
Reply : Comparison of Ga-PSMA-11 and F-Fluciclovine PET/CT in a Case Series of 10 Patients with Prostate Cancer Recurrence: Prospective Trial Is on Its WayIn: Journal of Nuclear Medicine (JNM) Jg. 59 (2018) Nr. 5, S. 861Online Volltext: dx.doi.org/ (Open Access)
-
Simultaneous multiparametric PET/MRI for the assessment of therapeutic response to chemotherapy or concurrent chemoradiotherapy of cervical cancer patients : preliminary resultsIn: Clinical Imaging Jg. 49 (2018) S. 163 - 168Online Volltext: dx.doi.org/
-
Strategies and technical challenges for imaging oligometastatic disease : Recommendations from the European Organisation for Research and Treatment of Cancer imaging groupIn: European Journal of Cancer (EJC) Jg. 91 (2018) S. 153 - 163Online Volltext: dx.doi.org/
-
Targeting CXCR4 (CXC Chemokine Receptor Type 4) for molecular imaging of aldosterone-producing adenomaIn: Hypertension Jg. 71 (2018) Nr. 2, S. 317 - 325Online Volltext: dx.doi.org/; Online Volltext: dx.doi.org/ (Open Access)
-
Use of FET PET in glioblastoma patients undergoing neurooncological treatment including tumour-treating fields : initial experienceIn: European Journal of Nuclear Medicine and Molecular Imaging Jg. 45 (2018) Nr. 9, S. 1626 - 1635Online Volltext: dx.doi.org/
-
Use of modern imaging methods to facilitate trials of metastasis-directed therapy for oligometastatic disease in prostate cancer : a consensus recommendation from the EORTC Imaging GroupIn: The Lancet Oncology Jg. 19 (2018) Nr. 10, S. e534 - e545Online Volltext: dx.doi.org/ Online Volltext (Open Access)
-
[¹⁸F]FDG PET/MR enterography for the assessment of inflammatory activity in Crohn’s disease: comparison of different MRI and PET parametersIn: European Journal of Nuclear Medicine and Molecular Imaging Jg. 45 (2018) Nr. 8, S. 1382 - 1393Online Volltext: dx.doi.org/
-
⁶⁸Ga-PSMA-11 PET/CT mapping of prostate cancer biochemical recurrence after radical prostatectomy in 270 patients with a PSA level of less than 1.0 ng/mL : Impact on salvage radiotherapy planningIn: Journal of Nuclear Medicine (JNM) Jg. 59 (2018) Nr. 2, S. 230 - 237Online Volltext: dx.doi.org/ (Open Access)
-
(18)F-FDG PET/MRI in patients suffering from lymphoma : how much MRI information is really needed?In: European Journal of Nuclear Medicine and Molecular Imaging Jg. 44 (2017) Nr. 6, S. 1005 - 1013Online Volltext: dx.doi.org/
-
177Lu-PSMA Radioligand Therapy for Prostate CancerIn: Journal of Nuclear Medicine (JNM) Jg. 58 (2017) Nr. 8, S. 1196 - 1200Online Volltext: dx.doi.org/ (Open Access)
-
18 F-FDG PET/MR imaging in patients with suspected liver lesions: Value of liver-specific contrast agent Gadobenate dimeglumine.In: PLoS ONE Jg. 12 (2017) Nr. 7, S. e0180349Online Volltext: dx.doi.org/ (Open Access)
-
18F-Fluorodeoxyglucose Positron Emission Tomography/Computed Tomography May Exclude Malignancy in Sonographically Suspicious and Scintigraphically Hypofunctional Thyroid Nodules and Reduce Unnecessary Thyroid SurgeriesIn: Thyroid Jg. 27 (2017) Nr. 10, S. 1300 - 1306Online Volltext: dx.doi.org/
-
68Ga-DOTATATE PET/CT Interobserver Agreement for Neuroendocrine Tumor Assessment : Results of a Prospective Study on 50 PatientsIn: Journal of Nuclear Medicine (JNM) Jg. 58 (2017) Nr. 2, S. 307 - 311Online Volltext: dx.doi.org/ Online Volltext (Open Access)
-
68Ga-PSMA PET/CT : Joint EANM and SNMMI procedure guideline for prostate cancer imaging: version 1.0In: European Journal of Nuclear Medicine and Molecular Imaging Jg. 44 (2017) Nr. 6, S. 1014 - 1024Online Volltext: dx.doi.org/
-
68Ga-PSMA-11 PET/CT Interobserver Agreement for Prostate Cancer Assessments : An International Multicenter Prospective StudyIn: Journal of Nuclear Medicine (JNM) Jg. 58 (2017) Nr. 10, S. 1617 - 1623Online Volltext: dx.doi.org/
-
A PET for All Seasons : 18F-Fluorodeoxyglucose to Characterize Inflammation and Malignancy in Retroperitoneal Fibrosis?In: European Urology Jg. 71 (2017) Nr. 6, S. 934 - 935Online Volltext: dx.doi.org/
-
CXCR4 ligands : The next big hit?In: Journal of Nuclear Medicine (JNM) Jg. 58 (2017) Nr. Suppl. 2, S. 77S - 82SOnline Volltext: dx.doi.org/
-
CXCR4-directed endoradiotherapy induces high response rates in extramedullary relapsed Multiple MyelomaIn: Theranostics Jg. 7 (2017) Nr. 6, S. 1589 - 1597Online Volltext: dx.doi.org/ (Open Access)
-
Cholinergic activity and levodopa-induced dyskinesia: a multitracer molecular imaging studyIn: Annals of Clinical and Translational Neurology Jg. 4 (2017) Nr. 9, S. 632 - 639Online Volltext: dx.doi.org/ (Open Access)
-
Current Concepts in 68Ga-DOTATATE Imaging of Neuroendocrine Neoplasms : Interpretation, Biodistribution, Dosimetry, and Molecular StrategiesIn: Journal of Nuclear Medicine (JNM) Jg. 58 (2017) Nr. 11, S. 1718 - 1726Online Volltext: dx.doi.org/ (Open Access)
-
Diagnostic accuracy of 18F–FDG PET/CT and MR imaging in patients with adenoid cystic carcinomaIn: BMC Cancer Jg. 17 (2017) Nr. 1, S. 887Online Volltext: dx.doi.org/ Online Volltext (Open Access)
-
Establishing 177Lu-PSMA-617 Radioligand Therapy in a Syngeneic Model of Murine Prostate CancerIn: Journal of Nuclear Medicine (JNM) Jg. 58 (2017) Nr. 11, S. 1786 - 1792Online Volltext: dx.doi.org/ (Open Access)
-
Evaluation of 68Ga-DOTATOC PET/MRI for whole-body staging of neuroendocrine tumours in comparison with 68Ga-DOTATOC PET/CTIn: European Radiology Jg. 27 (2017) Nr. 10, S. 4091 - 4099Online Volltext: dx.doi.org/
-
From NETTER to PETTER : PSMA-Targeted radioligand therapyIn: Journal of Nuclear Medicine (JNM) Jg. 58 (2017) Nr. 1, S. 9 - 10Online Volltext: dx.doi.org/
-
Human Biodistribution and Radiation Dosimetry of 18F-Clofarabine, a PET Probe Targeting the Deoxyribonucleoside Salvage PathwayIn: Journal of Nuclear Medicine (JNM) Jg. 58 (2017) Nr. 3, S. 374 - 378Online Volltext: dx.doi.org/
-
Imaging children suffering from lymphoma : an evaluation of different ; 18F-FDG PET/MRI protocols compared to whole-body DW-MRIIn: European Journal of Nuclear Medicine and Molecular Imaging Jg. 44 (2017) Nr. 10, S. 1742 - 1750Online Volltext: dx.doi.org/
-
Imaging of Chemokine Receptor 4 Expression in Neuroendocrine Tumors - a Triple Tracer Comparative ApproachIn: Theranostics Jg. 7 (2017) Nr. 6, S. 1489 - 1498Online Volltext: dx.doi.org/ (Open Access)
-
Integrated 18F–FDG PET/MRI compared to MRI alone for identification of local recurrences of soft tissue sarcomas : a comparison trialIn: European Journal of Nuclear Medicine and Molecular Imaging Jg. 44 (2017) Nr. 11, S. 1823 - 1831Online Volltext: dx.doi.org/
-
Investigating the Chemokine Receptor 4 as Potential Theranostic Target in Adrenocortical Cancer PatientsIn: Clinical Nuclear Medicine Jg. 42 (2017) Nr. 1, S. e29 - e34Online Volltext: dx.doi.org/
-
Most of the Intended Management Changes After 68Ga-DOTATATE PET/CT Are ImplementedIn: Journal of Nuclear Medicine (JNM) Jg. 58 (2017) Nr. 11, S. 1793 - 1796Online Volltext: dx.doi.org/ Online Volltext (Open Access)
-
Neuroendocrine Tumors of the Gastrointestinal TractIn: Visceral Medicine Jg. 33 (2017) Nr. 5, S. 368 - 371Online Volltext: dx.doi.org/ (Open Access)
-
PSMA ligands for PET imaging of prostate cancerIn: Journal of Nuclear Medicine (JNM) Jg. 58 (2017) Nr. 10, S. 1545 - 1552Online Volltext: dx.doi.org/
-
PSMA ligands in prostate cancer – Probe optimization and theranostic applicationsIn: Methods: A Companion to Methods in Enzymology Jg. 130 (2017) S. 42 - 50Online Volltext: dx.doi.org/
-
Prostate-specific membrane antigen ligands for imaging and therapyIn: Journal of Nuclear Medicine (JNM) Jg. 58 (2017) Nr. Suppl. 2, S. 67S - 76SOnline Volltext: dx.doi.org/
-
Radiation Dosimetry for 177Lu-PSMA I&T in Metastatic Castration-Resistant Prostate Cancer : Absorbed Dose in Normal Organs and Tumor LesionsIn: Journal of Nuclear Medicine (JNM) Jg. 58 (2017) Nr. 3, S. 445 - 450Online Volltext: dx.doi.org/ (Open Access)
-
Re: Diagnostic Accuracy of Ga-68-HBED-CC-PSMA-ligand-PET/CT Before Salvage Lymph Node Dissection for Recurrent Prostate CancerIn: European Urology Jg. 72 (2017) Nr. 3, S. 470 - 471Online Volltext: dx.doi.org/
-
Response assessment of bevacizumab therapy in GBM with integrated 11C-MET-PET/MRI : a feasibility studyIn: European Journal of Nuclear Medicine and Molecular Imaging Jg. 44 (2017) Nr. 8, S. 1285 - 1295Online Volltext: dx.doi.org/
-
Targeting CXCR4 with [68Ga]Pentixafor : A suitable theranostic approach in pleural mesothelioma?In: OncoTarget Jg. 8 (2017) Nr. 57, S. 96732 - 96737Online Volltext: dx.doi.org/ (Open Access)
-
The impact of somatostatin receptor-directed PET/CT on the management of patients with neuroendocrine tumor : A systematic review and meta-analysisIn: Journal of Nuclear Medicine (JNM) Jg. 58 (2017) Nr. 5, S. 756 - 761Online Volltext: dx.doi.org/ (Open Access)
-
Therapy assessment in prostate cancer using choline and PSMA PET/CTIn: European Journal of Nuclear Medicine and Molecular Imaging Jg. 44 (2017) Nr. Suppl. 1, S. S78 - S83Online Volltext: dx.doi.org/
-
Whitening and Impaired Glucose Utilization of Brown Adipose Tissue in a Rat Model of Type 2 Diabetes MellitusIn: Scientific Reports Jg. 7 (2017) Nr. 1, S. 16795Online Volltext: dx.doi.org/ (Open Access)
-
Whole-body staging of female patients with recurrent pelvic malignancies : Ultra-fast 18F-FDG PET/MRI compared to 18F-FDG PET/CT and CTIn: PLoS ONE Jg. 12 (2017) Nr. 2, S. e0172553Online Volltext: dx.doi.org/ (Open Access)
-
[68Ga]Pentixafor-PET/CT for imaging of chemokine receptor CXCR4 expression in multiple myeloma - Comparison to [18F]FDG and laboratory valuesIn: Theranostics Jg. 7 (2017) Nr. 1, S. 205 - 212Online Volltext: dx.doi.org/ (Open Access)
-
¹¹C-Methionine-PET in Multiple Myeloma : A Combined Study from Two Different InstitutionsIn: Theranostics Jg. 7 (2017) Nr. 11, S. 2956 - 2964Online Volltext: dx.doi.org/ (Open Access)
-
(68)Ga-labeled Prostate-specific Membrane Antigen Positron Emission Tomography for Prostate Cancer Imaging : The New Kid on the Block-Early or Too Early to Draw Conclusions?In: European Urology Jg. 70 (2016) Nr. 6, S. 938 - 940Online Volltext: dx.doi.org/
-
First-in-human experience of CXCR4-directed endoradiotherapy with ¹⁷⁷Lu-and ⁹⁰Y-labeled pentixather in advanced-stage multiple myeloma with extensive intra-and extramedullary diseaseIn: Journal of Nuclear Medicine (JNM) Jg. 57 (2016) Nr. 2, S. 248 - 251Online Volltext: dx.doi.org/
-
Impact of (68)Ga-PSMA PET/CT on salvage radiotherapy planning in patients with prostate cancer and persisting PSA values or biochemical relapse after prostatectomyIn: EJNMMI Research Jg. 6 (2016) Nr. 1, 78Online Volltext: dx.doi.org/ (Open Access)
-
Initial Preclinical Evaluation of 18F-Fluorodeoxysorbitol PET as a Novel Functional Renal Imaging AgentIn: Journal of Nuclear Medicine (JNM) Jg. 57 (2016) Nr. 10, S. 1625 - 1628Online Volltext: dx.doi.org/
-
Prostate specific membrane antigen (PSMA) ligands for diagnosis and therapy of prostate cancerIn: Expert Review of Molecular Diagnostics Jg. 16 (2016) Nr. 11, S. 1177 - 1188Online Volltext: dx.doi.org/
-
The incidence of thyroid cancer in focal hypermetabolic thyroid lesions : an 18F-FDG PET/CT study in more than 6000 patientsIn: Nuclear Medicine Communications Jg. 37 (2016) Nr. 12, S. 1290 - 1296Online Volltext: dx.doi.org/ Online Volltext (Open Access)
-
¹¹C-methionine-PET in multiple myeloma : Correlation with clinical parameters and bone marrow involvementIn: Theranostics Jg. 6 (2016) Nr. 2, S. 254 - 261Online Volltext: dx.doi.org/ (Open Access)
-
In vivo molecular imaging of chemokine receptor CXCR4 expression in patients with advanced multiple myelomaIn: EMBO Molecular Medicine Jg. 7 (2015) Nr. 4, S. 477 - 487Online Volltext: dx.doi.org/ (Open Access)
-
¹¹C-Methionine-PET : A novel and sensitive tool for monitoring of early response to treatment in multiple myelomaIn: OncoTarget Jg. 6 (2015) Nr. 10, S. 8418 - 8429Online Volltext: dx.doi.org/ (Open Access)
-
Somatostatin receptor expression in Merkel cell carcinoma as target for molecular imagingIn: BMC Cancer Jg. 14 (2014) Nr. 1,Online Volltext: dx.doi.org/ (Open Access)
-
¹⁸FDG-PET/CT for prognostic stratification of patients with multiple myeloma relapse after stem cell transplantationIn: OncoTarget Jg. 5 (2014) Nr. 17, S. 7381 - 7391Online Volltext: dx.doi.org/ (Open Access)
-
A genome-wide RNAi screen identifies proteins modulating aberrant FLT3-ITD signalingIn: Leukemia Jg. 27 (2013) Nr. 12, S. 2301 - 2310Online Volltext: dx.doi.org/
-
Nuclear medicine in the assessment and prevention of cancer therapy-related cardiotoxicity : Prospects and proposal of use by the European Association of Nuclear Medicine (EANM)In: European Journal of Nuclear Medicine and Molecular Imaging Jg. 50 (2023) Nr. 3, S. 792 - 812Online Volltext: dx.doi.org/ (Open Access)
-
A New Chapter in Neoadjuvant Therapy for High-risk Prostate Cancer?In: European Urology Jg. 85 (2024) Nr. 3, S. 227 - 228Online Volltext: dx.doi.org/
-
Prostate-specific Membrane Antigen (PSMA) Spatial Biomarker : Standardized Positron Emission Tomography Disease Maps Provide Accurate Prediction of Overall Survival in Prostate CancerIn: European Urology (2024) in pressOnline Volltext: dx.doi.org/
-
The novel PROMISE framework for PSMA-PET reporting : Ready for the clinical routine?In: Clinical and Translational Imaging Jg. 12 (2024) Nr. 1, S. 1 - 3Online Volltext: dx.doi.org/ (Open Access)
-
An EANM position paper on advancing radiobiology for shaping the future of nuclear medicineIn: European Journal of Nuclear Medicine and Molecular Imaging Jg. 50 (2023) Nr. 2, S. 242 - 246Online Volltext: dx.doi.org/ (Open Access)
-
Defining the role of nuclear medicine in haematological tumours—EANM Focus 4 : consensus on molecular imaging and therapy in haematological tumoursIn: European Journal of Nuclear Medicine and Molecular Imaging Jg. 50 (2023) Nr. 10, S. 2925 - 2926Online Volltext: dx.doi.org/ (Open Access)
-
EANM position paper: theranostics in brain tumours : The present and the futureIn: European Journal of Nuclear Medicine and Molecular Imaging Jg. 51 (2023) Nr. 1, S. 202 - 205Online Volltext: dx.doi.org/ (Open Access)
-
Fibroblast Activation Protein as a Diagnostic and Therapeutic Target : Where Do We Go from Here?In: PET Clinics Jg. 18 (2023) Nr. 3, S. xv - xxOnline Volltext: dx.doi.org/
-
How to attract young talent to nuclear medicine step 1 : a survey conducted by the EANM Oncology and Theranostics Committee to understand the expectations of the next generationIn: European Journal of Nuclear Medicine and Molecular Imaging Jg. 51 (2023) Nr. 1, S. 3 - 11Online Volltext: dx.doi.org/ (Open Access)
-
More Accurate Imaging Is Not Stage Migration : Time To Move from “Hubble” to “Webb” in Hormone-sensitive Prostate CancerIn: European Urology Jg. 83 (2023) Nr. 1, S. 6 - 9Online Volltext: dx.doi.org/
-
Positive Prostate-specific Membrane Antigen Findings : How To Interpret ThemIn: European Urology Oncology Jg. 6 (2023) Nr. 2, S. 113 - 115Online Volltext: dx.doi.org/
-
Strategy planning for turbulent times in nuclear medicine : Time to begin at the beginning?In: European Journal of Nuclear Medicine and Molecular Imaging Jg. 51 (2023) Nr. 1, S. 12 - 19Online Volltext: dx.doi.org/ (Open Access)
-
What Is Theranostics?In: Journal of Nuclear Medicine (JNM) Jg. 64 (2023) Nr. 5, S. 669 - 670Online Volltext: dx.doi.org/ (Open Access)
-
European Association of Nuclear Medicine (EANM) response to the proposed ASTRO’s framework for radiopharmaceutical therapy curriculum development for traineesIn: European Journal of Nuclear Medicine and Molecular Imaging Jg. 50 (2022) Nr. 1, S. 1 - 3Online Volltext: dx.doi.org/ (Open Access)
-
Role of Prostate-Specific Membrane Antigen PET in Metastatic Prostate Cancer : We Have the AnswersIn: Journal of Nuclear Medicine (JNM) Jg. 63 (2022) Nr. 10, S. 1480 - 1481Online Volltext: dx.doi.org/ (Open Access)
-
2021: the year [¹⁷⁷Lu]Lu-PSMA-617 RLT PSMA is ready for incorporation into clinical guidelines? : Reply to “A perspective on the EANM procedure guidelines for radionuclide therapy with 177Lu-labelled PSMA-ligands” by Dr. Germo GerickeIn: European Journal of Nuclear Medicine and Molecular Imaging (2021)Online Volltext: dx.doi.org/ Online Volltext (Open Access)
-
EANM Focus 3: The International Conference on Molecular Imaging and Theranostics in Neuroendocrine Tumours—the consensus in a nutshellIn: European Journal of Nuclear Medicine and Molecular Imaging Jg. 48 (2021) S. 1276 - 1277Online Volltext: dx.doi.org/ (Open Access)
-
Kamingespräch § 13 (2b) AMG in der nuklearmedizinischen Therapie : Eine Follow-up-Veranstaltung der NuklearMedizin 2020 - DigitalIn: Nuklearmedizin = Nuclear Medicine Jg. 60 (2021) Nr. 4, S. 262 - 263Online Volltext: dx.doi.org/
-
Nuclear Medicine Beyond VISIONIn: Journal of Nuclear Medicine (JNM) Jg. 62 (2021) Nr. 7, S. 916 - 917Online Volltext: dx.doi.org/ (Open Access)
-
Real-World Data as an Evidence Source in Nuclear MedicineIn: Journal of Nuclear Medicine (JNM) Jg. 62 (2021) Nr. 2, S. 156 - 157Online Volltext: dx.doi.org/ (Open Access)
-
COVID-19 pandemic : guidance for nuclear medicine departmentsIn: European Journal of Nuclear Medicine and Molecular Imaging Jg. 47 (2020) Nr. 7, S. 1615 - 1619Online Volltext: dx.doi.org/ (Open Access)
-
HybridbildgebungIn: Der Radiologe Jg. 60 (2020) Nr. 5, S. 375Online Volltext: dx.doi.org/ (Open Access)
-
Influence of androgen deprivation therapy on PSMA expression and PSMA-ligand PET imaging of prostate cancer patientsIn: European Journal of Nuclear Medicine and Molecular Imaging Jg. 47 (2020) Nr. 1, S. 9 - 15Online Volltext: dx.doi.org/ (Open Access)
-
Metabolic response assessment and PET-guided treatment of esophageal cancerIn: Annals of Oncology Jg. 31 (2020) Nr. 2, S. 163 - 164Online Volltext: dx.doi.org/ (Open Access)
-
Nuclear medicine services after COVID-19: gearing up back to normalityIn: European Journal of Nuclear Medicine and Molecular Imaging Jg. 47 (2020) Nr. 9, S. 2048 - 2053Online Volltext: dx.doi.org/ (Open Access)
-
Proposal for Systemic-Therapy Response-Assessment Criteria at the Time of PSMA PET/CT Imaging : The PSMA PET Progression CriteriaIn: Journal of Nuclear Medicine (JNM) Jg. 61 (2020) Nr. 5, S. 678 - 682Online Volltext: dx.doi.org/ (Open Access)
-
Realising the potential of radioligand therapy: policy solutions for the barriers to implementation across EuropeIn: European Journal of Nuclear Medicine and Molecular Imaging Jg. 47 (2020) Nr. 6, S. 1335 - 1339Online Volltext: dx.doi.org/ (Open Access)
-
Caveat Emptor : Let our acclaim of the apotheosis of PRRT not blind us to the error of PrometheusIn: Journal of Nuclear Medicine (JNM) Jg. 60 (2019) Nr. 1, S. 7 - 8Online Volltext: dx.doi.org/ (Open Access)
-
EJNMMI supplement : bringing AI and radiomics to nuclear medicineIn: European Journal of Nuclear Medicine and Molecular Imaging Jg. 46 (2019) S. 2627 - 2629Online Volltext: dx.doi.org/ (Open Access)
-
Zukunftsworkshop 1.0 : Aufbruch in die Zukunft oder ein Strohfeuer?In: Nuklearmedizin = Nuclear Medicine Jg. 58 (2019) Nr. 4, S. 297 - 300Online Volltext: dx.doi.org/
-
PrefaceIn: PET/MR Imaging: Current and Emerging Applications / Umutlu, Lale; Herrmann, Ken (Hrsg.) (2018) S. vii
-
Theranostic concepts: More than just a fashion trend-introduction and overviewIn: Journal of Nuclear Medicine (JNM) Jg. 58 (2017) S. 1S - 2SOnline Volltext: dx.doi.org/
-
A Conversation Between Christoph Zindel and Ken HerrmannIn: Journal of Nuclear Medicine (JNM) Jg. 61 (2020) Nr. 8, S. 1088 - 1090Online Volltext: dx.doi.org/ (Open Access)
-
Baseline ctDNA analyses and associations with outcomes in taxane-naive patients with mCRPC treated with 177Lu-PSMA-617 versus change of ARPI in PSMAforeIn: Journal of Clinical Oncology (JCO) Jg. 42 (2024) Nr. Suppl. 16, 5008Online Volltext: dx.doi.org/ (Open Access)
-
First-line efficacy of [177Lu]Lu-DOTA-TATE in patients with advanced grade 2 and grade 3, well-differentiated gastroenteropancreatic neuroendocrine tumors by tumor grade and primary origin: Subgroup analysis of the phase III NETTER-2 study
ESMO Gastrointestinal Cancers Congress 2024, 26-29 June 2024, Munich, Germany,In: Annals of Oncology Jg. 35 (2024) Nr. Supplement 1, S. S92 - S93Online Volltext: dx.doi.org/ -
Health-related quality of life and pain in a phase 3 study of [177Lu]Lu-PSMA-617 in taxane-naïve patients with metastatic castration-resistant prostate cancer (PSMAfore)In: Journal of Clinical Oncology (JCO) Jg. 42 (2024) Nr. Suppl. 16, 5003Online Volltext: dx.doi.org/
-
Prognostic PSMA-PET PROMISE nomograms for patients with prostate cancerIn: Journal of Clinical Oncology (JCO) Jg. 42 (2024) Nr. Suppl. 16, 5016Online Volltext: dx.doi.org/
-
Safety and time to response of [177Lu]Lu-DOTATATE in patients with newly diagnosed advanced grade 2 and grade 3, well-differentiated gastroenteropancreatic neuroendocrine tumors : Sub-analysis of the phase 3 randomized NETTER-2 studyIn: Journal of Clinical Oncology (JCO) Jg. 42 (2024) Nr. Suppl. 16, 4131Online Volltext: dx.doi.org/ (Open Access)
-
[177Lu]Lu-DOTA-TATE in newly diagnosed patients with advanced grade 2 and grade 3, well-differentiated gastroenteropancreatic neuroendocrine tumors : Primary analysis of the phase 3 randomised NETTER-2 studyIn: Journal of Neuroendocrinology Jg. 36 (2024) Nr. Suppl. 1, S. 203
-
[177Lu]Lu-DOTA-TATE in newly diagnosed patients with advanced grade 2 and grade 3, well-differentiated gastroenteropancreatic neuroendocrine tumors : Primary analysis of the phase 3 randomized NETTER-2 studyIn: Journal of Clinical Oncology (JCO) Jg. 42 (2024) Nr. Suppl. 3, LBA588Online Volltext: dx.doi.org/
-
68Ga-FAPI PET/CT novel diagnostic tool in sarcoma
Annual Congress of the European Association of Nuclear Medicine, 9-13 September 2023 Vienna, Austria,In: European Journal of Nuclear Medicine and Molecular Imaging Jg. 50 (2023) Nr. 1 supplement, S. S415Online Volltext: dx.doi.org/ (Open Access) -
68Ga-FAPI-46 PET for imaging of FAP expressing cancer - interim findings from a single-center prospective interventional single-arm clinical trialIn: Journal of Nuclear Medicine (JNM) Jg. 64 (2023) Nr. Suppl. 1, P706
-
68Ga-NeoB PET for Glioma and Breast Cancer : First Results from a Prospective Observational Trial
Annual Congress of the European Association of Nuclear Medicine, 9-13 September 2023 Vienna, Austria,In: European Journal of Nuclear Medicine and Molecular Imaging Jg. 50 (2023) Nr. 1 supplement, S. S265Online Volltext: dx.doi.org/ (Open Access) -
68Ga-SSO-120 versus 18F-FDG PET in the Initial Staging of Small-Cell Lung Cancer PatientsIn: European Journal of Nuclear Medicine and Molecular Imaging Jg. 50 (2023) Nr. Suppl. 1, Annual Congress of the European Association of Nuclear Medicine September 9–13, 2023 Vienna, Austria, S. 488 - S489Online Volltext: dx.doi.org/
-
68Ga-Satoreotide PET for Staging of Small-Cell Lung Cancer PatientsIn: Journal of Nuclear Medicine (JNM) Jg. 64 (2023) Nr. Suppl. 1, P165
-
A retrospective multicenter analysis of the incidence of bone only disease at PSMA PET/CT in Castration Resistant Prostate Cancer (CRPC) patients
55th Annual Conference of the Society-of-Nuclear-Medicine (SNMICON); NOV 16-19, 2023; Jodhpur, India,In: Journal of Nuclear Medicine (JNM) Jg. 64 (2023) Nr. Suppl. 1, P299 -
Added diagnostic sensitivity of MTV and TLG in the assessment of left adrenal gland metastasis in lung cancer with [18F]FDG PET/CT
Annual Congress of the European Association of Nuclear Medicine, 19-13 September 2023, Vienna, Austria,In: European Journal of Nuclear Medicine and Molecular Imaging Jg. 50 (2023) Nr. 1 supplement, S. S485Online Volltext: dx.doi.org/ (Open Access) -
Analysing the Tumour Transcriptome of Prostate Cancer to Predict Efficacy of Lu-PSMA Therapy
Annual Congress of the European Association of Nuclear Medicine, 9-13 September 2023 Vienna, Austria,In: European Journal of Nuclear Medicine and Molecular Imaging Jg. 50 (2023) Nr. 1 supplement, S. S180Online Volltext: dx.doi.org/ (Open Access) -
Assessment of Response Evaluation Criteria in PSMA PET/CT (RECIP 1.0) in Metastatic Castration-Resistant Prostate Cancer
Annual Congress of the European Association of Nuclear Medicine, 9-13 September 2023 Vienna, Austria,In: European Journal of Nuclear Medicine and Molecular Imaging Jg. 50 (2023) Nr. 1 supplement, S. S544 - S545Online Volltext: dx.doi.org/ (Open Access) -
Association of baseline quantitative [68Ga]Ga-PSMA-11 PET imaging parameters with clinical outcomes in patients with mCRPC receiving [177Lu]Lu-PSMA-617 : a VISION sub-study
Annual Congress of the European Association of Nuclear Medicine, 9-13 September 2023 Vienna, Austria,In: European Journal of Nuclear Medicine and Molecular Imaging Jg. 50 (2023) Nr. 1 supplement, S. S155Online Volltext: dx.doi.org/ (Open Access) -
Fet pet sensitivity in primary brain tumors according to cns who 2021 : value and pitfalls in presurgical implementationIn: Neuro-Oncology Jg. 25 (2023) Nr. Suppl. 5, S. v204 - v205Online Volltext: dx.doi.org/
-
Fibroblast activation protein alpha (FAPα) directed imaging and radioligand therapy in patients with solitary fibrous tumor (SFT)In: Journal of Nuclear Medicine (JNM) Jg. 64 (2023) Nr. Suppl. 1, P714
-
From CHAARTED low- and high-volume disease to PSMA PET imaging volume in mHSPC patients : an international multicenter retrospective study
Annual Congress of the European Association of Nuclear Medicine, 9-13 September 2023 Vienna, Austria,In: European Journal of Nuclear Medicine and Molecular Imaging Jg. 50 (2023) Nr. 1 supplement, S. S230 - S231Online Volltext: dx.doi.org/ (Open Access) -
Head-to-head comparison of68Ga-FAPI46 PET/CT,18F-FDG PET/CT, and contrast- enhanced CT in patient with various solid tumors
Annual Congress of the European Association of Nuclear Medicine, 9-13 September 2023 Vienna, Austria,In: European Journal of Nuclear Medicine and Molecular Imaging Jg. 50 (2023) Nr. 1 supplement, S. 166 - S167Online Volltext: dx.doi.org/ (Open Access) -
Improving radical prostatectomy with intraoperative ex-vivo PSMA-PET/CT imaging
Annual Congress of the European Association of Nuclear Medicine, 9-13 September 2023 Vienna, Austria,In: European Journal of Nuclear Medicine and Molecular Imaging Jg. 50 (2023) Nr. 1 supplement, S. S586Online Volltext: dx.doi.org/ (Open Access) -
Inter-institutional differences and common ground in 177Lu-PSMA radionuclide therapy : International survey in 95 theranostic centers
55th Annual Conference of the Society-of-Nuclear-Medicine (SNMICON); NOV 16-19, 2023; Jodhpur, India,In: Journal of Nuclear Medicine (JNM) Jg. 64 (2023) Nr. Suppl. 1, P843 -
Inter-institutional differences and common ground in 177Lu-PSMA radionuclide therapy : International survey in 95 theranostic centersIn: European Journal of Nuclear Medicine and Molecular Imaging Jg. 50 (2023) Nr. Suppl. 1, S. S92Online Volltext: dx.doi.org/ (Open Access)
-
Intraoperative microPET/CT imaging for PSMA-positive cancer foci in radical prostatectomy – feasibility study
38th Annual EAU (European Association of Urology) Congress ; EAU23 ; 10 - 13 March 2023, Milan, Italy,In: European Urology Jg. 83 (2023) Nr. Supplement 1, S. S687Online Volltext: dx.doi.org/ -
Long-term Survival in Patients with oligometastatic Lung Cancer (cT4 or cN2-3, cM1a-c) after thoracic Chemoradiation, Metastasis-directed and Systemic Therapy compared with the Outcome in locally advanced Lung Cancer (cT4 or cN2-3, cM0)In: Strahlentherapie und Onkologie: Journal of Radiation Oncology, Biology, Physics Jg. 199 (2023) Nr. Suppl. 1, S. S101 - S102Online Volltext: dx.doi.org/
-
Occupational Radiation exposure from PET/CT during patient positioning
Annual Congress of the European Association of Nuclear Medicine, 19-13 September 2023, Vienna, Austria,In: European Journal of Nuclear Medicine and Molecular Imaging Jg. 50 (2023) Nr. 1 supplement, S. S150 - S150Online Volltext: dx.doi.org/ (Open Access) -
Occurence of hematotoxic side effects during 90Y-FAPI-46 radioligand therapy (RLT) in patients with advanced metastatic tumor diseases
Annual Congress of the European Association of Nuclear Medicine, 9-13 September 2023 Vienna, Austria,In: European Journal of Nuclear Medicine and Molecular Imaging Jg. 50 (2023) Nr. 1 supplement, S. S671Online Volltext: dx.doi.org/ (Open Access) -
PET Quantification Performance of the Oversize-Volume-of-Interest Approach in the Context of Tumour Dosimetry in Radionuclide Therapy Planning
Annual Congress of the European Association of Nuclear Medicine, 19-13 September 2023, Vienna, Austria,In: European Journal of Nuclear Medicine and Molecular Imaging Jg. 50 (2023) Nr. 1 supplement, S. S363Online Volltext: dx.doi.org/ (Open Access) -
Performance Evaluation of 18F-PSMA and 68Ga-PSMA in a Novel MicroPET/CT System Dedicated to Radioguided Surgery
Annual Congress of the European Association of Nuclear Medicine, 9-13 September 2023, Vienna, Austria,In: European Journal of Nuclear Medicine and Molecular Imaging Jg. 50 (2023) Nr. 1 supplement, S. S131Online Volltext: dx.doi.org/ (Open Access) -
Phase III trial of [177Lu]Lu-PSMA-617 in taxane-naive patients with metastatic castration-resistant prostate cancer (PSMAfore)
ESMO Congress 2023 ; 20 - 24 October 2023, Madrid, Spain,In: Annals of Oncology Jg. 34 (2023) Nr. Supplement 2: Abstract Book of the ESMO Congress 2023, 20 - 24 October 2023, S. S1324 - S1325Online Volltext: dx.doi.org/ -
Practical RECIP : Visual assessment of Response Evaluation Criteria In PSMA-PET/CT in metastatic castration-resistant prostate cancer
55th Annual Conference of the Society-of-Nuclear-Medicine (SNMICON); NOV 16-19, 2023; Jodhpur, India,In: Journal of Nuclear Medicine (JNM) Jg. 64 (2023) Nr. Suppl. 1, P1619 -
Pre-surgical 68Ga-PSMA-11 PET for biochemical recurrence risk assessment: a surrogate of Pelvic Lymph Node Dissection? : Follow-up analysis of a Multicenter Prospective Phase 3 Imaging Trial
55th Annual Conference of the Society-of-Nuclear-Medicine (SNMICON); NOV 16-19, 2023; Jodhpur, India,In: Journal of Nuclear Medicine (JNM) Jg. 64 (2023) Nr. Suppl. 1, P440 -
Prognostic value of the post-treatment 177Lu-DOTATOC scintigraphy in NET patients undergoing PRRT
Annual Congress of the European Association of Nuclear Medicine, 9-13 September 2023, Vienna, Austria,In: European Journal of Nuclear Medicine and Molecular Imaging Jg. 50 (2023) Nr. 1 supplement, S. S134Online Volltext: dx.doi.org/ (Open Access) -
Prostate Cancer Molecular Imaging Standardized Evaluation : The PROMISE V2 Framework Including Response Evaluation for Clinical TrialsIn: Strahlentherapie und Onkologie: Journal of Radiation Oncology, Biology, Physics Jg. 199 (2023) Nr. Suppl. 1, S. S150Online Volltext: dx.doi.org/ (Open Access)
-
Safety and Efficacy of Extended 177Lu-PSMA Therapy: Multi-Center Retrospective Analysis
Annual Congress of the European Association of Nuclear Medicine, 9-13 September 2023 Vienna, Austria,In: European Journal of Nuclear Medicine and Molecular Imaging Jg. 50 (2023) Nr. 1 supplement, S. S152Online Volltext: dx.doi.org/ (Open Access) -
Screening for occult transthyretin amyloidosis in patients with degenerative aortic stenosis and amyloid red-flagsIn: European Journal of Heart Failure Jg. 25 (2023) Nr. Suppl. 2, S. 359 - 359
-
Temporal muscle thickness as a prognostic marker in a real-life cohort of newly diagnosed MGMT promoter methylated glioblastoma patients : a multicentric imaging analysisIn: Neuro-Oncology Jg. 25 (2023) Nr. Suppl. 5, S. v192 - v193Online Volltext: dx.doi.org/
-
The Updated Prostate Cancer Molecular Imaging Standardized Evaluation (PROMISE V2.0) Framework for Standardized Reporting of PSMA-PET
Annual Congress of the European Association of Nuclear Medicine, 19-13 September 2023, Vienna, Austria,In: European Journal of Nuclear Medicine and Molecular Imaging Jg. 50 (2023) Nr. 1 supplement, S. S177Online Volltext: dx.doi.org/ (Open Access) -
68GA-FAPI PET/CT in the evaluation of Non-Small Cell Lung Cancer (NSCLC)
EANM‘22 ; 35th Annual Congress of the European Association of Nuclear Medicine ; October 15-19, 2022, Barcelona, Spain,In: European Journal of Nuclear Medicine and Molecular Imaging Jg. 49 (2022) Nr. Supplement 1, S. S107Online Volltext: dx.doi.org/ (Open Access) -
902TiP COMPOSE : Pivotal phase III trial to compare 177Lu-edotreotide with best standard of care for well-differentiated aggressive grade 2 and grade 3 gastroenteropancreatic neuroendocrine tumours
Annual Meeting of the European-Society-for-Medical-Oncology (ESMO),In: Annals of Oncology Jg. 33 (2022) Nr. Suppl. 7, S. S960Online Volltext: dx.doi.org/ (Open Access) -
Changes in Tumor-Blood Ratio as a prognostic marker for progression-free survival and overall survival in neuroendocrine tumor patients undergoing PRRT
EANM‘22 ; 35th Annual Congress of the European Association of Nuclear Medicine ; October 15-19, 2022, Barcelona, Spain,In: European Journal of Nuclear Medicine and Molecular Imaging Jg. 49 (2022) Nr. Supplement 1, S. S80Online Volltext: dx.doi.org/ (Open Access) -
Combination of Trofosfamide and Etoposide in Recurrent GliomaIn: Neuro-Oncology Jg. 24 (2022) Nr. Suppl. 2, S. ii89 - ii89Online Volltext: dx.doi.org/ (Open Access)
-
Dosimetry of 177Lu-PSMA-617 for the treatment of metastatic castration-resistant prostate cancer : Results from the VISION trial sub-studyIn: Journal of Clinical Oncology (JCO) Jg. 40 (2022) Nr. Suppl. 6, 97Online Volltext: dx.doi.org/ (Open Access)
-
EBUS-TBNA within 8 days prior to (18)FDG PET/CT affects (18)FDG uptake in mediastinal and hilar lymph nodes of patients during staging for lung cancer
EANM‘22 ; 35th Annual Congress of the European Association of Nuclear Medicine ; October 15-19, 2022, Barcelona, Spain,In: European Journal of Nuclear Medicine and Molecular Imaging Jg. 49 (2022) Nr. Supplement 1, S. S166Online Volltext: dx.doi.org/ (Open Access) -
Efficacy estimation of filter pads in expiratory filter/valve sets by means of Tc-99m-labeled graphite aerosolIn: European Respiratory Journal (ERJ) Jg. 60 (2022) Nr. Suppl. 66, 1793Online Volltext: dx.doi.org/
-
FAPI, PSMA and FDG PET/CT in patients with advanced metastatic castration-resistant prostate cancer (mCRPC) : a triple tracer comparison
EANM‘22 ; 35th Annual Congress of the European Association of Nuclear Medicine October ; 15-19, 2022 Barcelona, Spain,In: European Journal of Nuclear Medicine and Molecular Imaging Jg. 49 (2022) Nr. Supplement 1, S. S118 - S119Online Volltext: dx.doi.org/ (Open Access) -
Health-related quality of life (HRQoL), pain and safety outcomes in the phase 3 VISION study of 177Lu-PSMA-617 in patients with metastatic castration-resistant prostate cancer
EANM‘22 ; 35th Annual Congress of the European Association of Nuclear Medicine October ; 15-19, 2022 Barcelona, Spain,In: European Journal of Nuclear Medicine and Molecular Imaging Jg. 49 (2022) Nr. Supplement 1, S. S55 - S56Online Volltext: dx.doi.org/ (Open Access) -
Lu-DOTA-TATE as First-line Therapy for Patients With Grade 2 and 3 Advanced Gastroenteropancreatic Neuroendocrine Tumors (GEP-NETs) : The NETTER-2 Study
14th Annual Multidisciplinary Neuroendocrine Tumor Medical Virtual Symposium of the North American Neuroendocrine Tumor Society: 2021 Multidisciplinary NET Medical Symposium, November 4-6, 2021, Chicago, Virtual,In: Pancreas Jg. 51 (2022) Nr. 3, Abstracts Presented at the 14th Annual Multidisciplinary Neuroendocrine Tumor Medical Virtual Symposium of the North American Neuroendocrine Tumor Society, November 4-6, 2021, S. E58 - E58Online Volltext: dx.doi.org/ (Open Access) -
Measuring response in metastatic castration-resistant prostate cancer using PSMA PET/CT : Comparison of RECIST 1.1, aPCWG3, aPERCIST, PPP, and RECIP 1.0 criteria
EANM‘22 ; 35th Annual Congress of the European Association of Nuclear Medicine ; October 15-19, 2022, Barcelona, Spain,In: European Journal of Nuclear Medicine and Molecular Imaging Jg. 49 (2022) Nr. Supplement 1, S. S267Online Volltext: dx.doi.org/ (Open Access) -
Metabolic Tumor Volume for Outcome Prediction in Patients with Large B-Cell Lymphoma Undergoing Chimeric Antigen Receptor T-Cell Treatment
EANM‘22 ; 35th Annual Congress of the European Association of Nuclear Medicine ; October 15-19, 2022, Barcelona, Spain,In: European Journal of Nuclear Medicine and Molecular Imaging Jg. 49 (2022) Nr. Supplement 1, S. S211Online Volltext: dx.doi.org/ (Open Access) -
Multi-cycle dosimetry of [Lu-177]Lu-PSMA-617 for the treatment of metastatic castration-resistant prostate cancer : results from the VISION trial sub-study
EANM‘22 ; 35th Annual Congress of the European Association of Nuclear Medicine October ; 15-19, 2022 Barcelona, Spain,In: European Journal of Nuclear Medicine and Molecular Imaging Jg. 49 (2022) Nr. Supplement 1, S. S129Online Volltext: dx.doi.org/ (Open Access) -
Novel framework for treatment response evaluation using PSMA-PET/CT in patients with metastatic castration-resistant prostate cancer (RECIP 1.0) : an international multicenter study
EANM‘22 ; 35th Annual Congress of the European Association of Nuclear Medicine ; October 15-19, 2022 Barcelona, Spain,In: European Journal of Nuclear Medicine and Molecular Imaging Jg. 49 (2022) Nr. Supplement 1, S. S269Online Volltext: dx.doi.org/ (Open Access) -
Novel framework for treatment response evaluation using PSMA-PET/CT in patients with metastatic castration-resistant prostate cancer (RECIP 1.0) : An international multicenter study
EAU22: 37th Annual EAU Congress, 01.-04.07.2022, Amsterdam,In: European Urology Jg. 81 (2022) Nr. Supplement 1: Abstracts EAU22 - 37th Annual EAU Congress, S. S794 - S795Online Volltext: dx.doi.org/ -
Novel framework for treatment response evaluation using PSMA-PET/CT in patients with metastatic castration-resistant prostate cancer (RECIP 1.0) : an international multicenter study
2022 ASCO Genitourinary Cancers Symposium, 17.-19.02.2022, San Fransisco,In: Journal of Nuclear Medicine (JNM) Jg. 40 (2022) Nr. 6, Supplement: 2022 ASCO Genitourinary Cancers Symposium, jnumed.121.263072Online Volltext: dx.doi.org/ (Open Access) -
Novel framework for treatment response evaluation using PSMA-PET/CT in patients with metastatic castration-resistant prostate cancer (RECIP) : An international multicenter studyIn: Journal of Clinical Oncology (JCO) Jg. 40 (2022) Nr. Suppl. 6, 42Online Volltext: dx.doi.org/ Online Volltext (Open Access)
-
Observer Reproducibility in the Calculation of Yttrium-90 Absorbed Dose in Patients with Hepatocellular Carcinoma : The Round Robin Sub-Study of The Global Retrospective TARGET Study
EANM‘22 ; 35th Annual Congress of the European Association of Nuclear Medicine ; October 15-19, 2022 Barcelona, Spain,In: European Journal of Nuclear Medicine and Molecular Imaging Jg. 49 (2022) Nr. Supplement 1, S. S62Online Volltext: dx.doi.org/ (Open Access) -
PSMA PET disease extent for European Association of Urology biochemical recurrence risk groups : An international multicentre study
EAU22: 37th Annual EAU Congress, 01.-04.07.2022, Amsterdam,In: European Urology Jg. 81 (2022) Nr. Supplement 1: Abstracts EAU22 - 37th Annual EAU Congress, S. S291Online Volltext: dx.doi.org/ -
PSMA-directed imaging and therapy of salivary gland tumors : a single-center retrospective study
EANM‘22 ; 35th Annual Congress of the European Association of Nuclear Medicine ; October 15-19, 2022, Barcelona, Spain,In: European Journal of Nuclear Medicine and Molecular Imaging Jg. 49 (2022) Nr. Supplement 1, S. S229Online Volltext: dx.doi.org/ (Open Access) -
Pulmonary right-to-left shunt estimation with (99)mTc-labeled macroaggregated albumin (MAA) : Establishing a normal range with correction for unbound (99)mTc
EANM‘22 ; 35th Annual Congress of the European Association of Nuclear Medicine ; October 15-19, 2022, Barcelona, Spain,In: European Journal of Nuclear Medicine and Molecular Imaging Jg. 49 (2022) Nr. Supplement 1, S. S93 - S94Online Volltext: dx.doi.org/ (Open Access) -
Radiation Exposure of I-124-MIBG Imaging in Adult Patients with Neuroendocrine Tumours
EANM‘22 ; 35th Annual Congress of the European Association of Nuclear Medicine ; October 15-19, 2022, Barcelona, Spain,In: European Journal of Nuclear Medicine and Molecular Imaging Jg. 49 (2022) Nr. Supplement 1, S. S36 - S37Online Volltext: dx.doi.org/ (Open Access) -
Re: Diagnostic Accuracy of 68Ga-PSMA-11 PET for Pelvic Nodal Metastasis Detection prior to Radical Prostatectomy and Pelvic Lymph Node Dissection : A Multicenter Prospective Phase 3 Imaging TrialIn: The Journal of Urology Jg. 207 (2022) Nr. 4, S. 930Online Volltext: dx.doi.org/
-
Robuste und lang-andauernde Wirksamkeit der Durvalumab-Konsolidierung bei NSCLC im Stadium III nach Induktionschemotherapie und definitiver Radiochemotherapie : Fokus auf Behandlungsauswahl und prognostische Faktoren
28. Kongress der Deutschen Gesellschaft für Radioonkologie ; DEGRO 2022 ; 26. bis 28.05.2022, Stuttgart, Germany,In: Strahlentherapie und Onkologie: Journal of Radiation Oncology, Biology, Physics Jg. 198 (2022) Nr. Supplement 1, S. S15Online Volltext: dx.doi.org/ (Open Access) -
Safety and efficacy of [90Y]Y-FAPI-46 radioligand therapy in patients with advanced sarcomas and other cancer entities
ESMO Congress 2022, 9 - 13 September 2022, Paris, France,In: Annals of Oncology Jg. 33 (2022) Nr. Supplement 7: Abstract Book of the ESMO Congress 2022, 9 - 13 September 2022, S. S1231 - S1232Online Volltext: dx.doi.org/ (Open Access) -
Superiority of [68Ga]Ga-FAPI-46 over [18F]F-FDG PET/CT for cholangiocarcinoma imaging
EANM‘22 ; 35th Annual Congress of the European Association of Nuclear Medicine ; October 15-19, 2022 Barcelona, Spain,In: European Journal of Nuclear Medicine and Molecular Imaging Jg. 49 (2022) Nr. Supplement 1, S. S192 - S193Online Volltext: dx.doi.org/ (Open Access) -
Target Expression and FAP-Directed Tumour Imaging in a Large, Single-Centre PET Database of 324 Patients and 21 Tumour Entities
EANM‘22 ; 35th Annual Congress of the European Association of Nuclear Medicine ; October 15-19, 2022, Barcelona, Spain,In: European Journal of Nuclear Medicine and Molecular Imaging Jg. 49 (2022) Nr. Supplement 1, S. S119 - S120Online Volltext: dx.doi.org/ (Open Access) -
Tolerability of [177Lu]Lu-PSMA-617 by treatment exposure in patients with metastatic castration-resistant prostate cancer (mCRPC) : A VISION study subgroup analysisIn: Journal of Clinical Oncology (JCO) Jg. 40 (2022) Nr. 16_Suppl., S. 5047Online Volltext: dx.doi.org/
-
Trial in Progress: [177Lu]Lu-DOTA-TATE Combination Therapy in Treatment-Naïve Extensive Stage Small Cell Lung CancerIn: Journal of Thoracic Oncology Jg. 17 (2022) Nr. 9, S. 534Online Volltext: dx.doi.org/
-
[177Lu]Lu-Dota-Tate as First-Line Therapy for Patients with Grade 2 and 3 Advanced Gastroenteropancreatic Neuroendocrine Tumours (GEP-NETS) : The NETTER-2 StudyIn: Radiotherapy and Oncology (The Green Journal) Jg. 174 (2022) Nr. Suppl. 1, S. 40 - S41Online Volltext: dx.doi.org/
-
A novel theranostic approach for sarcoma : Insights on diagnostic and therapeutic use of FAP-radioligands
Gemeinsame Jahrestagung der Deutschen, Österreichischen und Schweizerischen Gesellschaften für Hämatologie und Medizinische Onkologie ; 01.-04. Oktober 2021, Hybrid-Kongress,In: Oncology Research and Treatment Jg. 44 (2021) Nr. Supplement 2, S. 11 - 12Online Volltext: dx.doi.org/ (Open Access) -
Additional Benefit of FDG-PET when Discontinuing Immune Checkpoint Inhibitor Therapy in Patients with metastatic MelanomaIn: Journal der Deutschen Dermatologischen Gesellschaft (JDDG) Jg. 19 (2021) Nr. Suppl. 4, S. 75 - 76
-
Complete metabolic response in advanced non-small cell lung cancer patients with prolonged response to immune checkpoint inhibitor therapyIn: Journal of Clinical Oncology (JCO) Jg. 39 (2021) Nr. 15_Suppl, S. 9050 - 9050Online Volltext: dx.doi.org/
-
Development of a novel framework for treatment response evaluation using PSMA-PET/CT in patients with metastatic castration-resistant prostate cancer (RECIP) : An international multicenter study
EANM‘21 ; 34th Annual Congress of the European Association of Nuclear Medicine ; October 20-23, 2021, Virtual,In: European Journal of Nuclear Medicine and Molecular Imaging Jg. 48 (2021) Nr. Suppl. 1, S. S311 - S312Online Volltext: dx.doi.org/ (Open Access) -
Dynamic Ga-68-DOTA PET/CT and Compartmental Modelling to Non-invasively Estimate the Glomerular Filtration RateIn: Journal of Nuclear Medicine (JNM) Jg. 62 (2021) Nr. Suppl. 1, 88
-
EBUS-TBNA and [F-18] FDG-PET/CT for precise Target Volume Definition prior to Chemoradiotherapy : Lymphonodular Spreading Patterns in Stage III NSCLCIn: Strahlentherapie und Onkologie: Journal of Radiation Oncology, Biology, Physics Jg. 197 (2021) Nr. Suppl. 1, S. 142
-
Efficacy and safety of 124-I-MIBG guided high activity 131-I-MIBG therapy of metastatic pheochromocytoma and neuroblastomaIn: European Journal of Nuclear Medicine and Molecular Imaging Jg. 48 (2021) Nr. Suppl. 1, S. 290 - S291
-
Evaluation of Dynamic Renal Ga-68-DOTA PET/CT to Monitor the Urinary Efflux and to Estimate the Glomerular Filtration Rate Using a Compartmental Kinetic Modelling ApproachIn: European Journal of Nuclear Medicine and Molecular Imaging Jg. 48 (2021) Nr. Suppl. 1, S. 340
-
FDG-PET avidity as a prognostic biomarker for overall survival in renal cell carcinoma
2021 ASCO Annual Meeting, 4. - 8. June 2021, virtuell,In: Journal of Clinical Oncology (JCO) Jg. 39 (2021) Nr. Suppl. 15, S. e16564Online Volltext: dx.doi.org/ (Open Access) -
Ga-68-FAPI for sarcoma imaging : Data from the FAPI-PET prospective observational trialIn: Journal of Nuclear Medicine (JNM) Jg. 62 (2021) Nr. Suppl. 1, 126
-
Ga-68-versus F-18-PSMA for Cerenkov Luminescence and autoradiography in a prostate cancer mouse modelIn: European Journal of Nuclear Medicine and Molecular Imaging Jg. 48 (2021) Nr. Suppl. 1, S. 17
-
Health-related quality of life (HRQoL), pain and safety outcomes in the phase III VISION study of 177Lu-PSMA-617 in patients with metastatic castration-resistant prostate cancerIn: Annals of Oncology Jg. 32 (2021) Nr. Suppl. 5, S. 627 - S628Online Volltext: dx.doi.org/ (Open Access)
-
Initial clinical experience with [Y-90]Y-FAPI-46 radioligand therapy for advanced stage solid tumorsIn: European Journal of Nuclear Medicine and Molecular Imaging Jg. 48 (2021) Nr. Suppl. 1, S. 290
-
Interim PSMA PET/CT for response evaluation during LuPSMA treatment in mCRPC (INTERIM PET) : An explorative, multicenter studyIn: Journal of Clinical Oncology (JCO) Jg. 39 (2021) Nr. 15_Suppl, S. 5066 - 5066Online Volltext: dx.doi.org/
-
Nomograms to predict outcome after LuPSMA radionuclide therapy in men with metastatic castration-resistant prostate cancer : An international multicenter retrospective studyIn: European Journal of Nuclear Medicine and Molecular Imaging Jg. 48 (2021) Nr. Suppl. 1, S. 63 - S64
-
PSMA PET and radiomics for the evaluation of liver metastases in castration-resistant prostate cancer patients : A multicenter retrospective studyIn: European Journal of Nuclear Medicine and Molecular Imaging Jg. 48 (2021) Nr. Suppl. 1, S. 234
-
Pain efficacy with radium-223 (Ra-223) in patients (pts) with metastatic castration-resistant prostate cancer (mCRPC) in the PARABO observational studyIn: Annals of Oncology Jg. 32 (2021) Nr. Suppl. 5, S. 641Online Volltext: dx.doi.org/ (Open Access)
-
Pain response and clinical outcomes in patients with metastatic castration-resistant prostate cancer (mCRPC) treated with radium-223 (Ra-223) : Final results from a prospective, noninterventional study (PARABO)In: European Journal of Nuclear Medicine and Molecular Imaging Jg. 48 (2021) Nr. Suppl. 1, S. 313 - S314
-
Phase 3 Study of Lu-177-PSMA-617 in Patients with Metastatic Castration-Resistant Prostate Cancer (VISION)In: European Journal of Nuclear Medicine and Molecular Imaging Jg. 48 (2021) Nr. Suppl. 1, S. 63
-
Phase 3 multicenter randomized trial of PSMA PET/CT prior to definitive radiation therapy for unfavorable intermediate-risk or high-risk prostate cancer [PSMA dRT] : Study ProtocolIn: Cancer Research Jg. 81 (2021) Nr. 13, CT257
-
Phase III randomized trial of PSMA PET prior to definitive radiation therapy for unfavorable intermediate-risk or high-risk prostate cancer [PSMA dRT] : Study protocol NCT04457245
2021 Genitourinary Cancers Symposium, 11 - 13 Feb 2021, online,In: Journal of Clinical Oncology (JCO) Jg. 39 (2021) Nr. 6, Supplement, S. TPS172Online Volltext: dx.doi.org/ (Open Access) -
Phase III study of lutetium-177-PSMA-617 in patients with metastatic castration-resistant prostate cancer (VISION)
2021 ASCO Annual Meeting, 4. - 8. June 2021, virtuell,In: Journal of Clinical Oncology (JCO) Jg. 39 (2021) Nr. 18_suppl, S. LBA4 - LBA4Online Volltext: dx.doi.org/ (Open Access) -
Prognostic Significance of the metabolic Response during Induction Chemotherapy for the definitive Chemoradiotherapy of locally advanced Squamous Cell Carcinoma of the EsophagusIn: Strahlentherapie und Onkologie: Journal of Radiation Oncology, Biology, Physics Jg. 197 (2021) Nr. Suppl. 1, S. 154 - S155
-
Radioembolization with chemotherapy for colorectal liver metastases : A randomized, open-label, international, multicenter, phase III trial (EPOCH study)
ESMO Congress 2021 ; 16 – 21 September 2021, online,In: Annals of Oncology Jg. 32 (2021) Nr. Suppl. 5, S. S1295Online Volltext: dx.doi.org/ (Open Access) -
Visualization of fibroblast activation after myocardial infarction using 68Ga-FAPI-PETIn: European Heart Journal Jg. 42 (2021) Nr. Supplement_1, ehab724.0255Online Volltext: dx.doi.org/ (Open Access)
-
18F-FDG -PET/MRI in patients with Graves’ orbitopathy
EANM‘20 ; Annual Congress of the European Association of Nuclear Medicine ; October 22 – 30, 2020, Wien, Virtual,In: European Journal of Nuclear Medicine and Molecular Imaging Jg. 47 (2020) Nr. Supplement 1, S. S251 - S252Online Volltext: dx.doi.org/ (Open Access) -
18F-Fluorethyltyrosine positron emission tomography versus magnetic resonnace spectroscopy in preoperative detection of newly diagnosed gliomas by using machine learningIn: Neuro-Oncology Jg. 22 (2020) Nr. Supplement 2, S. ii149Online Volltext: dx.doi.org/ Online Volltext (Open Access)
-
Accuracy of 68Ga-PSMA-11 for pelvic nodal metastasis detection prior to radical prostatectomy and pelvic lymph node dissection : A multicenter prospective phase III imaging study
EANM‘20 ; Annual Congress of the European Association of Nuclear Medicine ; October 22 – 30, 2020, Wien, Virtual,In: European Journal of Nuclear Medicine and Molecular Imaging Jg. 47 (2020) Nr. Supplement 1, S. S209Online Volltext: dx.doi.org/ (Open Access) -
Comparison of Lesion Detectability and Image Quality among Digital and Analog PET Systems for Recurrence in Thyroid Cancer Patients Using I-124
EANM‘20 ; Annual Congress of the European Association of Nuclear Medicine ; October 22 – 30, 2020, Wien, Virtual,In: European Journal of Nuclear Medicine and Molecular Imaging Jg. 47 (2020) Nr. Supplement 1, S. S429Online Volltext: dx.doi.org/ (Open Access) -
Digital high sensitivity I-124 PET/CT improves the detectability of thyroid cancer metastasesIn: Journal of Nuclear Medicine (JNM) Jg. 61 (2020) Nr. Suppl. 1, S. 255
-
Early metabolic evaluation using F-18-FDG PET/CT might help to identify patients who benefit from treatment with cdk4/6 inhibitors
Virtuelle Jahrestagung der Deutschen, Österreichischen und Schweizerischen Gesellschaften für Hämatologie und Medizinische Onkologie, 09.–11. Oktober 2020,In: Oncology Research and Treatment Jg. 43 (2020) Nr. Suppl. 4, S. 121 - 122Online Volltext: dx.doi.org/ (Open Access) -
Effects of anti-TNF-therapy on osteoblastic activity in ankylosing spondylitis : Results from a prospective study using PET-MRI of SIJ and SPINE
EULAR: Annual European Congress of Rheumatology, 2020, 03.-06.06.2020, Frankfurt,In: Annals of the Rheumatic Diseases (ARD) Jg. 79 (2020) Nr. Suppl. 1, S. 1125 - 1126Online Volltext: dx.doi.org/ (Open Access) -
Efficacy and safety of 177Lu-PSMA radionuclide treatment in patients with diffuse bone marrow involvement : a multicenter retrospective study
EANM‘20 ; Annual Congress of the European Association of Nuclear Medicine ; October 22 – 30, 2020, Wien, Virtual,In: European Journal of Nuclear Medicine and Molecular Imaging Jg. 47 (2020) Nr. Supplement 1, S. S491Online Volltext: dx.doi.org/ (Open Access) -
Efficacy and safety of Lu ¹⁷⁷-PSMA radionuclide treatment in patients with diffuse bone marrow involvement : A multicenter retrospective study
2020 ASCO Annual Meeting; 29.05.2020 - 02.06.2020; Chicago, USA,In: Journal of Clinical Oncology (JCO) Jg. 38 (2020) Nr. Suppl. 15, S. e17543Online Volltext: dx.doi.org/ (Open Access) -
Efficacy and safety of Lu-177-PSMA radionuclide treatment in patients with diffuse bone marrow involvement : a multicenter retrospective studyIn: Journal of Nuclear Medicine (JNM) Jg. 61 (2020) Nr. Suppl. 1, S. 1284
-
Emission time optimisation for [68Ga]Ga-PSMA-11 with a SiPM PET/CT based on phantom measurements
EANM‘20 ; Annual Congress of the European Association of Nuclear Medicine ; October 22 – 30, 2020, Wien, Virtual,In: European Journal of Nuclear Medicine and Molecular Imaging Jg. 47 (2020) Nr. Supplement 1, S. S256Online Volltext: dx.doi.org/ (Open Access) -
Emission time reduction for 2-[18F]FDG examinations in lymphoma patients with a PET/CT with SiPM - a feasibility phantom study
EANM‘20 ; Annual Congress of the European Association of Nuclear Medicine ; October 22 – 30, 2020, Wien, Virtual,In: European Journal of Nuclear Medicine and Molecular Imaging Jg. 47 (2020) Nr. Supplement 1, S. S257 - S258Online Volltext: dx.doi.org/ (Open Access) -
Evaluation of 68Ga-PSMA PET/CT Images Acquired with a Reduced Scan Time Duration in Prostate Cancer Patients using a Digital PET/CT Scanner
EANM‘20 ; Annual Congress of the European Association of Nuclear Medicine ; October 22 – 30, 2020, Wien, Virtual,In: European Journal of Nuclear Medicine and Molecular Imaging Jg. 47 (2020) Nr. Supplement 1, S. S27Online Volltext: dx.doi.org/ (Open Access) -
FDG PET/CT to detect bone marrow involvement in the initial staging of patients with aggressive non-Hodgkin lymphoma : results from the prospective, multicenter PETAL and OPTIMAL > 60 trials
Virtuelle Jahrestagung der Deutschen, Österreichischen und Schweizerischen Gesellschaften für Hämatologie und Medizinische Onkologie, 09.–11. Oktober 2020,In: Oncology Research and Treatment Jg. 43 (2020) Nr. Suppl. 4, S. 55 - 56Online Volltext: dx.doi.org/ (Open Access) -
Impact of(68)Ga-PSMA-11 PET on the Management of recurrent Prostate Cancer in a Prospective Single-Arm Clinical TrialIn: Journal of Nuclear Medicine (JNM) Jg. 61 (2020) Nr. Suppl. 1, S. 43
-
Lymphknoten-Staging von lokal fortgeschrittenen, nicht kleinzelligen Lungenkarzinomen (NSCLC) : Wert von [18F] FDG-PET/CT und EBUS/TBNA zur Festlegung des Zielvolumens bei definitiver Radiotherapie in kurativer Intention
26. Jahrestagung der Deutschen Gesellschaft für Radioonkologie (DEGRO) ; 24. Juni - 28. Juni 2020, Wiesbaden, Germany,In: Strahlentherapie und Onkologie: Journal of Radiation Oncology, Biology, Physics Jg. 196 (2020) Nr. 1 Supplement: Abstracts DEGRO 2020, S. S143Online Volltext: dx.doi.org/ (Open Access) -
Lymphonodular anthracosis in patients undergoing FDG PET/CT for initial lung cancer diagnostics and/or staging is a mayor pitfall : a comparison to the histological gold standard
EANM‘20 ; Annual Congress of the European Association of Nuclear Medicine ; October 22 – 30, 2020, Wien, Virtual,In: European Journal of Nuclear Medicine and Molecular Imaging Jg. 47 (2020) Nr. Supplement 1, S. S565 - S566Online Volltext: dx.doi.org/ (Open Access) -
Mapping prostate cancer lesions pre/post unsuccessful salvage lymph node dissection employing PSMA-PETIn: Journal of Nuclear Medicine (JNM) Jg. 61 (2020) Nr. Suppl. 1, S. 1270
-
Overall survival after177Lu-PSMA-617 molecular radiotherapy in patients with metastatic castrate-resistant prostate cancer : Post-hoc analysis of a prospective phase II trial
EANM‘20 ; Annual Congress of the European Association of Nuclear Medicine ; October 22 – 30, 2020, Wien, Virtual,In: European Journal of Nuclear Medicine and Molecular Imaging Jg. 47 (2020) Nr. Supplement 1, S. S488Online Volltext: dx.doi.org/ (Open Access) -
Overall survival after177Lu-PSMA-617 molecular radiotherapy in patients with metastatic castrateresistant prostate cancer : Post-hoc analysis of a prospective phase II trial
EANM‘20 ; Annual Congress of the European Association of Nuclear Medicine ; October 22 – 30, 2020, Wien, Virtual,In: European Journal of Nuclear Medicine and Molecular Imaging Jg. 47 (2020) Nr. Supplement 1, S. S488Online Volltext: dx.doi.org/ (Open Access) -
PERCIST-derived metabolic volume response predicts overall and progression-free survival in patients with malignant pleural mesothelioma treated with Pembrolizumab
EANM‘20 ; Annual Congress of the European Association of Nuclear Medicine ; October 22 – 30, 2020, Wien, Virtual,In: European Journal of Nuclear Medicine and Molecular Imaging Jg. 47 (2020) Nr. Supplement 1, S. S353Online Volltext: dx.doi.org/ (Open Access) -
PERCIST-derived metabolic volume response predicts overall and progression-free survival in patients with malignant pleural mesothelioma treated with PembrolizumabIn: Journal of Nuclear Medicine (JNM) Jg. 61 (2020) Nr. Suppl. 1, S. 243
-
PSMA-PET identifies PCWG3 target populations with high concordance however superior reproducibility when compared to conventional imagingIn: Journal of Nuclear Medicine (JNM) Jg. 61 (2020) Nr. Suppl. 1, S. 1260
-
Preclinical and clinical assessment of immune checkpoint inhibitor-associated left ventricular dysfunction
ESC Congress 2020 – The Digital Experience 29 August – 1 September 2020,In: European Heart Journal Jg. 41 (2020) Nr. Supplement_2, S. 3260Online Volltext: dx.doi.org/ -
Predictive factors and prediction nomograms for LuPSMA radioligand therapy in patients with metastatic castration-resistant prostate cancer : an international multicentre retrospective studyIn: Journal of Nuclear Medicine (JNM) Jg. 61 (2020) Nr. Suppl. 1, S. 593
-
Preliminary Investigations on Radiation Exposure in [68Ga]Ga-PSMA-11 based Cerenkov Luminescence Imaging Procedures
EANM‘20 ; Annual Congress of the European Association of Nuclear Medicine ; October 22 – 30, 2020, Wien, Virtual,In: European Journal of Nuclear Medicine and Molecular Imaging Jg. 47 (2020) Nr. Supplement 1, S. S212Online Volltext: dx.doi.org/ (Open Access) -
Prognostic markers for overall survival and outcome to LuPSMA radionuclide treatment in patients with metastatic castration-resistant prostate cancer
EANM‘20 ; Annual Congress of the European Association of Nuclear Medicine ; October 22 – 30, 2020, Wien, Virtual,In: European Journal of Nuclear Medicine and Molecular Imaging Jg. 47 (2020) Nr. Supplement 1, S. S487Online Volltext: dx.doi.org/ (Open Access) -
Prognostic markers for overall survival and outcome to LuPSMA radionuclide treatment in patients with metastatic castration-resistant prostate cancerIn: Journal of Clinical Oncology (JCO) Jg. 38 (2020) Nr. 15_Suppl., S. 5548Online Volltext: dx.doi.org/
-
Volumetric PET response assessment outperforms conventional criteria in patients receiving high-dose pembrolizumab for malignant mesothelioma
ESMO Virtual Congress 2020, 19.-21.09- und 16.-18.10.2020,In: Annals of Oncology Jg. 31 (2020) Nr. Suppl. 4, S. S1076 - S1077Online Volltext: dx.doi.org/ (Open Access) -
Prognostic Value of Metabolic Tumor Volume after Induction Chemotherapy in Stage IIIA/B Non-Small-Cell Lung Cancer : Secondary Analysis of a Randomized Phase 3 Trial
61st Annual Meeting of the American Society for Radiation Oncology ; September 15-18, 2019, Chicago, IL, USA,In: International Journal of Radiation Oncology, Biology, Physics Jg. 105 (2019) Nr. 1, Supplement, S. S146 - S147Online Volltext: dx.doi.org/ (Open Access) -
RESIST-PC phase 2 trial : 177Lu-PSMA-617 radionuclide therapy for metastatic castrate-resistant prostate cancerIn: Journal of Clinical Oncology (JCO) Jg. 37 (2019) Nr. 15, S. 5028 - 5028Online Volltext: dx.doi.org/ (Open Access)
-
Role of FDG PET/CT to Detect Bone Marrow Involvement in the Initial Staging of Aggressive Non-Hodgkin Lymphoma
Konferenz 61st ASH (American Society of Hematology) Annual Meeting & Exposition; Dec 07 - 10 2019; Orlando, USA,In: Blood Jg. 134 (2019) Nr. Supplement_1, S. 2892 - 2892Online Volltext: dx.doi.org/ (Open Access) -
A whole blood gene expression signature accurately diagnoses multiple myeloma and differentiates patients in remission from those with active and progressive disease
Jahrestagung der Deutschen, Österreichischen und Schweizerischen Gesellschaften für Hämatologie und Medizinische Onkologie ; 28. September - 2. Oktober 2018, Wien,In: Oncology Research and Treatment Jg. 41 (2018) Nr. Suppl. 4, S. 231Online Volltext: dx.doi.org/ (Open Access) -
Accuracy of 68Ga-PSMA11 PET/CT on recurrent prostate cancer : Preliminary results from a phase 2/3 prospective trialIn: Journal of Clinical Oncology (JCO) Jg. 36 (2018) Nr. Suppl. 15, S. 5001 - 5001Online Volltext: dx.doi.org/ (Open Access)
-
Ascertaining F18 positron-emission tomography skill in glioma classification pursuant to the revised WHO classification 2016In: European Journal of Nuclear Medicine and Molecular Imaging Jg. 45 (2018) Nr. Suppl. 1, S. 354 - S355Online Volltext: dx.doi.org/ (Open Access)
-
BRAF Mutation Analysis for Initial Risk Stratification in High Risk Papillary Thyroid CarcinomaIn: European Journal of Nuclear Medicine and Molecular Imaging Jg. 45 (2018) Nr. Suppl. 1, S. 551Online Volltext: dx.doi.org/ (Open Access)
-
Comparison evaluation of the diagnostic potential of PET/MRI and PET/CT using mIBG-Iod-124 in neuroendocrine and neuroectodermal tumors
Annual Congress of the European Association of Nuclear Medicine, EANM‘18, October 13 – 17, 2018, Düsseldorf, Germany,In: European Journal of Nuclear Medicine and Molecular Imaging Jg. 45 (2018) Nr. Suppl. 1, S. S65Online Volltext: dx.doi.org/ (Open Access) -
Comparison of 68Ga-PSMA-11 PET/CT and F-18-Fluciclovine PET/CT in recurrent Prostate CancerIn: European Journal of Nuclear Medicine and Molecular Imaging Jg. 45 (2018) Nr. Suppl. 1, S. 150Online Volltext: dx.doi.org/ (Open Access)
-
Correction of radiation induced stunning (CRIS) in pretherapeutic radioiodine-131 uptake test of patients suffering from goiterIn: European Journal of Nuclear Medicine and Molecular Imaging Jg. 45 (2018) Nr. Suppl. 1, S. 420Online Volltext: dx.doi.org/ (Open Access)
-
Correlation of immunohistochemical parameters, apparent diffusion coefficient (ADC) and standardized uptake value (SUV) in lung cancer using hybrid PET/MRIIn: European Journal of Nuclear Medicine and Molecular Imaging Jg. 45 (2018) Nr. Suppl. 1, S. 176Online Volltext: dx.doi.org/ (Open Access)
-
Development and Characterization of a PSMA-targeting Antibody for SPECT/CT, Fluorescence Imaging and Targeted Photodynamic Therapy of PSMA-expressing TumorsIn: European Journal of Nuclear Medicine and Molecular Imaging Jg. 45 (2018) Nr. Suppl. 1, S. 39 - S40Online Volltext: dx.doi.org/ (Open Access)
-
Development of predictors for PD-1/PD-L1-directed therapy of non-small cell lung cancer (NSCLC) by gene expression profiling of small diagnostic biopsies (DBX)In: Journal of Clinical Oncology (JCO) Jg. 36 (2018) Nr. 15 Suppl., S. e15121Online Volltext: dx.doi.org/ (Open Access)
-
Extrahepatic Comorbidities Do Not Alter the Safety and Efficacy of Radioembolization of NAFLD-Associated HCCIn: Hepatology Jg. 68 (2018) Nr. S1, S. 852A - 853AOnline Volltext: dx.doi.org/
-
Inflammation focus search with 18F-FDG-PET/MRI: comparative or additive value of PET and MRIIn: European Journal of Nuclear Medicine and Molecular Imaging Jg. 45 (2018) Nr. Suppl. 1, S. 259 - S260Online Volltext: dx.doi.org/ (Open Access)
-
Intraindividual comparison of subsequently performed PET/MRI to PET/CT for whole-body staging : Results of a unicenter trial in 1000 patientsIn: European Journal of Nuclear Medicine and Molecular Imaging Jg. 45 (2018) Nr. Suppl. 1, S. 210 - S211Online Volltext: dx.doi.org/ (Open Access)
-
NIMG-32. COMPARISON OF L-METHYL-11C-METHIONINE POSITRON EMISSION TOMOGRAPHY WITH MAGNETIC RESONANCE SPECTROSCOPY IN DETECTING NEWLY DIAGNOSED GLIOMA
23rd Annual Scientific Meeting and Education Day of the Society for Neuro-Oncology November 15 – 18, 2018 New Orleans, USA,In: Neuro-Oncology Jg. 20 (2018) Nr. suppl_6, S. vi182 - vi183Online Volltext: dx.doi.org/ (Open Access) -
Prospective comparison of F-18-FDG PET/MRI and F-18-FDG PET/CT for thoracic staging of non-small cell lung cancerIn: European Journal of Nuclear Medicine and Molecular Imaging Jg. 45 (2018) Nr. Suppl. 1, S. S502 Abstract EP-0517Online Volltext: dx.doi.org/ (Open Access)
-
Radiation induced stunning in patients suffering from benign thyroid diseases due to pre-therapeutic radioiodine-131 uptake testIn: European Journal of Nuclear Medicine and Molecular Imaging Jg. 45 (2018) Nr. Suppl. 1, S. 351 - S352Online Volltext: dx.doi.org/ (Open Access)
-
Anatomy-Guided Pathology SegmentationIn: Medical Image Computing and Computer Assisted Intervention – MICCAI 2024: 27th International Conference, Marrakesh, Morocco, October 6–10, 2024, Proceedings, Part VIII / MICCAI 2024, 27th International Conference, Marrakesh, Morocco, October 6–10, 2024 / Linguraru, Marius George; Dou, Qi; Feragen, Aasa (Hrsg.) 2024, S. 3 - 13Online Volltext: dx.doi.org/
-
Introduction : The Case for Radiopharmaceutical TherapyIn: Radiopharmaceutical Therapy / Bodei, Lisa; Lewis, Jason S.; Zeglis, Brian M. (Hrsg.) 2023, S. 3 - 11Online Volltext: dx.doi.org/
-
Combined medical therapy, nuclear medicine therapy and other therapies in metastatic neuroendocrine tumorIn: Nuclear Medicine and Molecular Imaging: Volume 4: Nuclear Medicine Therapy / Signore, Alberto / Sathekge, Mike; Luster, Markus (Hrsg.) 2022, S. 145 - 156Online Volltext: dx.doi.org/
-
Musculoskeletal imagingIn: Clinical PET/MRI / Catalano, Onofrio Antonio (Hrsg.) 2022, S. 199 - 224Online Volltext: dx.doi.org/
-
Specific PET Tracers for Solid Tumors and for Definition of the Biological Target VolumeIn: Image-Guided High-Precision Radiotherapy / Troost, Esther G. C. 2022, S. 31 - 53Online Volltext: dx.doi.org/
-
Proton Beam Range Verification with Secondary Radiation from Titanium ImplantsIn: 2019 IEEE Nuclear Science Symposium and Medical Imaging Conference, NSS/MIC 2019 / IEEE Nuclear Science Symposium 2019 Manchester, 26 Oct.-2 Nov. 2019 2019Online Volltext: dx.doi.org/
-
CXCR4-Directed Endoradiotherapy as New Treatment Option in Advanced Multiple MyelomaIn: Clinical Applications of Nuclear Medicine Targeted Therapy / Bombardieri, Emilio; Seregni, Ettore; Evangelista, Laura; Chiesa, Carlo; Chiti, Arturo 2018, S. 475 - 481Online Volltext: dx.doi.org/
-
Current and emerging applicationsIn: PET/MR Imaging: Current and Emerging Applications / Umutlu, Lale; Herrmann, Ken (Hrsg.) 2018, S. 1 - 8Online Volltext: dx.doi.org/
-
Lung CancerIn: PET/CT in Cancer: An Interdisciplinary Approach to Individualized Imaging / Beheshti, Mohsen; Langsteger, Werner; Rezaee, Alireza (Hrsg.) 2018, S. 23 - 42Online Volltext: dx.doi.org/
-
Artificial Intelligence/Machine Learning in Nuclear Medicine and Hybrid ImagingCham (2022) XIV, 210 SeitenOnline Volltext: dx.doi.org/
-
Association of health-related quality of life with efficacy outcomes in the VISION study of patients with metastatic castration-resistant prostate cancer
ESMO Congress 2023 ; 20 - 24 October 2023, Madrid, Spain,In: Annals of Oncology Jg. 34 (2023) Nr. Supplement 2: Abstract Book of the ESMO Congress 2023, 20 - 24 October 2023, S. S979 - S980Online Volltext: dx.doi.org/ -
Low- and high-volume disease in mHSPC : From CHAARTED to PSMA PET
ESMO Congress 2023 ; 20 - 24 October 2023, Madrid, Spain,In: Annals of Oncology Jg. 34 (2023) Nr. Supplement 2: Abstract Book of the ESMO Congress 2023, 20 - 24 October 2023, S. S967Online Volltext: dx.doi.org/ -
Prognostic value of neutrophil-to-lymphocyte ratio and lymphopenia in patients with metastatic castration-resistant prostate cancer (mCRPC) treated with [177Lu]Lu-PSMA-617 : VISION post hoc analysis
ESMO Congress 2023 ; 20 - 24 October 2023, Madrid, Spain,In: Annals of Oncology Jg. 34 (2023) Nr. Supplement 2: Abstract Book of the ESMO Congress 2023, 20 - 24 October 2023, S. S995 - S996Online Volltext: dx.doi.org/ (Open Access) -
A planned, prospective, international, multi-center, open-label, single-arm phase II study investigating the predictive value of [68Ga]GaPentixaFor PET imaging in primary and isolated secondary CNS lymphoma patients
EANM‘22 ; 35th Annual Congress of the European Association of Nuclear Medicine ; October 15-19, 2022, Barcelona, Spain,In: European Journal of Nuclear Medicine and Molecular Imaging Jg. 49 (2022) Nr. Supplement 1, S. S415Online Volltext: dx.doi.org/ (Open Access) -
Comparison of the Safety and Tolerability of Paraaminohippurate (PAH) and Amino Acid (AA) Co-Infusion in Patients with Neuroendocrine Tumours Receiving Peptide Receptor Radionuclide Therapy (PRRT) : A Case Series of Eight Patients
EANM‘22 ; 35th Annual Congress of the European Association of Nuclear Medicine October ; 15-19, 2022 Barcelona, Spain,In: European Journal of Nuclear Medicine and Molecular Imaging Jg. 49 (2022) Nr. Supplement 1, S. S579Online Volltext: dx.doi.org/ (Open Access) -
Determination of the Efficiency of Filter Pads in expiratory Filters with 99mTc-labelled Graphite Eerosol
62. Kongress der Deutschen Gesellschaft für Pneumologie und Beatmungsmedizin e. V.; 25.–28.05.2022; Leipzig,In: Pneumologie Jg. 76 (2022) Nr. Supplement 1, S. S68Online Volltext: dx.doi.org/ -
Expiratory filter sets substantially reduce exhaled small bioaerosol particles and potential COVID-19 virus load
EANM‘22 ; 35th Annual Congress of the European Association of Nuclear Medicine ; October 15-19, 2022, Barcelona, Spain,In: European Journal of Nuclear Medicine and Molecular Imaging Jg. 49 (2022) Nr. Supplement 1, S. S318Online Volltext: dx.doi.org/ (Open Access) -
Immuntherapie eines Mikrosatelliten-instabilen metastasierten Talgdrüsenkarzinoms der Glandula submandibularis mit Pembrolizumab
Jahrestagung der Deutschen, Österreichischen und Schweizerischen Gesellschaften für Hämatologie und Medizinische Onkologie, 7.–10. Oktober 2022, Wien, Austria,In: Oncology Research and Treatment Jg. 45 (2022) Nr. Supplement 2, S. 230 - 231Online Volltext: dx.doi.org/ (Open Access) -
Lesion Quantification Accuracy of Digital 90Y PET Imaging in the Context of Dosimetry in Systemic FAPI Radionuclide Therapy
EANM‘22 ; 35th Annual Congress of the European Association of Nuclear Medicine ; October 15-19, 2022, Barcelona, Spain,In: European Journal of Nuclear Medicine and Molecular Imaging Jg. 49 (2022) Nr. Supplement 1, S. S636Online Volltext: dx.doi.org/ (Open Access) -
LiMAx faciliates patient selection prior radioembolization for patients with hepatocellular carcinoma in liver cirrhosis
The International Liver Congress 2022 ; 22-26 June 2022, London, UK,In: Journal of Hepatology Jg. 77 (2022) Nr. Supplement 1: Abstracts of The International Liver CongressTM 2022, S. S378 - S379Online Volltext: dx.doi.org/ (Open Access)